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ABBREVIATIONS
A-P - anterior to posterior
BMP - bone morphogenetic protein
bp- base pairs
ca - carotid artery
cb - cerebellum
cc - cerebral cortex
CNS - central nervous system
DMSO - dimethyl sulphoxide
DNA - deoxyribonucleic acid
dt - dorsal thalamus
E - embryonic age (E0.5 is defined here as the day of discovering vaginal plug)
e - eye
EB - embryoid body
ES - embryonic stem cell
FACS - fluorescence activated cell sorting
FCS - foetal calf serum
FGF - fibroblast growth factor
GFP - green fluorescent protein
ht - hypothalamus
ic- internal capsule (of the ventral forebrain)
iz - intermediate zone (of the cerebral cortex)
kb - kilobase pairs
LIF - leukaemia inhibitory factor
MTOC - microtubule organising centre
P - postnatal age (day of birth is PO)
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RA - retinoic acid
Sey - small eye (null) mutant allele ofPax6
shh - sonic hedgehog
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In the mature mammalian brain the thalamus relays sensory information from the
periphery to the cerebral cortex via the thalamocortical axon tract. In the mouse, the
thalamocortical tract is generated during embryogenesis as axons projecting from the
dorsal thalamus navigate through the ventral thalamus and ventral telencephalon to
reach the cerebral cortex where they form and refine connections with layer IV neurons
during subsequent development. The mechanisms by which axons navigate the complex
geometry of this route are largely unknown.
Studies of mutant mice whose thalamocortical tract is disrupted illustrate that
genes involved in programming thalamocortical tract navigation are required by
projecting cells of the dorsal thalamus and along its route to supply axon navigation
cues. Small-eye homozygotes (Pax6Sey/Sey) in which the transcription factor Pax6 is
inactivated exhibit a range of defects throughout the developing central nervous system,
including a failure in thalamocortical tract formation, and die at birth. The Pax6Sey/Sey
phenotype describes disruption of both the dorsal thalamus and the tissues through
which the thalamocortical tract navigates so does not reveal whether axons projected by
the dorsal thalamus fail to navigate due to intrinsic mis-programming or due to a lack of
important navigational cues along the route. To test the hypothesis that Pax6 is required
within the dorsal thalamus for tract projection I developed a novel in vitro assay for
thalamic axon navigation and cell surface properties.
First I generated lines of embryonic stem (ES) cells which ubiquitously express a
tau tagged green fluorescent protein (tau-GFP) transgene. Germline transmission of ES
lines produced two lines of transgenic mice designated TgTP6.3 and TgTP6.4. I show
that the tau-GFP transgene is ubiquitously expressed in developing TgTP6.3 brain and
that tau tagging anchors tau-GFP to the microtubule component of the cytoskeleton
resulting in clear fluorescent marking of subcellular structures, including axons and the
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mitotic machinery. The experimental potential of the TgTP6.3 mice is demonstrated in
several cell mixing paradigms, including mouse chimeras and brain cell and tissue
culture systems, where tau-GFP cells and axons can easily be detected against a
background of unlabeled cells and tissues. The TgTP6.4 line exhibits very low levels of
tau-GFP expression in the developing brain so is unsuitable for these experiments.
I next used a novel in vitro assay to show that tau-GFP:Pax6+/+ dorsal thalamic
axons are able to navigate through unlabelled Pax6+/+ ventral telencephalon whereas
tau-GFP:Pax6Sey/Sey axons are not. Seeding experiments show that tau-GFP:Pax6+/+
dorsal thalamic cells adhere to slices of Pax6+/+ ventral telencephalon at the point of
thalamocortical tract entry (the internal capsule) whereas tau-GFP:Pax6Sey/Sey cells do
not. I conclude that Pax6 is required autonomously within the dorsal thalamus to
program successful axon navigation through the ventral telencephalon, presumably by
controlling the transcription of genes which directly or indirectly modulate adhesive




The mammalian brain forms from a morphologically undifferentiated sheet of
cells (the neural plate) during embryogenesis. The anatomical changes in the developing
embryonic brain are shown in Fig. 1.1 A. The development of the mature brain from the
neural plate is moulded by processes of cell division, cell death, cell migration, cell-cell
interaction, and the formation of connections between cells over long distances. The
brain is then able to receive and interpret information from the periphery, and to refine
its connections and structure in the light of experience.
Much study has gone into attempting to understand the mechanisms of brain
development and recent advances in genetics have provided a clearer understanding of
how genes control many of the processes involved.
The thalamocortical tract
The thalamus can be thought of as a 'relay station' for sensory information from
the periphery (sight, touch, taste, smell, and hearing) passing through the thalamus en
route to the cerebral cortex for processing and interpretation. This information pathway
consists of axons, bundled together into fibre tracts, which connect different regions of
the brain and transmit information in the form of nerve impulses which travel along
axons from cell to cell.
The spatial organisation of sensory information is precisely maintained as it
passes from the thalamus to the cortex. The layout of the cortex reflects its functions.
Mapping which regions of the cortex respond to stimulation of areas of the body surface
reveals that the body surface is 'represented' on the surface of the cortex
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Figure 1.1
(A) Anatomy of brain development spanning the period of thalamocortical tract
formation. Diagrams of developing mouse brain (rostral to left) at ages E9, E10, E12,
and El4.5 showing the locations of major anatomical structures in sagittal section.
Figure adapted from Altman and Bayer, (1995). (B) Topographical organisation of
information is precisely maintained as it passes from the whisker pad on the face to
the brain stem, thalamus and cerebral cortex. Figure adapted from Kandel et ah,
(2000). (C) Diagram of a mouse brain to show various cortical sensory areas
determined by evoked potential techniques. Note that the body surface is precisely
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(Woolsey and Van Der Loos, 1970 and Fig. 1.1C).
In the somatosensory system the pattern of whiskers on the rodent snout is
precisely mapped onto the 'barrel fields' in the somatosensory cortex. This process
involves the precise topographic organisation of axon projection from the whisker pad to
the brainstem, brainstem to thalamus, and thalamus to cerebral cortex (for example
Vanderhaeghen et al., 2000) as depicted in Fig. 1.1B. The identification of
thalamocortical tract defects in animals carrying mutations in certain genes (see below)
shows that genetic control is required for certain aspects of thalamocortical tract
formation. This mapping is also dependent on experience since ablation of a whisker
results in loss of the corresponding barrel in the cortex (Van der Loos and Woolsey,
1973). The formation of connections between cortex and thalamus therefore has a
genetic component and an experience based component. Broadly, the establishment of
the tract is genetically programmed but its refinement relies on sensory input. This
thesis concentrates on the early aspects of thalamocortical tract projection which are
primarily under genetic rather than epigenetic control.
Development of the thalamocortical tract
In the mouse, axons exit the dorsal thalamus at El2.5 and grow through the
ventral thalamus. They make a sharp lateral turn at the hypothalamus and enter the
ventral telencephalon through the internal capsule as illustrated in Fig 1.2A (Braisted et
al., 1999, Tuttle et al., 1999, Auladell et al., 2000). The thalamic axons then grow into
the cerebral cortex where they form synapses with layer 4 neurons. The basic
thalamocortical circuitry is complete at this point. This timetable is illustrated in Fig.
1,2B but note that tract navigation is in reality more complex in space (as the tract
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Figure 1.2
Thalamocortical tract formation during mouse embryogenesis. (A) Diagram showing
the location of the thalamocortical tract in an E14.5 embryo (left panels) and the
trajectory of the thalamocortical tract (red arrow on coronal tracing in right panel).
Some images taken from Kaufman, (1995) and Altman and Bayer, (1995). The
internal capsule is marked *. (B) The timetable of thalamocortical tract formation.
Dorsal thalamus neurogenesis and key events in thalamocortical tract formation are
related to embryonic age. (C) Mechanisms by which genetic control is exerted on
thalamic axons navigating the thalamocortical route. 'Autonomous' implies that a
particular gene is required only within the dorsal thalamus for axon navigation.
'Non-autonomous' implies that a particular gene is required only by cells along the
pathway of the tract for thalamocortical axon navigation. 'Autonomous and non-
autonomous' implies that a particular gene is required both within the dorsal
thalamus and in cells along the pathway of the tract for axon navigation. The gene
may have different functions within different cells. The blue arrows indicate whether
the genetic instructions defining growth cone behaviour originate from the dorsal




























describes a three dimensional geometry) and time (as all thalamic axons do not navigate
synchronously).
Autonomous and non-autonomous genetic control of axon navigation
How is genetic control of this complex journey achieved? There are several
formal possibilities that are not mutually exclusive. These are depicted in figure 1.2C.
1. 'Autonomous': A particular gene is required within the dorsal thalamus to program
axon navigation. If this gene is inactivated, thalamic growth cones will be incompetent
to recognise navigation cues that are present along the tract and will become misrouted.
2. 'Non-autonomous': A particular gene is required along the pathway of the tract. If
this gene is inactivated, navigation cues will not be supplied. The otherwise functional
thalamic axon will become misrouted.
3. 'Autonomous and non-autonomous'. A particular gene is required both within the
thalamic cell and along the pathway of the tract. The gene may have different roles in
the different cell types involved. If this gene is inactivated the navigation cues along the
pathway will be missing and the thalamic axon would not be able to recognise them in
any case. The thalamic axon would become misrouted.
Different genes may participate in one or more aspects of thalamocortical tract
formation. For example, genetic control may be required to regulate the proliferation of
cells in one structure or to define the adhesive properties of those in another.
Motives for studying mechanisms of thalamocortical tract formation.
Apart from the intrinsic biological interest of understanding the mechanisms of
tract formation, there are, albeit in the distant future, prospects for the application of this
knowledge in medicine. If damaged brains are to be repaired, it is essential to
understand how tracts form. For example, if a problem is caused by a defect in the tract,
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there is unlikely to be much benefit gained from replacing the projecting structure
without regenerating the tract. Attempts to replace the missing navigation landmarks
may prove successful.
Key experiments in understanding thalamocortical tract formation
Much of the work on thalamocortical tract formation is focused on the
termination of thalamic axons in the cerebral cortex and the formation of appropriate
connections with layer 4 neurons. The focus of this thesis however is the mechanisms by
which thalamic axons navigate to the cortex during embryogenesis. Some key
experiments in understanding this process are listed below. The use of genetic
approaches are discussed in following sections.
Tract labelling studies
1,1 '-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (Dil)
labelling experiments exploit diffusion of the red fluorescent dye Dil along axons. A
crystal of Dil placed in the thalamus will label thalamic axons and allow their trajectory
to be mapped. The technique can be refined using differently coloured dyes such as DiA
(green) in double labelling experiments to label different subpopulations of axons. Dil
experiments in rat (Molnar and Blakemore, 1998) and mouse (Auladell et al., 2000,
Braisted et al., 1999, Tuttle et al., 1999) embryos in which labelling was performed at
various ages has allowed the spatial and temporal route of thalamic axon growth to the
cortex to be mapped. Interestingly, these studies also identified subpopulations of
neurons in the ventral thalamus, hypothalamus, and ventral telencephalon that projected
axons to the dorsal thalamus prompting the idea that thalamic axons might be guided by
interaction with these axons. This idea resembles the 'handshake hypothesis' (Molnar
and Blakemore, 1998) which suggested that corticothalamic axons project to the dorsal
21
thalamus and guide the thalamic axons. This hypothesis has been discredited by the
observation that the thalamocortical and corticothalamic axons do not appear to come
into contact, at least during the early stages of tract formation (Auladell et al., 2000).
This issue remains controversial not least because it is hard to distinguish whether axons
navigate along one another as opposed to both navigating along a common path
simultaneously but independently. Another way of studying the thalamocortical tract is
by immunostaining for molecules expressed on axons. This allows the staining of
particular subpopulations of thalamocortical axons (Vitalis et al., 2000, Kawano et al.,
1999, Vanderhaeghen et al., 2000, Pratt et al., 2000b, Tuttle et al., 1999, Braisted et al.,
2000).
In vitro models of thalamocortical tract formation
Another approach has been to use organotypic culture systems in which thalamic
explants are challenged in vitro with tissues which thalamic axons encounter during
their journey to the cortex (ventral telencephalon, hypothalamus, and cerebral cortex).
The use of such systems shows that thalamic axons are repelled by hypothalamus and
attracted by ventral telencephalon (Braisted et al., 1999, Pratt et al., 2000b). This
process presumably involves secreted factors as the attractive and repulsive behaviours
are seen when the explants were separated in collagen gels (Braisted et al., 1999). The
spatial organisation of these guidance cues is maintained in culture, perhaps anchored to
the cell surface or extracellular matrix, in ventral telencephalic explants as labelled
thalamic axons follow a trajectory within the explant similar to that seen in vivo (Pratt et
al., 2000b). Co-cultures of thalamic explants with cortical explants (Molnar and
Blakemore 1991, Molnar and Blakemore 1999, Goetz et al., 1992, Rennie et al., 1994,
Pratt et al., 2000b) also showed that aspects of the in vivo innervation pattern were
recapitulated. These studies show that the thalamic axons do not have to encounter
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intervening tissues in order to respond correctly to tissues along the thalamocortical
pathway.
In vitro models can also be used to test the function of molecules in
thalamocortical tract formation. Netrinl is a secreted protein originally isolated from
chick for its ability to promote spinal cord axon growth (Tessier-Lavigne and Goodman,
1996). Netrinl is expressed in the ventral telencephalon at the time thalamic axons
penetrate so it is a candidate for the chemoattractive activity. However, although Netrinl
has a chemoattractive activity for thalamic axons in vitro, the chemoattractive effect of
the ventral telencephalon for thalamic axons was not abolished by a Netrinl blocking
antibody so Netrinl cannot be solely responsible for this effect (Braisted et ah, 2000).
Seeding experiments in which fluorescently labelled thalamic cells are seeded
onto tissues taken from the thalamocortical tract show that the adhesive properties of
thalamic cells are matched to adhesive properties along the thalamocortical tract.
Thalamic cells adhere selectively to the ventral telencephalon in the region where the
thalamocortical tract penetrates (the internal capsule). Heparin-binding growth
associated molecule (HB-GAM) and N-syndecan are extracellular matrix molecules
expressed along the developing thalamocortical tract and their enzymatic removal
abolishes this adhesion (Kinnunen et ah, 1999). Similar experiments using slices of
cortex (Emerling and Lander, 1994, Emerling and Lander, 1996) showed that the
adhesion pattern and neurite outgrowth of the thalamic cells was reminiscent of the
pattern of thalamic innervation. Thalamic cells adhere selectively to the intermediate
zone rather than to the ventricular zone or cortical plate. This study implicated the
extracellular matrix chondroitin sulphate proteoglycans (CSPGs) in axon navigation as
enzymatic CSPG removal abolished the thalamic cell adhesion pattern (Emerling and
Lander, 1996).
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Genetic control of early brain development and tract formation
Tract formation in the forebrain mainly occurs after its basic functional units
become discernible based on their morphology and patterns of gene expression. Recent
advances in our understanding of the roles of transcription factors and secreted
morphogens in establishing this basic structure are briefly outlined below. There are still
large gaps in our knowledge as to how this original genetic patterning influences the
mature cellular phenotype including cell surface and growth cone properties.
Forebrain
In the forebrain, secreted proteins Sonic Hedgehog (Shh), Bone Morphogenetic
Proteins (BMPs), and Fibroblast Growth Factors (FGFs) modulate the expression of
transcription factors implicated in subsequent development (Lumsden and Krumlauf,
1996). These interactions are suggested by the expression patterns of these genes and
have been characterised in neural plate explants experiments. In vitro, ventrally Shh can
induce expression ofNkx2.1, dorsally BMP7 induces Msxl, and FGF8 can induce either
BF1 (forebrain marker) or En2 (midbrain marker) depending on the anterior-posterior
positioning of the FGF8 source. These secreted proteins induce gradients of
transcription factor expression which sometimes end in a sharp boundary, but no dose
response data was presented (Shimamura et al., 1997). In vitro experiments have
described antagonistic roles for Shh and BMP2 in forebrain cells with Shh promoting
neuronal and oligodendroglial lineages and BMP2 promoting astroglial differentiation
(Zhu et al., 1999). FGFs and Shh signals appear to cooperate in the specification of
dopaminergic and serotonergic cell fate. Shh and FGF8 induce dopaminergic neurons in
the midbrain and forebrain and Shh and FGF4 induce serotonergic neurons in the
hindbrain (Ye et al., 1998). The transcription factor Otx2 is required for controlling
expression of the cell adhesion molecule R-Cadherin and the secreted protein ephrinA2.
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Otx2 mutant cells contribute poorly to the forebrain in Otx2+/+ <H> Otx2~'~ chimeras
demonstrating the direct influence of this transcription factor on cell surface properties
and cell sorting (Rhinn et al., 1999, Nguyen Ba-Charvet et ah, 1998).
Midbrain
Expression gradients are important for tissue determination and axon navigation
in the midbrain (Lumsden & Krumlauf, 1996). The transcription factor Enl is expressed
strongly at the midbrain isthmus (the junction between the mid-brain and the hindbrain)
with expression falling off in a gradient both anteriorly (into the midbrain) and
posteriorly (into the hindbrain). Secreted proteins FGF8 and Wntl, co-operate with Enl
to maintain each other's expression gradients and influence axon navigation by
controlling the expression of cell surface molecules. For example the expression of Eph-
related receptor tyrosine kinases are induced by En-1 and ectopic expression of Enl and
En2 results in misrouting of retinal axons (Friedman and O'Leary, 1996). Members of
this receptor family interact with axon associated ligands (the ephrins) to regulate cell
sorting (Cooke et ah, 2001) and co-ordinate axon navigation (Friedman and O'Leary,
1996, Tessier-Lavigne and Goodman, 1996, Vanderhaeghen et ah, 2000).
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Hindbrain
In the hindbrain and spinal cord, expression of Shh ventrally in the notochord
and the expression of BMPs dorsally set up opposing gradients of Shh and BMP
concentration (Tanabe & Jessell, 1996). These secreted proteins influence the expression
of the transcription factors with Shh repressing Pax6 expression and Pax3, Pax7, and
Nkx2.2 being expressed ventrally (Briscoe et al., 2000, Ericson et ah, 1997). Ultimately
these interactions define the combination of LIM homeobox genes (LIM code)
expressed by motor neurons and the path taken by their axons (Ericson et ah, 1997,
Osumi et ah, 1997).
The prosomeric hypothesis of forebrain development
The regionalisation of the prosencephalic neural plate has been interpreted in
terms of transverse and longitudinal domains of gene expression which relate to
developing anatomical landmarks and functional units. These domains are defined by
expression genes encoding transcription factors including Nkx2.1, Nkx2.2, Dlx2, Gbx2,
Otx2, Nkx2.1, and Pax6 and secreted proteins including Shh and Wnt3. The prosomeric
model proposes that these domains correspond to segmental units of forebrain
development called prosomeres (Puelles and Rubenstein, 1993, Bulfone et ah, 1993,
Rubenstein et ah, 1994, Rubenstein et ah, 1998). The diencephalon comprises
prosomeres 1 to 3 (pi posterior to p3 anterior) with pi corresponding to the pretectum
and epithalamus, p2 to the dorsal thalamus and p3 to the ventral thalamus. The
secondary prosencephalon (p4 to p6) consists of the hypothalamus, ventral
telencephalon, and cerebral cortex (dorsal telencephalon) and the nature of the
segmental organisation is less clear than in the diencephalon. A simplified version of the
prosomeric map at E12.5 showing genes relevant to this study is shown in Fig. 1.4. The
term 'prosomere' is intentionally similar to the term 'rhombomere' used to define
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segmental units in the hindbrain or rhombencephalon (Tanabe and Jessell, 1996,
Lumsden and Krumlauf, 1996) but it is by no means certain that the prosomeres fulfil
the criteria of segmental identity.
For the purpose of this thesis, the prosomeric terminology is useful as it
describes regions of the developing brain involved in thalamocortical tract formation in
terms of gene expression patterns, which can be used to identify these regions. Whether,
as was first thought (Fidgor and Stern, 1993, Shimumura et al., 1995) the boundaries of
regulatory gene expression provide a scaffold for axon tract formation is less certain
(Mastick and Easter, 1996, Nguyen Ba-Charvet et al., 1998). The sections below
describe the emergence of these domains of gene expression and their relationship to the
developing thalamocortical tract.
Regional gene expression defines developing thalamic territories
The prosomeric structure in the mouse becomes recognisable between E8.5 and
E12.5 (Rubenstein et al., 1994, Rubenstein et al., 1998, illustrated in Fig 1.4A) and the
first thalamocortical axons exit the dorsal thalamus at E12.5. The boundary between p2
(dorsal thalamus) and p3 (ventral thalamus) corresponds to the zona limitans
intrathalamica (zli). Shh is expressed in the zli flanked by expression of the transcription
factors Nkx2.2 and Otx2 (Pratt et al, 2000b, Nguyen Ba-Charvet et al, 1998).
Prosomeres p2 and p3 can be identified by their expression of Wnt3, Pax6, and Dlx2.
Wnt3 is expressed in p2 with a sharp ventral border of expression at the zli. Pax6 and
Dlx2 are expressed in p3 with a sharp dorsal border of expression at the zli and this
expression persists for several days (Bulfone et al., 1993, Stoykova et al., 1996, Warren
and Price, 1997). This is an oversimplification as Pax6 is also expressed in the
ventricular zone of the dorsal thalamus but not throughout it as is seen in the ventral
thalamus (Warren and Price, 1997, Stoykova et al., 1996, Vitalis et al., 2000, Fig. 1.4A).
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Segmental nature of the forebrain and thalamocortical tract formation
It has been proposed that forebrain axons use the same gene expression
boundaries used to define the prosomeres as navigation cues (Rubenstein et al., 1994).
This section examines restricted cell mixing and axon navigation (which is a special
case of cell mixing) across those boundaries encountered by the thalamocortical tract.
Thalamocortical axons emanating from dorsal thalamus (p2) cross the p2/p3
boundary (Nguyen Ba-Charvet et al., 1998) and become highly fasiculated as they cross
into the ventral thalamus (p3). This has been interpreted as evidence that the ventral
thalamus is an unfavourable environment for these axons (Tuttle et al. 1999, Braisted et
al, 1999). Short term (2 to 3 days) tracer labelling studies in chick diencephalon showed
that cell mixing is restricted by borders of regulatory gene expression used to define
prosomeres, and that fasiculated axons grow along these borders (Figdor and Stem,
1993). As retrovirally labelled thalamic cell clones allowed to develop for longer
periods (16 days) can contribute to several prosomeres (Golden and Cepko, 1996), these
boundaries are not absolutely respected by all thalamic cells throughout development.
The prosomeres p4, p5, and p6 comprising the hypothalamus and telencephalon
are less defined than pi, p2, and p3 and have been interpreted differently by different
authors (compare Rubenstein et al., 1994 to Vitalis et al., 2000). Borders of gene
expression demarcating domains of the telencephalon and the hypothalamus have been
described which the developing thalamocortical tract encounters as it navigates to the
cerebral cortex. Thalamocortical axons do not cross the border between the ventral
thalamus and the hypothalamus but do grow into the ventral telencephalon. The ventral
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telencephalon and hypothalamus have been shown to be respectively attractive and
repulsive to thalamocortical axons in vitro (Braisted et al., 1999, Pratt et ah, 2000b).
Cell mixing is restricted at the boundary between the ventral (basal ganglia) and
dorsal (cerebral cortex) telencephalon although there is significant migration of cells
across this boundary (Fishell et ah, 1993, Anderson et ah, 1997, Inoue et ah, 2001,
Chapouton et ah, 1999, Gotz et ah, 1996). Thalamocortical axons become densely
packed as they cross this boundary to enter the intermediate zone of the cerebral cortex
(Auladell et ah, 2000, Braisted et al 1999, Molnar and Blakemore, 1998).
If thalamic axons do not use segmental boundaries to navigate to the cerebral
cortex, then how do they navigate this complex route (Molnar and Blakemore, 1995)?
There is growing evidence from several points along the thalamocortical pathway that
the growth cones of thalamic axons respond to gene products which are expressed in
graded domains which bear no obvious relation to the sharp boundaries of gene
expression defining prosomeric structure. Any segmented features described by
prosomeres most likely represent a transient developmental point of restricted cell
mixing corresponding to an evolutionary solution to brain development common to all
vertebrates.
Secreted proteins, their receptors and thalamocortical navigation
Several secreted proteins have been shown to influence axon navigation in
various regions of the brain by interacting with cell surface receptors expressed by axon
projecting cells. The secreted proteins include Netrinl, and members of the semaphorin,
ephrin and slit families. These bind to their respective cell surface receptors DCC,
neogenin, Unc5 (receptors for Netrinl), plexin and neuropillin (receptors for the
semaphorins), Eph receptors (receptors for the ephrins), and Robol and Robo2
(receptors for Slitl and Slit2). To date it has been shown that Netrinl, LAMP, Sema6A,
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and Eph4A mediate aspects of thalamocortical axon growth (Vanderhaeghen et ah,
2000, Mann et ah, 1998, Braisted et al., 2000, Leighton et al., 2001). Other secreted
proteins such as the Slits, semaphorins, and molecules yet to be identified, are likely to
be involved in thalamocortical tract development. The sections below examine
molecules known to have roles in thalamocortical tract development.
Axons in other systems have been shown to respond to gradients of the secreted
protein Netrinl (Tessier-Lavigne and Goodman, 1996) and Netrinl is expressed by cells
along the thalamocortical tract (Braisted et al., 2000). The attractive Netrinl receptor
DCC is expressed in the dorsal thalamus suggesting a mechanism for thalamocortical
axon response to this secreted protein (Braisted et al., 2000). The roles of Netrinl in
thalamocortical tract formation are discussed in more detail elsewhere in this Chapter.
The limbic associated membrane protein (LAMP) has been shown to mediate
thalamocortical tract projection. LAMP is expressed in the limbic cortex and in the
limbic thalamus (but not in the non-limbic cortex or non-limbic thalamus). In vivo
axons project from the limbic thalamus to the limbic cortex and in vitro LAMP is
permissive for limbic axon outgrowth but not for non-limbic axon outgrowth (Mann et
al., 1998).
The secreted ephrin proteins and their Eph receptors are implicated in axon
navigation (Marcus et al., 2000, Tessier-Lavigne and Goodman, 1996). EphrinA5 has
been shown to repel thalamic axons and is expressed in a gradient in the developing
cerebral cortex. Its receptors. EphA3, EphA4, and EphA5 are expressed in the dorsal
thalamus (Mackarehtschian et al., 1999). EphrinA5 protein is expressed as a gradient in
the cerebral cortex and expression of the corresponding Eph receptor, EphA4, is graded
in a matching way in the dorsal thalamic cells, which will project axons to this region.
In vitro these axons are repelled by EphrinA5 and the normal projection pattern of these
thalamic axons on arriving in the cerebral cortex is disrupted in EphrinA5 knockout
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mice (Vanderhaeghen et al., 2000). As the thalamocortical tract reaches the cerebral
cortex in these mutant mice ephrinA5 is not essential for tract projection. The Eph
receptors show promiscuity in ephrin binding and expression of several ligands
(ephrinA5 and ephrinA4) and receptors (EphA3, EphA4, and EphA5) in overlapping
gradients in thalamocortical territory may allow some redundancy. This might
ameliorate the severity of phenotype seen when one of these genes is inactivated
(Mackarehtschian et al., 1999, Vanderhaeghen et al., 2000). Contrary to the repulsive
interaction in the thalamocortical system, an attractive interaction has been reported
between the EphA family receptors and their ligands in the vomeronasal axon system
(Knoll et al., 2001).
In mouse, Slit family proteins are secreted ligands for the Robo receptors.
Analysis of their expression patterns show that they are expressed at positions along the
thalamocortical tract consistent with a role in thalamocortical axon guidance (Nguyen
Ba-Charvet et al., 1999, Yuan et al., 1999, Ringstedt et al., 1999). In other developing
brain systems Robos and Slits play critical roles in axon navigation. Slit2 acts as a
repellent for retinal, olfactory and hippocampal axons and treatment with Slit2 in vitro
collapses their growth cones (Nguyen Ba-Charvet et al., 1999, Erskine et al., 2000).
Slit2 is secreted by the choroid plexus and repels neuronal migration by cortical and
olfactory neurons (Hu, 1999). Retinal ganglion cells express Robo2 at the time their
axons are navigating through territory expressing Slitl and Slit2 (Erskine et al., 2000).
The semaphorins are secreted proteins implicated in axon navigation (Tessier-
Lavigne and Goodman, 1996). It has recently been shown that Semaphorin6A
(Sema6A) is required for caudal thalamocortical tract projection (Leighton et al., 2001).
Although Sema6A is expressed in several fibre tract systems including the
thalamocortical tract, only the caudal thalamocortical tract is severely disrupted when
Sema6A is mutated (Leighton et al., 2001). Another example of system-specific
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Semaphorin action is seen in cortical neurons. Cortical axons are repelled by
Semaphorin3A (Sema3A) whereas dendrites from the same cortical cell are attracted
towards Sema3A (Polleux et al., 1998, Polleux et ah, 2000). Both axons and dendrites
express the Sema3A receptor Neuropilinl and it is the asymmetric subcellular
distribution of a soluble guanylate cyclase that is responsible for mediating these
opposite cellular responses to the Sema3A/ Neuropilinl interaction (Polleux et ah,
2000). These are clear illustrations that a particular cell surface molecule (Sema3A,
Sema6A, or Neuropilinl) can have different roles in different systems, presumably
reflecting system-specific differences in local genetic and biochemical environment.
Transcription factors regulate expression of cell surface molecules involved in
cell adhesion and axon navigation (see above). In the developing cerebral cortex there
are opposing gradients of transcription factors Pax6 and Emx2 and alterations in these
gradients in Pax6 and Emx2 mutants result in corresponding alterations to the expression
gradients of Cadherins (cell adhesion molecules) and disruption to area specific
thalamocortical projections (Bishop et ah, 2000). In the ventral thalamus gradients of
Pax6 and RPTP5 (a transmembrane phosphotyrosine phosphatase) are formed and their
disruption coincides with thalamic axons failing to navigate these territories (Tuttle et
ah, 1999).
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Mutants illustrate genetic control of thalamocortical tract formation.
The study of mutant animals in which thalamocortical tract formation is
disrupted has provided several important insights into the genetic control of this process.
Much of this work has been carried out in mice due to their amenability to
genetic manipulation. The sections below describe mutant animals which illustrate that
thalamocortical axon navigation requires autonomous genetic input in the dorsal
thalamus (Gbx2) and non-autonomous input along the thalamocortical pathway (Mashl)
as illustrated in Fig. 1.3.
Gbx2 is required within the dorsal thalamus only
Gbx2 is a homeobox containing transcription factor, which is expressed by cells
of the developing dorsal thalamus. The Gbx2 gene is not expressed in other domains of
the thalamocortical axon tract. In mice lacking Gbx2 gene function, the dorsal thalamus
differentiates abnormally and analysis of regional markers Id.4 and Lefl suggests that
normal dorsal thalamic post-mitotic cells are not produced in the absence of Gbx2
function (Miyashita-Lin et al., 1999). Dil labelling experiments show that the
thalamocortical tract does not form in the Gbx2 mutants and that thalamic axons stop in
the internal capsule. These findings are confirmed by immunostaining for serotonin and
calretinin which specifically label subsets of thalamic axons. Since Gbx2 is expressed in
the dorsal thalamus itself but not along the thalamocortical pathway, this study shows
that Gbx2 is an example of a gene whose function is required only within the dorsal




Mouse mutants illustrating genetic control of thalamocortical tract formation. A
tracing of a coronal section of E14.5 brain is shown with the dorsal thalamus,
ventral thalamus, hypothalamus, ventral telencephalon, and cerebral cortex
marked in the left panel in (A). Blue Xs in the left half mark the position of wild-
type gene expression in (B to D). Red arrow in the right half indicates the
trajectory of the thalamocortical tract in (A) the wild-type and (B,C,D) the mutant.
Red X indicates tract termination. (B) in Gbx2 mutants the tract becomes stalled as
it leaves the thalamus. The transcription factor Gbx2 is expressed only in the
dorsal thalamus. (C) in Mashl mutants the tract becomes stalled within the
thalamus. The transcription factor Mashl is expressed in the ventral thalamus,
hypothalamus, and ventral telencephalon (but not in the dorsal thalamus). (D) in
Netrinl mutants a reduced tract (indicated by thin red arrow) reaches the cerebral
cortex. The secreted protein Netrinl is expressed in the dorsal thalamus and along






Mashl is required along the thalamocortical tract only
Mashl a basic helix-loop-helix transcription factor which is highly expressed in
the proliferative zones of the forebrain that give rise to the domains along the
thalamocortical tract. Mashl is a mammalian homologue of the Drosophila achaete-
scute complex genes which are involved in neuroblast specification. During
embryogenesis Mashl is expressed in the ventricular zone of the ventral thalamus,
hypothalamus, zona limitans intrathalamica, and the lateral, medial, and caudal
ganglionic eminencies of the ventral telencephalon. Mashl is not expressed in the dorsal
thalamus itself. Dil labelling experiments showed that the thalamic axons projecting
from the Mashl mutant dorsal thalamus fail to reach the cerebral cortex with many
becoming stalled in the ventral thalamus and the remaining axons becoming stalled in
the ventral telencephalon (see Fig. 1.3C). The failure of tract formation in mutants
coincided with the disappearance of Mashl expressing cell domains in the thalamus and
ventral telencephalon which project to the dorsal thalamus in the wild type during tract
formation (these cells were retrogradely labelled after Dil placement in the dorsal
thalamus). The loss of Mashl also resulted in alterations in the expression patterns of
genes implicated in axon pathfmding including a steepening of the gradient of RPTP5
expression in the ventral thalamus and loss of Netrinl in populations of cells in the
ventral telencephalon. These observations prompt the speculation that the
thalamocortical tract is guided by the axons of cells along the thalamocortical tract
projecting back into the dorsal thalamus and by gradients of cell surface and secreted
molecules such as RPTP8 and Netrinl. Mashl is required to regulate the paving of this
pathway for thalamic axons to navigate along (Tuttle et ah, 1999).
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Netrin 1 is required along the thalamocortical tract
Netrinl is a secreted protein which has been implicated in axon guidance and
shown to be chemoattractive for some axons and chemorepellent for others (Tessier-
Lavigne and Goodman, 1996). These dual roles are thought to be mediated by different
axon cell surface receptors for Netrinl with DCC and neogenin mediating attractant
effects and unc5h2 and unc5h3 mediating repulsive effects. Netrin-1 is expressed in the
dorsal thalamus itself and in close association with the thalamocortical tract as it passes
through the internal capsule and into the ventral telencephalon. Netrinl has been
disrupted in transgenic mice, these mice do not have a total loss of Netrinl function
(Serafini et ah, 1996) and the thalamocortical phenotype in these animals is variable. In
any case, disruption of Netrin-1 function does appear to correlate with a defect in
thalamocortical tract formation and this fits nicely with the notion that Netrin-1
expressing cells guide DCC and neogenin expressing thalamic axons along sections of
the thalamocortical route. This model does not explain why many axons do successfully
navigate to the cerebral cortex in these mutant animals. This observation, taken together
with the failure of blocking Netrinl in vitro to abolish the attraction of thalamic axons
for internal capsule, suggests that Netrinl is not the only molecule involved and may be
at least partially redundant (Braisted et al. 2000). It would be interesting to know the
thalamocortical phenotype in animals lacking DCC and neogenin function (Deiner et ah,
1999). As Netrinl is expressed in the dorsal thalamus and along the thalamocortical tract
it is not possible to determine whether the defect reflects a requirement for Netrinl in
the dorsal thalamus (source defect) or along the tract (pathway defect) based on its
expression pattern and analysis of mutant animals. This type of situation is also
encountered in Pax6 mutants (see below). Tissue culture experiments described above in
which Netrinl activity was blocked using antibodies (Braisted et ah, 2000) were
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interpreted as evidence for a pathway defect but did not test the capacity of Netrinl
mutant dorsal thalamus to project a tract into a wild-type tract environment.
Pax6 is a transcription factor with many developmental roles
Pax6 is a transcription factor containing a paired DNA binding domain and a
homeobox DNA binding domain (Walther & Gruss, 1991, Hill et al., 1991). Pax6 is
widely expressed throughout the central nervous system during development and
expression persists into adulthood in some cells. Pax6 is also expressed in the pancreas
(Stoykova et al 1996, Stoykova et al., 1997, Warren and Price 1997, Grindley et al.,
1997, Mansouri et al., 1994). Mutant mice lacking functional Pax6 exhibit a wide range
of defects from early in development and die at birth. Defects in homozygous mutant
embryos (Pax6~/~) have been detected in all Pax6 expressing structures examined to date
arguing that Pax6 plays a fundamental role in the development of these diverse
structures in the wild-type, some of which are listed below.
Pax6 and the eye
Pax6 is expressed in several eye tissues throughout development. Mutants
lacking functional Pax6 fail to develop eyes. Ectopic expression of Pax6 in Drosophila
(Haider et al., 1995) and Xenopus (Chow et al., 1999) has been shown to induce eye
formation, suggesting that Pax6 can orchestrate the genetic program required for eye
formation. Pax6 has been shown to directly regulate the transcription of many genes
involved in eye formation by binding to their promoters. The downstream target genes
identified to date include transcription factors Pax6 and Pax2, and structural proteins
aB-, aA , /3B1-, J3- ,5- , and £-crystallins (Duncan et al., 1998, Richardson et al., 1995,
Cvekl et al., 1995, Schwarz et al., 2000). Pax6 appears to be able to positively
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Figure 1.4
Pax6 and thalamocortical tract formation. (A) (top panel) Mapping of the
expression pattern of transcription factors Pax6 (red) and Dlxl (yellow) at E12.5
on the prosomeric model of Puelles and Rubenstein (1993). (lower panels)
Mapping of the expression pattern of Pax6 (red) and Dlxl (yellow) onto coronal
sections of Pax6+/+ (middle panel) and Pax6Sey/Sey (bottom panel) at E12.5, E14.5,
and El 8.5 during the period of thalamocortical tract formation. Figure adapted
from Stoykova et ah, 1996. Abbreviations: AA, Amydala; ACX, Archicortex, AD,
Hypothalamic nucleus, anterodorsal; AEP, Anterior entopeduncular area; AH,
Anterior hypothalamus; CGE, Caudal ganglionic eminence; DB, Diagonal band;
DT, Dorsal thalamus; EMT, Eminentia thalami; EP, Entopeduncular nucleus; ET,
Epithalamus; HCC, Hypothalamic cell cord; HT, hypothalamus; LGE, Lateral
ganglionic eminence; LV, Lateral ventricle; M, Mesencephalon; MGE, Medial
ganglionic eminence; NCX, Neocortex; OB, Olfactory bulb; PI to P6, Prosomeres
1 to 6; POA, Anterior preoptic area; POP, Posterior preoptic area; PT, Pretectum;
rl to r7, Rhombomeres 1 to 7; SE, Septum; SCH, Suprachiasmatic area; SPV,
Supraoptic/paraventricular area; STM, Stria medullaris; VLG, Ventral lateral
geniculate body; VT, Ventral thalamus; ZI, Zona incerta; 3V, Third ventricle.
(B) Thalamocortical axon trajectory (brown) and Pax6 protein expression (green)
in camera lucida drawings of serial sections (rostral-most at front) taken from El 6
rat embryos (equivalent to mouse E14.5). Left panel shows Pax6+/+ embryonic
brain, right panel shows Pax6rSey/rSey embryonic brain (which does not express Pax6
protein). In the mutant, thalamocortical axons become stalled in the ventral
telencephalon forming a characteristic mushroom shaped structure rostrally. This
figure was taken from Kawano et ah, 1999. (C) Comparison of the timetables of
thalamocortical tract projection (left) and Pax6 gene expression (right) in tissues
neighbouring the thalamocortical tract at mouse embryonic ages shown in the
middle. Black arrows on the right indicate that Pax6 is expressed within a
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regulate expression of some genes (Pax6, aB- , ccA- , J3- , S- , and £-crystallins) and
negatively regulate the transcription of others (Pax2, j3Bl-crystallin).
Examination of mouse. Pax6+/+ Pax6'' chimeras has shown that Pax6 is
required in the optic vesicle for maintenance of contact with the overlying lens
epithelium, a necessary event in eye formation, and a clue that Pax6 may be involved in
defining the adhesive properties of these cells. Pax6 appears to act in a cell autonomous
manner in these aspects of eye development (Collinson et al., 2000, Quinn et al., 1996).
The dosage of Pax6 expression also appears to be important (Schedl et al., 1996) as
increasing Pax6 gene dosage in the eye results in aberrant eye development although
unlike Pax6'A animals these mice are viable beyond birth.
Pax6 and the thalamus
Pax6 is expressed in the proliferating ventricular neuroepithelium of the
thalamus. Mutants lacking functional Pax6 do produce a dorsal thalamus (prosomere p2)
and ventral thalamus (prosomere p3) as judged by anatomical features and Pax6, Dlx2
and Wnt3a expression (Warren & Price 1997, Grindley et al., 1997, Stoykova et al,
1996, Pratt et al., 2000b, Fig. 1.4A). Thalamic morphology is severely disrupted
however and axons projecting from the dorsal thalamus fail to reach the cortex (Warren
and Price, 1997, Kawano et al., 1999, Vitalis et al., 2000, Pratt et al., 2000b, Fig. 1.4B).
The rates of thalamic cell proliferation are abnormally low, and this may explain the
reduced size of the mutant thalamus during subsequent development (Warren and Price,
1997).
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Pax6 and the cerebral cortex
Pax6 is expressed mainly in the proliferative ventricular zone of the cerebral
cortex. Mutants lacking functional Pax6 do develop a cerebral cortex but its morphology
is severely disrupted (Stoykova et ah, 1996, Schmahl et al., 1993, Caric et al., 1997,
Warren et al., 1999). Pax6 is expressed in radial glial cells and radial glial morphology
and tenascin-C gene expression is altered in developing Pax6 mutant cortex. Pax6 acts
through both cell autonomous and non-autonomous mechanisms in influencing glial cell
morphology and glial cell number respectively (Gotz et al., 1998). The adhesive
properties of cortical cells are also altered in Pax6 mutants. An in vitro segregation
assay shows that the segregation (failure to mix) seen between cortical and striatal cells
from wild type embryos (Gotz et al., 1996) was lost when cortical and striatal cells from
mutants were mixed (Stoykova et al., 1997). Mutant and wild type cortical cells also
appeared to segregate from one another in this in vitro assay. This alteration in adhesive
properties may reflect a loss of R-Cadherin observed in the mutant cortex (Stoykova et
al., 1997). Comparisons between the expression patterns of several genes including
transcription factors Dlxl, Ngnl, Ngn2, Mashl, Emx2 and cell surface molecules TrkB,
R-Cadherin, tenascin-C certainly show differences which can be attributed to the loss of
Pax6 function (Warren et al., 1999, Gotz et al., 1998, Stoykova et al., 1997, Bishop et
al., 2000, Toresson et al., 2000) but it is not certain which if any of these genes are
directly under Pax6 transcriptional control. Pax6 mutant cortical cells also exhibit
increased rates of proliferation and disrupted interkinetic nuclear movement during cell
division in the ventricular zone (Gotz et al., 1998, Warren et al., 1999). Cortical cells
show defective migration from the ventricular zone to the cortical plate in Pax6 mutants
(Caric et al., 1997). The migratory defect appears to require non-cell autonomous Pax6
function as mutant cells transplanted into a wild-type cortex migrate to their normal
positions (Caric et al., 1997) although the mutant cells do not mix with cells in the wild
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type cortex and aggregate into clumps (David J. Price, unpublished observation) arguing
that Pax6 also has cell autonomous roles. As cortical neurons migrate along radial glia,
which are themselves disrupted in the Pax6 mutant (Gotz et ah, 1998), it is possible that
these transplant experiments highlight a separation of the roles of Pax6 in neuronal and
glial development.
Pax6 and the cerebellum
Pax6 is strongly expressed in the rhombic hp of the cerebellar system and in
cells migrating away from it. In Pax6 mutants, some precerebellar nuclei fail to form
and migratory streams from the precerebellar neuroepithelium are absent. There are no
proliferative defects in the cerebellar granule cell population. In vitro assays show that
cerebellar explants from wild-type embryos form long neurites along which cells from
the explant migrate but comparable explants isolated from Pax6 mutants do not
(Engelkamp et al., 1999).
Pax6 and the hindbrain
Pax6 is expressed in the ventral part of the developing spinal cord in
undifferentiated motor neuron progenitor cells destined to form the hypoglossal nucleus
which projects the hypoglossal motor nerve to the periphery. Other motor neuron
progenitors contribute to other nuclei including the vagal nucleus. In Pax6 mutants, the
hypoglossal motor nerve is missing but the number of motor neuron progenitors is not
reduced. This implies that Pax6 is required to program the projection pattern of these
motor neurons (Osumi et al., 1997, Ericson et al., 1997). Further experiments have
investigated the molecules involved in the specification of motor neuron subtype by
Pax6. The secreted protein Sonic Hedgehog (Shh) is a key regulator of brain and spinal
cord development and mutants lacking Shh fail to develop a brain (Chiang et al., 1996).
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In vivo Pax6 and Shh are expressed in complementary dorsal to ventral gradients (Pax6
levels are high dorsally and Shh levels are high ventrally). Exogenously applied Shh
represses Pax6 expression in vitro in a dose dependent manner and immunodepletion of
Shh in explant cultures results in an increase in the number of Pax6 expressing cells
(Ericson et al., 1997). Different motor neurons express characteristic combinations of
LIM homeodomain proteins (the LIM code). Hypoglossal motor neurons express Isll,
Isl2, Gsh4, and Lim3 whereas vagal motor neurons express only Isll and Gsh4. In Pax6
mutants, Lim3 and Isl2 are not expressed in cells which would normally express Pax6
indicating a transition from a 'hypoglossal LIM code' to a 'vagal LIM code'(Ericson et
al., 1997). The transcription factor Nkx2.2 is not expressed in Pax6 expressing motor
neuron progenitors (Ericson et al., 1997) and the expression domain of the secreted
protein Wnt7b overlaps with that of Pax6 (Osumi et al., 1997). Another Wnt gene,
Wnt7a, has been shown to induce axon remodelling (Lucas & Salinas, 1997, Hall et al.,
2000). Loss of Pax6 function results in an increase in the number of motor neuron
progenitor cells expressing Nkx2.2 (Ericson et al., 1997) and a loss of Wnt7b expression
in these cells (Osumi et al., 1997). A model emerges in which Pax6 interprets the
gradient of Shh signalling and transduces this signal by regulating the expression of
several transcription factors and at least one secreted protein (Ericson et al., 1997,
Osumi et al., 1997). How this signalling cascade influences axon navigation is yet to be
determined.
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Pax6 and the pancreas
Pax6 is expressed in the developing pancreas. In Pax6 mutants pancreatic
morphology is abnormal, numbers of all four types of endocrine cells in the pancreas (a,
P, 5, and PP cells) are decreased, and production of the hormones glucagon, insulin, and
somatostatin (particularly glucagon) are reduced (Sander et al., 1997). The reduction in
hormone production is greater than can be accounted for by the reduced number of
hormone secreting cells implying that Pax6 is required both for the generation of
pancreatic cells and for the induction of hormone production. In vitro studies showed
that Pax6 protein binds to DNA sequence elements in the promoters of glucagon,
insulin, and somatostatin and that Pax6 can activate transcription from the glucagon and
insulin promoters (Sander et al., 1997). Interestingly, a slightly different pancreatic
phenotype was reported in a line of mice in which a null allele of Pax6 had been
generated by gene targeting (St-Onge et al., 1997). In this line it appeared that no a-cells
were generated leading to the suggestion that Pax6 was specifically required for their
specification although it was subsequently revealed that insulin levels were also reduced
(see Sander et al., 1997 for a full discussion of this discrepancy). Methodological
differences between these two studies make it hard to see whether there is a fundamental
conflict between the pancreatic phenotypes which both describe loss of cells and
reduction in hormone production.
Extrapolating the role of Pax6 from other systems
As described above, the roles of Pax6 have been studied in a range of developing
systems other than the thalamocortical tract which is the main focus of this thesis. These
studies do not however reveal a unified picture of Pax6 function. For example loss of
Pax6 results in reduced proliferation in the thalamus and increased proliferation in the
cerebral cortex, while having no effect on proliferation in the cerebellum or spinal cord.
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That a human Pax6 protein can orchestrate eye development in the leg of a fruitfly
(Haider et ah, 1995) or toad (Chow et ah, 1999) provides a clear demonstration of a
gene specifying a structure but does not explain why a pancreas or thalamus does not
emerge along with the ectopic eye. In this context it is useful to remember that a gene is
not a protein. The level timing and position of protein expression are also critical.
Protein function is also dependent on the availability of the various cofactors with which
the protein interacts. The Drosophila transcription factor orthodenticles (Otd) gene has
two mouse homologues, Otxl and Otx2 which are expressed in the developing forebrain.
'Knock-in' experiments in which the Otxl coding sequence was replaced with either
Otx2 or Otd showed a rescue of the Otxl mouse mutant phenotype indicating that the
proteins themselves were equivalent (Acampora et ah, 1999). Similarly Enl and En2
mouse mutants have distinct midbrain phenotypes but En2 under the control of the Enl
gene promoter could rescue the Enl mutant phenotype showing that functionally
equivalent proteins can have different roles in development of the mouse (Hanks et ah,
1995).
This highlights the fundamental difference in the ways different systems exploit
similar genes. As a particular transcription factor can program different phenotypes
depending on the context of its expression, the genetic cascades initiated by these genes
in different species or tissues are certain to have diverged from one another.
Extrapolating the role of Pax6 from other systems to thalamocortical tract formation is
therefore a hazardous undertaking.
44
Untangling potential roles for Pax6 in thalamocortical tract
Because Pax6 is so widely expressed in the central nervous system, it is often
difficult to determine from observation of mutants lacking Pax6 function alone where
the primary defect lies. The scope for both cell autonomous and non cell autonomous
roles for Pax6 in the development of the thalamocortical tract exemplifies this problem.
A comparison of the timetables of Pax6 expression and thalamocortical tract formation
show several points at which Pax6 expressing cells could influence the developing tract
(see Fig. 1.4C). It is conceivable that the failure of tract formation resides in a defective
dorsal thalamus (as seen in Gbx2 mutants) or in a defect in the structures through which
the tract navigates (as seen in Mashl mutants) or both. The situation is analogous to the
discovery of a broken wing and a broken propeller amongst the wreckage of a crashed
aeroplane not establishing which (if either) caused the crash as both were intimately
associated with the aeroplanes' ability to fly and its subsequent destruction.
One way to establish whether Pax6 has an autonomous role in programming
thalamic axons to respond appropriately to navigational cues would be to replace the
route present in the mutant with one from the wild-type. If the mutant dorsal thalamus
still cannot project a tract then this shows a defect within the dorsal thalamus itself. This
experiment requires that thalamic axons can be visualised clearly. Given the importance
of the extracellualar matrix in thalamocortical tract formation (see above), I deemed it
important to see the axons as they navigated through intact tissue. A tractable way to
achieve this is to generate a transgenic mouse ubiquitously expressing a tau tagged
green fluorescent protein (tau-GFP). Tracts projected by dorsal thalamic explants from
tau-GFP embryos would be expected to be clearly visible against a background of
unlabelled tissue (see below).
The sections below discuss the considerations involved in making a transgenic
mouse ubiquitously expressing tau-GFP. The experiment described above was the
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primary motive behind the production of these animals. The decision to generate a
ubiquitously expressing mouse (rather than one expressing solely in the dorsal thalamus)
allows for the use of cells and tissues from this animal with a wide variety of
applications in cell mixing experiments. The decision to exploit germline transmission
via embryonic stem (ES) cells supplies the extra benefit of tau-GFP labelled ES cells.
The need to mark cells
The processes involved in the development of neuronal circuitry are extremely
dynamic. Axons navigate through complex cellular environments and follow complex
trajectories in space and time. Any study of axon behaviour demands that the
experimenter is able to record the events involved in axon extension. In some cases this
can be achieved in vitro by culturing an isolated neuron on a microscope slide and
watching the process form or recording its responses to gradients of applied factors
(Tessier Lavigne and Goodman, 1996) or substrate molecules (Mann et al., 1998,
Braisted et al., 2000, Vanderhaeghen et al., 2000). This approach is generally not
feasible in vitro if the cell of interest is interacting with other cells or tissues which make
identification of the cell of interest difficult and is completely impossible in vivo, at
least for the mammalian brain. In these cases it becomes necessary to mark the cell of
interest in some way so that it and its extensions can be distinguished from the cells and
tissues with which it is interacting.
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Reporter genes
Several genes have been identified which have proved useful as reporter genes.
The two most widely used in transgenic mice are LacZ and GFP.
LacZ
Exploitation of the LacZ gene dates back to the middle of the last century and the
foundation of molecular biology (Judson, 1979). LacZ forms part of the E. coli Lac
Operon and encodes the hydrolytic enzyme P-Galactosidase (LacZ). The active enzyme
functions as a tetramer. Over the years, synthetic substrates for P-Galactosidase have
been developed. The most commonly used is X-gal which is converted to an insoluble
blue precipitate by P-Galactosidase. Cells expressing LacZ can be identified because
they turn blue when incubated with X-gal. More recently, substrates have been
developed which fluoresce when processed by P-Galactosidase and this has permitted
the option of viewing living LacZ expressing cells (although initially marking was not
efficient because the fluorescent product tended to diffuse out of the cell). Increasingly
sophisticated LacZ substrates which can freely diffuse into the cell, but are converted
into fluorescent products which cannot leave the cell, have permitted the staining of
living cells expressing a LacZ transgene. These have provided a means for identifying
LacZ expressing targets for injection of fluorescent dyes (Studer et al., 1996) or for
electrophysiological recordings from single cells (Pettit et al., 1994). The sensitivity of
fluorescent detection of P-Galactosidase using these fluorescent products appears to be
lower than that of detection by the more conventional X-Gal assay (Westerfield et al.,




Green fluorescent protein (GFP) was isolated from the jellyfish Aequorea
victoria. In its natural context GFP is a companion protein to aequorin. GFP converts
the blue light emitted by the chemiluminesent aequorin to the green glow seen in the
intact jellyfish cells. Although it remains unclear exactly what ecological function is
served by bioluminescence, related fluorescent proteins exist in a variety of
coelenterates (jelly fish and corals) where they partner and modulate the emission of
chemiluminescent proteins (Tsien et al., 1998). Importantly, the GFP gene encodes all
the information necessary for the post-translational synthesis of its chromophore, and no
jellyfish-specific proteins are needed. This has been demonstrated by the expression of
GFP as a transgene in other organisms (Chalfie et al, 1994).
GFP protein structure
Wild-type GFP is a 238 amino acid protein with a calculated molecular mass of
26888 Da (Prasher et ah, 1996). The chromophore is a p-hydroxy-
benzylideneimidazolinone formed by oxidative cyclization of the Ser-Tyr-Gly
tripeptide (residues 65, 66, and 67 in the native protein). The crystal structure of GFP
has been solved to atomic resolution (Ormo et ah, 1996, Yang et ah, 1996) and shows
that the GFP folds into an hollow cylinder composed of 11 P-strands through which is
threaded an a-helix bearing the chromophore (Fig. 1.5). Residue 1 at the N terminal end
and residues 230 to 238 at the C-terminal end appear to be disorganised. Deletion
analysis of GFP has shown that residues 2 to 232 are necessary for fluorescence (Dopf
and Horiagon, 1996). A fluorescence spectrum for wild-type GFP is shown in Fig. 1.6A
along with the spectra of the thermostable GFP variant GFP5 (Siemmering et ah, 1996).
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Figure 1.5
Structure of green fluorescent protein. A ribbon model of green fluorescent protein
is shown from two perspectives. Eleven strands of (3-sheet (green arrows,
numbered in red on left) form the walls of a cylinder. Short segments of a-helices
(blue) cap the top and bottom of the 'P-can' and also provide a scaffold for the
fluorophore (yellow ball-and-stick) which is near the geometric centre of the can.
This folding motif, with P-sheet outside and helix inside, represents a new class of
proteins. This figure is taken from Yang et ah, (1996).
Figure 1.6
Spectra of green fluorescent protein and variants. (A) Alterations to GFP sequence
results in altered spectral properties. Excitation (ex) and emission (em) spectra of
wild type GFP and the thermotolerant GFP variant GFP5 generated by the
substitutions VI63A and S175G. The GFP variant MGFP6 used in this study (see
Chapter 2) was generated from GFP5 by additional substitutions I167T to increase
absorption in blue part of spectrum, S65T to enhance the second absorption peak,
and F64L to improve solubility (Zernika-Goetz et al., 1996, 1997). This figure is
adapted from Siemering et al., (1996). (B) Excitation and emission spectra of GFP
spectral variants commercially available from Clontech. This figure was taken




Spectral characteristics of the major classes of green fluorescent proteins (GFPs).
a Substitutions from the primary sequence of GFP are given as the single-letter
code for the amino acid being replaced, its numerical position in the sequence and
the single letter code for its replacement. Phenotypically neutral mutations are
omitted.
b Xexc is the peak of the excitation spectrum (nm). s in parentheses is the
absorbance extinction coefficient (lO^M'cm1). Two numbers separated by a dash
indicate a range of reported values, two numbers on separate lines indicate two
distinct peaks in the excitation spectrum.
c Xem is the peak of the emission spectrum (nm). QY in parentheses is the
fluorescence quantum yield. The product of s and QY gives the overall brightness
of GFP.
dRelative fluorescence intensities for proteins expressed in E. coli at 37°C under
similar conditions. These have been arbitrarily normalised to 100 for the brightest
member of each class and cannot be used to compare classes. This figure is




Mutation" name (QY)< @ 37"C
Class I, wild-type
None or Q80R Wild type 395-397(25-30) 504 (0.79) 6
470-475 (9.5-14)
F99S, M153T, V163A Cycle 3 397 (30) 506 (0.79) 100
475 (6.5-8.5)
Class 2, phenolate anion
S65T 489(52-58) 509-511 (0.64) 12
F64L, S65T EGFP 488(55-57) 507-509 (0.60) 20
F64L, S65T, V163A 488(42) 511 (0.58) 54
S65T, S72A, N149K, Emerald 487 (57.5) 509 (0.68) 100
M153T, I167T
Class 3, neutral phenol
S202F, T203I H9 399 (20) 511 (0.60) 13
T203I, S72A, Y145F H9-40 399 (29) 511 (0.64) 100
Class 4, phenolate anion with stacked rr-electron system (yellow fluorescent proteins)
S65G, S72A, T203F 512(65.5) 522 (0.70) 6
S65G,S72A,T203H 508 (48.5) 518 (0.78) 12
S65G, V68L, Q69K 10CQ69K 516(62) 529(0.71) 50
S72A, T203Y
S65G/V68L, S72A, T203Y IOC 514(83.4) 527 (0.61) 58
S65G, S72A, K79R, Topaz 514(94.5) 527 (0.60) 100
T203Y
Class 5, indole iri chromophore (cyan fluorescent proteins)
Y66W 436 485 —
Y66W, N146I, M153T, W7 434 (23.9) 476 (0.42) 61
VI63A 452 505
F64L, S65T, Y66W, WlBor 434 (32.5) 476 (0.4) 80
N1461, M153T, VI63A ECFP 452 505
S65A, Y66W, S72A, W1C 435 (21.2) 495 (0.39) 100
N146I, M153T, V163A
Class 6, imidazole in chromophore (blue fluorescent proteins)
Y66H BFP 384 (21) 448 (0.24) 18
Y66H, Y145F P4-3 382 (22.3) 446 (0.3) 52
F64L, Y66H, Y145F EBFP 380-383 (26.3-31) 440-447 100
(0.17-0.26)
Class 7, phenyl in chromophore
Y66F 360 442 —
Directed evolution of GFP for use in transgenic mice
Despite its potential as a reporter gene, the wild type GFP protein is unsuitable
as a reporter in transgenic mice. The most extreme problem is the failure of wild-type
GFP to fluoresce at 37°C, although this problem would not arise in its natural context of
a jellyfish living in cooler seas. Mutations in GFP which suppress this thermosensitivity
were isolated by screening a panel of randomly mutagenised GFP variants for ability to
fluoresce at 37°C (Siemering et al., 1996). This improvement in fluorescence was
attributed to the amino acid substitutions Val to Ala at position 163 (V163A) and Ser to
Gly at position 175 (S175G) and resulted in a 35-fold increase in fluorescence at 37°C.
The substitution Phe to Leu at position 64 (F64L) improves the solubility of GFP and
may assist its folding properties (Cormack et al., 1996). Substitutions within the
chromophore itself have been identified which alter the fluorescence properties of GFP.
The substitution Ser to Thr at position 65 (S65T) improves chromophore ionisation and
so enhances fluorescence (Heim and Tsien, 1996). These advantageous mutations have
been combined in the GFP variants mgfp6 and MmGFP (Zericka-Goetz et al., 1996,
Zericka-Goetz et al., 1997) and EGFP (Zhang et al., 1996). A number of these mutations
and their properties are listed in Fig. 1.7.
Spectral variants of GFP
Other mutations have been exploited to alter the excitation and emission spectra
generating different 'colours' of GFP for double labelling and fluorescence resonance
energy transfer (FRET) experiments (Heim and Tsien, 1996). These versions are
marketed by Clontech as the 'Living colours series' and currently include Yellow, Cyan,
and Blue Fluorescent proteins (Fig. 1.6B). The green, cyan, and yellow variants have
been used successfully in transgenic mice (Feng et al., 2000, Hadjantonakis et al., 1998,





variant (Feng et al., 2000). A number of these GFP spectral variants are listed in Fig.
1.7.
Other Fluorescent Proteins
Although spectral variants of GFP have been generated, the green fluorescent
variants exhibit the strongest fluorescence and are the most widely used. This prompted
the search for other fluorescent proteins to increase the palette available for double
labelling experiments. The isolation of fluorescent proteins from nonbioluminescent
Anthozoa species (Matz et al., 1999) on the basis of sequence homology to the
Aequorea victoria GFP offers this potential. The red fluorescent protein DsRed
(originally named drFP583) from the coral Discosoma sp. is responsible for the red
coloration around the coral's oral disc. DsRed adsorbs maximally at 558nm (green) and
emits at 583nm (red) as shown in Fig. 1.6C, and can be detected using an
epifluorescence microscope equipped with a rhodamine filter. The DsRed protein is
predicted to have a similar 11-stranded (3-barrel structure to GFP (Fig. 1.5) and exhibits
similarities at other residues known to be critical for GFP fluorescence including the
chromophore residues Tyr-66 and Gly-67 and some of the important polar residues
contacting the chromophore such as Arg-96 and Glu-222.
Apart form the advantages of being red, DsRed is highly fluorescent and its
fluorescence may be more long lived than that for GFP. However, there are some
features of DsRed which may diminish its usefulness as a reporter molecule. DsRed
appears to take a long time (days) to mature which may be an unacceptable lag in
reporting on gene expression or for use in transient transfection experiments (Matz et al.,
1999, Baird et al., 2000). DsRed also appears to form a tetramer, which may limit its use
as a fusion tag as the tagged protein would also be forced into a tetramer conformation
which might have functional implications (Baird et al., 2000). Trangenic mice
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expressing DsRed have been generated and it was reported that the DsRed did not freely
diffuse throughout the cell (Feng et ah, 2000). It may be that these problems can be
resolved, as has been seen for the original GFP (Heim and Tsien, 1996, Siemmering et
al., 1996), and that these drawbacks can be engineered out of DsRed.
Problems with GFP
Despite its many appealing features, there are several drawbacks to working with
GFP molecules. A major advantage of GFP is that cells can be imaged in real time. The
corresponding drawback is the problem of phototoxicity. During fluorescence imaging,
the cell may be damaged by the light source used to excite the chromophore. This is a
particular problem for ultra-violet excitation and the problem is reduced for GFP excited
at longer, lower energy, wavelengths. The cell may also be damaged by fluorophore-
mediated generation of free radicals. In practice, however, continuous imaging of GFP
fluorescence has been reported in systems as sensitive as the developing mouse embryo
(Zernika-Goetz et al., 1997) which continued to develop despite continuous imaging
using a confocal microscope. GFP expressing morulae developed into normal mice after
observation using a microscope equipped for epifluorescence (Ikawa et al., 1995)
although many eggs did fail to form blastocysts if they were observed for longer than a
few minutes. Technological advances in the sensitivity of epifluorescence and confocal
microscopes may serve to alleviate this problem by reducing the doses of radiation the
cells must be exposed to generate a detectable fluorescent signal.
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Fusion proteins (tagging)
Modifications to the sequence of the reporter protein can be made so as to alter
the properties of the reporter (other than its fluorescence properties as described above).
Expression of LacZ or GFP results in labelling of the cell. The reporter molecule is in
principle free to diffuse throughout the cell. In the case of LacZ, labelling is not uniform
and this is a particular problem for visualisation of cellular processes and axons which
are not efficiently labelled with LacZ. GFP, perhaps because it is a smaller molecule
which functions as a monomer, diffuses throughout the cell more freely than LacZ.
In many cases it is useful to modify GFP so that its subcellular localisation or
other properties can be tailored for a particular experiment. GFP can be fused to an
intact protein, isolated protein domains, or peptide sequences for the dual purposes of
investigating their function and modifying the properties of GFP. If the properties of the
fusion tag are of interest then the reporter component of the fusion protein will report on
these properties. This could also be achieved by immunohistochemistry but this
provides a static view. By fusing to a vital reporter such as GFP the subcellular
localisation and dynamics of the protein can be detected in living cells and its response
to experimental manipulations monitored. This yields time lapse footage which is much
easier to interpret than a series of snap-shots each acquired from a different cell, albeit
grown under equivalent conditions. Since the start of this study, the generation of GFP
fusion proteins has become a standard technique in the study of protein function. Having
characterised the localisation of the fusion protein, presence of the reporter molecule can
be used as a marker for the protein so obviating the need for detection by other means
such as immunohistochemistry.
A concern in using GFP as a fusion tag is that the GFP may disrupt protein
function and provide a misleading account of protein behaviour. This problem is
generally applicable to all fusion tags. Given the globular structure of many proteins in
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which many domains function as semi-autonomous units and the compact globular
structure of GFP itself, the addition of an extra GFP domain may in many cases not have
a great effect. This appears to be the case with many GFP fusion proteins which retain
properties seen in the untagged protein (see below). The more that is known about the
structure and function of a protein, the easier it should be to design a fusion protein in
which the GFP tag does not interfere with functional domains, although this will remain
more of a problem for novel proteins. One way to ameliorate this problem is to compare
the behaviour of several positions of GFP fusion tag, for example N-, C- terminal and
internal fusions. Since different GFP tag positions are unlikely to influence protein
behaviour in the same way, similar behaviour seen for a variety of fusion tags will
suggest that the GFP is not interfering with protein function.
Some GFP fusion proteins
The usefulness of GFP tagging is attested to by the sheer number which have
been generated in the five years since GFP was isolated. It should be remembered that
published work is likely to emphasise 'positive' aspects of GFP as a fusion tag. Failed
GFP fusion proteins may not be reported and it may take longer for 'negative' aspects of
GFP to emerge. The examples below serve to indicate the versatility of GFP as a
reporter molecule and illustrates some considerations when using GFP as a fusion tag.
This list is not intended to be comprehensive.
The stability of GFP is a variable that can be manipulated experimentally.
Proteins containing the proline rich PEST motif domains are known to be targeted for
ubiquitination and degradation by the proteosome. Fusion of such motifs to the carboxyl
terminus of GFP dramatically reduced the half-life of the GFP from 26 hours to between
2 and 6 hours (Li et al., 1998, Corish and Tyler-Smith, 1999). These unstable GFPs
should prove useful as reporters for the cessation of gene expression as once GFP
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synthesis stops they will be cleared from the cell more rapidly than the more stable GFP
versions.
Fusion of GFP to cytoskeletal proteins has allowed new insights into
cytoskeletal dynamics (Olson et ah, 1995, Ludin and Matus, 1998) and this list is
increasing all the time. Fusion of GFP to cytoskeletal proteins allows direct visualisation
of the protein and functional analysis by site directed mutagenesis and deletion mapping
as exemplified for the microtubule associated protein MAP4 (Olson et al., 1995). The
availability of different GFP spectral variants allows for double labelling experiments in
which the interactions between cytoskeletal proteins can be monitored.
GFP tagging has proved generally useful for watching protein trafficking and
secretion (Stephens and Pepperkok, 2001). Fusion of GFP to the y-Subspecies of Protein
Kinase C (y-PKC-GFP) produced a fusion protein which retained kinase activity and
exhibited translocation to the plasma membrane in response to phorbol ester treatment,
K+ depolarisation, NMDA treatment, and mGluRl activation status. This showed that y-
PKC-GFP retained many aspects of its function despite the addition of a GFP tag (Sakai
et al., 1997). Similarly, fusion of GFP to secreted peptides chromogranin B or
neuropeptide Y allowed the dynamics of secretion to be monitored. These fusions
localised correctly to immunohistochemically identified granules within neurites
(although some did appear in unexpected locations) and Ca2+ treatment induced
appropriate secretion of the GFP fusion peptides (Lang et al., 1997) showing that the
GFP tag did not prevent correct processing and export.
A fusion between GFP and the shaker voltage-sensitive K+ channel (GFP-
Shaker) has been shown to provide a genetically encoded optical probe for membrane
voltage. Conformational changes in the shaker molecule associated with changes in the
voltage across the plasma membrane resulted in conformational changes to the GFP
structure resulting in a 5% alteration in fluorescence. This was sufficient to be detectable
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and the authors estimated a 30-fold increase in ease of detection over existing voltage-
sensitive dyes. This report was also interesting because the GFP was not fused as a C- or
N- terminal fusion but was fused internally to the shaker molecule (Siegel and Isacoff,
1997). This approach could potentially be used to detect conformational shifts in a wide
range of proteins although care must be taken to introduce the GFP so that protein
folding and function are maintained and this will require detailed characterisation of the
target molecule.
Transcription factors such as NFkB and members of the Gli gene family are
functionally restricted by intracellular compartmentalisation with translocation to the
nucleus being a prerequisite for transcription control. GFP fusions have allowed the
identification of the nuclear localisation sequences (NLS) required for nuclear
translocation in the Dlx3 gene (Bryan and Morasso, 2000) and several Kruppel gene
family members (Shields and Yang, 1997). This type of fusion is anticipated to be
useful in dissecting the relationship between subcellular localisation, function of
transcription factors, and nuclear dynamics.
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Driving reporter transgene expression in transgenic mice
There are several methodological approaches which can be used to introduce a
reporter transgene into the germline of transgenic mice. The choice of which method to
use depends on the reporter gene expression pattern desired. The section below briefly
summarises the methods available and comments on their applicability to generating a
transgenic mouse in which reporter gene expression is ubiquitous.
Random DNA integration and position effects
The transgene can be introduced as a random integration event. This can be
achieved by microinjection of DNA into a pronucleus of a fertilised mouse egg
(Jaenisch, 1988, Okabe et al., 1997) which is implanted and allowed to develop (Hogan
et ah, 1994) or by introduction into embryonic stem cells by electroporation
(Hadjantonakis et ah, 1998, Pratt et ah, 2000a, Kawamoto et ah, 2000, Hogan et ah,
1994) and the establishment of transgenic lines by germline transmission (Hogan et ah,
1994). In this approach the experimenter has no control of the genomic locus into which
the DNA will integrate. The transgene is therefore subject to position effects (Al-Shawi
et ah, 1990) caused by the influence of genomic sequence at the integration site on
transcription of the transgene. The result of this is that different transgenic lines
generated using the same transgene will exhibit different patterns of transgene
expression.
The spectrum of position effects obtained largely depends on the transgene
construct. This has been exploited in 'enhancer trap' (Korn et ah, 1992) and 'gene trap'
(Forrester et ah, 1996, Takeuchi et ah, 1995, Serafini et ah, 1996, Cecconi et ah, 2000,
Gossler et ah, 1989, Leighton et ah, 2001) experiments where the intention is to use the
cis-acting genomic elements at the integration site to drive expression of a transgene
with minimal cis-acting transcriptional elements of its own. At the other extreme, the
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introduction of large yeast artificial chromosome (YAC) genomic clones comprising
genes with large amounts of their own cis acting elements frequently results in transgene
expression patterns largely free of position effects (Peterson et ah, 1993, Schedl et ah,
1996).
Cell type specific expression accidental and intentional
The majority of transgenic mice which have been generated by random
integration have used relatively compact promoter elements 'designed' to drive a
particular pattern of gene expression. Transgenic mice generated by pronuclear injection
using a neuron specific enolase (NSE) promoter fragment to drive LacZ expression
exhibited LacZ expression which recapitulated the endogenous NSE expression in 2 out
of 7 transgenic lines (Forss-Petter et ah, 1990). In 2 out of 9 lines in which GFP
expression was driven by a glial fibrillary acidic protein (GFAP) promoter, GFP
recapitulated GFAP expression (Zhuo et al., 1997). In some cases unexpected but useful
expression patterns are obtained by position effects. The HZ1 line in which
somatosensory cortical barrels express LacZ (Cohen-Tandoui, 1994), a panel of
transgenic lines in which GFP spectral variants are expressed in different subsets of cells
in different lines despite the use of the same basic construct in all cases (Feng et ah,
2000). A recent gene trap screen has generated transgenic lines in which placental
alkaline phosphatase (PLAP) labels subpopulations of axons including those of the
thalamocortical tract (Sema6A gene trap) and cortical barrels (LST16 gene trap)
(Leighton et ah, 2001). A drawback of this approach is that large numbers of transgenic
lines often have to be screened in a to find one suitable for a particular experiment.
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Ubiquitous expression accidental and intentional
For some experiments, the aim is to drive expression of the reporter in all the
cells in an animal. The CAG promoter combines the cytomegalovirus immediate early
enhancer and P-actin promoter and first intron (Niwa et ah, 1991) and has been used
successfully to drive apparently ubiquitous reporter gene expression including GFP
(Hadjanonakis et ah, 1998, Kawamoto et ah, 2000, Pratt et ah, 2000a). The CAG
promoter is not immune from position effects and lines in which transgene expression is
clearly not ubiquitous are also obtained using this promoter. Ubiquitous expression can
also be achieved without the use of a strong transgene promoter. The ROSA26 line,
which ubiquitously expresses LacZ (Zambrowicz et al 1997) contains a randomly
integrated retroviral LacZ transgene (Friedrich and Soriano, 1991).
Targeted DNA integration
Reporter genes can also be integrated into a particular genomic locus by
exploiting the process of homologous recombination. Targeting constructs have been
devised that allow the expression of the reporter gene to come under the transcriptional
control of the targeted gene (Mountford et ah, 1994, St-Onge et ah, 1997, Godwin et ah,
1998). These include placing a tau-LacZ or tau-GFP transgene in the OMP locus
resulting in faithful reporter expression in OMP expressing olfactory neurons
(Mombaerts et ah, 1996, Rodriguez et ah, 1999) and the targeting of a GFP transgene to
the Hoxal and Hoxcl3 loci resulting in fluorescent labelling of Hoxal and Hoxcl3
expressing cells respectively (Godwin et ah, 1998). This approach can deliver accurate
reporter gene expression without the uncertainties introduced when relying on random
integration events. So long as a gene is known which has the expression pattern required
for the reporter gene expression, targeting is the method of choice. The main drawbacks
are that the production of a targeting construct requires detailed characterisation of the
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target locus which is time consuming, and the targeting event may disrupt or inactivate
the target gene.
Tau Biology
Tau proteins (particularly the human forms) have been the subject of intensive
research, largely prompted by their appearance in the neurofibrillar protein aggregates
which are one of the major diagnostic features of Alzheimer's Disease. In spite of this,
the exact biological function of tau remains largely unknown (Buee et al., 2000,
Mandelkow & Mandelkow, 1998, Spillantini & Goedert, 1998). The tau gene is highly
conserved between mammalian species including rodents, cows, and humans. The
discussion below focuses on the features of tau likely to be important when using a tau
tagged green fluorescent protein as a reporter gene in transgenic mice.
Tau gene and protein structure
In humans, there is a single tau gene located on chromosome 17 and spanning
lOOkb. Alternative splicing yields six transcripts which are translated to produce the six
human tau isoforms. These differ in having three (3R tau) or four (4R tau) 31 or 32
amino acid repeats at the carboxyl terminus and in the 0, 29 or 58 amino acid inserts
found at the amino terminus. In humans the three repeat isoform is found in foetal brains
whereas adult brains contain the four repeat isoforms. Further heterogeneity is
introduced by post-translational modifications including phosphorylation (Buee et al.,
2000, Mandelkow and Mandelkow, 1998, Spillantini and Goedert, 1998, Fig. 1.9).
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Figure 1.8
Schematic representation of the functional domains of the 4-repeat tau isoform.
The projection domain, including an acidic and a proline rich region, interacts
with cytoskeletal elements to determine the spacing between microtubules in
axons. The N-terminal part is also involved in signal transduction pathways by
interacting with proteins such as PLC-y and Src-kinases. The C-terminal part,
referred to as microtubules binding domain, regulates the rate of microtubule
polymerisation. It is also involved in binding with functional proteins such as
protein phosphatase 2A (PP2A) or presenilin-1 (PS 1). This figure is adapted from
Buee et ah, (2000).
Figure 1.9.
Phosphorylation control of tau. (A) Diagram of tau protein, its functional
domains, and sites of phosphorylation. The near-N-terminal inserts (exons 2 and 3,
grey) and the second of the four microtubules binding repeats (exon 10, grey) can
be absent owing to alternative splicing. The microtubule binding repeats are
numbered 1 to 4. SP and TP motif proline (P) resides can be phosphorylated by
proline directed kinases including MAPK, GSK-3(3, and Cdk5 and
dephosphorylated by protein phosphatases including PP2A and PP2B. KXGS
motifs can be phosphorylated at the serine (S) residue by kinases including protein
kinase A (PKA) and microtubule affinity regulating kinase (MARK). (B) Model
showing the link between the phosphorylation status of tau and its affinity for and
stabilisation of microtubules. Phosphorylation (P) of tau at crucial sites detaches
tau from microtubules (shown inn red and yellow). This figure is adapted from
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Subcellular localisation of tau protein
Tau protein has been described as an 'axonal' protein. The tau mRNA contains
sequence elements which result in trafficking to the axon where translation takes place
and tau protein is preferentially sorted into axons (Litman et al., 1994, Litman et al.,
1996, Kanai and Hirokawa, 1995, Hirokawa et al., 1996). Tau is however found in other
cellular compartments and the assignment 'axonal protein' may partly be attributed to
use of the antibody 'Tau-1' which recognises a dephosphorylated tau site and which
does predominantly label axons. Antibodies recognising other forms of tau label non-
axonal parts of the cell and ectopically expressed tau is found in the somatodendritic as
well as the axonal compartment (Buee et al., 2000, Brion et al., 1999, Ishihara et al.,
1999, Spittaels et al., 1999, and Gotz et al., 1995, Pratt et al., 2000a).
Tau and microtubules
One function of tau is as a microtubule associated protein (MAP) which binds to
microtubules and stabilises and promotes microtubule assembly. Protein structure and
function studies have mapped these activities to the carboxyl terminal 'Microtubule
Binding Domain' (Fig. 1.8). The highly conserved 18-amino acid sequence within the
31 or 32 amino acid repeat binds to the microtubules through a flexible array of
distributed weak sites (Butner and Kirschner, 1991). The KKVAVVR sequence found in
the proline rich region also contributes to microtubule binding. Tau also has been
implicated in assembly and stabilisation of microtubules. The 4R isoform is more
efficient at promoting microtubule assembly than the 3R isofonn in vitro and this has
been attributed to the 4R specific KVQIINKK sequence between repeats 1 and 2.
Overall the 4R isoform binds to microtubules 40-fold more strongly than the 3R
isoform. The N-terminal region of tau, the 'Projection Domain' comprises an 'Acidic
Region' and a 'Proline rich' region (Fig. 1.8). Different isoforms contain an insert of 0,
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29 or 58 amino acids. The projection domain is involved in determining the properties
of the microtubules themselves by determining the spacing between microtubules which
in turn will influence process properties such as diameter (Chen et al., 1992). This
notion is supported by the observation that a tau isoform called 'big-tau', which has a
large projection domain, is expressed in peripheral neurons with long axons of large
diameter.
Tau phosphorylation control
The tau protein contains numerous targets for a variety of kinases and
phosphatases (Fig. 1.9A) and one role of phosphorylation is to modulate the affinity of
tau for microtubules (Fig. 1.9B). This control is complex with some of the
phosphorylation sites having a greater impact on microtubule binding than others.
Phosphorylation is subject to developmental regulation and to cell-cycle regulation.
Phosphorylation is likely to be involved in regulating roles of tau not directly involved
in microtubule binding (Buee et al., 2000, Mandelkow and Mandelkow, 1998,
Spillantini and Goedert, 1998).
Phosphorylation is a developmentally regulated process with phosphorylation
levels being higher during foetal development than at later stages. Tau phosphorylation
also varies with the cell cycle (Preuss and Mandelkow, 1998, Mills et al., 1998). Tau
remains in a low state of phosphorylation in interphase cells but becoming highly
phosphorylated during mitosis leading to the suggestion that Alzheimer's Disease tau
hyperphosphorylation pathology may reflect inappropriate activation of regeneration
machinery in affected neurons (Preuss and Mandelkow, 1998).
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Tau phosphorylation: sites and enzymes
Proline directed protein kinases (PDPK) phosphorylate serine or threonine
residues at Ser-Pro (SP) or Thr-Pro (TP) motifs. The majority (but not all) of the tau
phosphorylation sites fall into this category including phosphorylation by mitogen
activated protein kinase (MAPK), glycogen synthase kinase 3 (GSK3), tau-tubulin
kinase, and cyclin dependent kinases including cdc2 and cdc5. Non ser/Thr-Pro sites can
be phosphorylated by kinases including microtubule affinity regulating kinase (MARX),
Ca2+ /Calmodulin dependent protein kinase II (CaMPK II), cyclic-AMP-dependent
kinase (PKA), and casein kinase II. Tau phosphorylation by the above kinases is
modulated by the activity of phosphatases including Ser/Thr phosphatase proteins 1, 2A
and 2B. The greater the phosphorylation of tau, the lower its affinity for microtubules
(with a corresponding reduction in its microtubule stabilising activity) although GSK3,
Cdk5, and MAP kinase phosphorylation have a smaller influence on microtubule
binding than MARK phosphorylation which causes tau to dissociate completely (Buee
et ah, 2000, Mandelkow & Mandelkow, 1998, Spillantini and Goedert, 1998, Fig. 1.9).
Interactions between tau and proteins other than microtubules
Tau binds to microtubules with its C-terminal 'Microtubule Binding Domain'
portion leaving the N-terminus 'Projection Domain' to project and potentially interact
with other proteins (Fig. 1.8). A number of other roles have been proposed for the
projection domain including binding to cytoskeletal proteins such as spectrin and actin
filaments and interaction with the plasma membrane and cytoplasmic organelles. The
interaction with the plasma membrane may be mediated by a PXXP motif located within
the proline rich region which has SH3 domain binding activity, this may interact with
the SH3 domains of proteins such as fyn (a src-family non-receptor tyrosine kinase) and
phospholipase-C y (PLC- y). Colocalisation experiments have suggested that this is the
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case and this would allow for a role for tau in signal transduction pathways. The tau-fyn
complexes might modulate the actin cytoskeleton via the src-family tyrosine kinase
signalling pathway and the tau- PLC- y interaction would allow a role for tau in the
PLC- y signalling pathway (Buee et ah, 2000).
Implications of manipulating tau protein expression in transgenic mice
Tau protein is implicated in major human neuropathological disorders including
Alzheimers disease, in which hyperphosphorylated tau forms tangles. Mutations in the
human tau gene have been linked to neuropathological disorders. The precise
mechanism, if any, by which wild-type tau can precipitate neurodegeneration remains
unknown and it may be that mutant rather than wild-type isoforms of tau have this
activity. Tau protein is a target for protein kinases and phosphatases involved in a range
of signal transduction pathways, and has a key role in defining the properties of axons
(Lee and Trojanowski, 1999, Buee et al., 2000, Mandelkow and Mandelkow, 1998,
Spillantini and Goedert, 1998). The balance of tau may therefore be delicately poised
and interference with tau might be expected to have catastrophic consequences. The
viability of several lines of transgenic mice in which tau levels have been manipulated
suggest this is not the case (below).
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Tau knockout mice
Mice in which the tau gene has been knocked out by homologous recombination
appear to be relatively normal with only a minor defect in a subset of axons (Harada et
al., 1994) although delayed maturation of hippocampal neurons was recently
demonstrated in another tau knockout line (Dawson et al., 2001). The survival of the
knockout animals could be explained by redundancy or compensation, and it has been
suggested that increased levels of another microtubule associated protein, MAPI A, in
tau knockout mice may compensate for loss of tau function (Harada et al., 1994).
Tau overexpressing mice
Transgenic mice ectopically expressing tau do not necessarily suffer any ill
effects. It might be that the level of tau protein is relatively unimportant. Tight post-
translational control (for example by phosphorylation or degradation) of tau might
maintain the pool of 'active' tau at the same level regardless of how much tau the cell is
producing. It appears from these reports that the ratio of transgenic to endogenous tau
protein is less than that for tau mRNA (Gotz et al., 1995, Brion et al., 1999). Although
this could conceivably be a artefact of differential detection of endogenous and
transgenic tau mRNA and protein it might reflect a cellular mechanism for controlling
levels of tau protein.
Interpretation of the reports of transgenic mouse lines overexpressing tau is
complicated because of differences in experimental method and interpretation. There
are, however, some features which are consistent between the studies reported so far
(Probst et al., 2000, Brion et al., 1999, Ishihara et al., 1999, Spittaels et al., 1999, and
Gotz et al., 1995). The aim of these was to generate animal models which would
recapitulate the pathology seen in neurological disorders such as Alzheimer's disease by
overexpressing tau protein in transgenic mice (Lee and Trojanowski et al., 1999). The
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studies differed in whether the four repeat (Probst et ah, 2000, Gotz et al., 1995,
Spittaels et ah, 1999) or three repeat (Brion et ah, 1999, Ishihara et ah, 1999) isoform of
tau was used. The subset of neurons in which transgenic tau was expressed also differ
reflecting the use of different promoters including the Thy-1 promoter (Probst et ah,
2000, Gotz et ah, 1995, Spittaels et ah, 1999), the PrP promoter (Ishihara et ah, 1999),
and the HMGCR promoter (Brion et ah, 1999) and position effects associated with the
site of transgene insertion. In all cases subsets of neurons expressed transgenic tau
protein showed some features of tau pathology (notably somatodendritic localisation and
phosphorylation status) but this did not necessarily appear to adversely affect the
transgenic animals (Gotz et ah, 1995, Brion et ah, 1999). In the lines where adverse
effects were reported (Spittaels et ah, 1999, Ishihara et ah, 1999, Probst et ah, 2000) it
appeared that these effects were of increasing severity with increased doses of tau
protein. The adverse effects included death in utero (observed for animals homozygous
for a high level expression tau transgene), and a panel of sensorimotor defects, and axon
degeneration. These effects were progressive in nature and the consequences became
more pronounced in aged mice.
The relationship between tau protein and neurodegeneration is yet to be resolved
and is not the main focus for this thesis. It does however appear that transgenic mice are
reasonably robust to experimental manipulation of the levels of tau protein.
Ectopically expressed tau efficiently labels axons
Tau is a good candidate for tagging reporter molecules and causing them to be
localised to axons. As discussed above, LacZ does not freely diffuse throughout the cell
and so does not label axons well. This is a problem if the aim of an experiment is to
visualise the axons of a LacZ labelled cell. Fusion of LacZ to tau generates a molecule
which efficiently labels axons in flies (Callahan & Thomas, 1994) and transgenic mice
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(Mombaerts et al., 1996) and the same is also true for tau-GFP fusions (Rodriguez et al.,
1999, Pratt et al., 2000a,b). This labelling does not appear to disrupt the trajectory of
axons formed by expressing cells as demonstrated by expressing tau fusion proteins in
neurons of the highly characterised olfactory (Mombaerts et al., 1996, Rodriguez et al.,
1999) and thalamocortical (Pratt et al., 2000b) fibre tract systems.
Although GFP is more diffusable than LacZ and does appear to be able to label
axons to some extent (Feng et al., 2000), tau tagging of GFP improves the quality of
axonal labelling (Rohm et al., 2000, Chapter 2).
Summary of following chapters
In Chapter 1 I have explained that one way to obtain a deeper understanding of
the mechanisms by which the transcription factor Pax6 influences the development of
the thalamocortical tract is to isolate Pax6+/+ and Pax6~/~ structures and test their
participation in thalamocortical tract projection individually. This type of experiment
demands that thalamic axons can be detected as they navigate through target tissues. I
discuss using a tau tagged green fluorescent protein (tau-GFP) reporter transgene as an
axonal label and considerations involved in generating transgenic mice ubiquitously
expressing this reporter. These mice can then be used as a source of tau-GFP labelled
cells and tissues, including dorsal thalamus.
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Chapter 2
I describe the generation of tau-GFP expressing embryonic stem cells and two
lines of transgenic mice. The consequences of transgene dosage on growth and viability
are also examined.
Chapter 3
I describe the characterisation of tau-GFP expression in these transgenic lines
and establish that all cells in the developing brain, including the dorsal thalamus,
express tau-GFP at the time of thalamocortical tract formation in one line (TgTP6.3) but
not in the other line (TgTP6.4). I show that tau-GFP efficiently labels microtubule
containing structures including.axons and the mitotic machinery.
Chapter 4
I describe 'proof of concept' experiments in which TgTP6.3 embryos are used as
a source of cells for cell mixing experiments. These demonstrate that tau-GFP labelled
cells and axons can readily be distinguished against a background of unlabelled cells
and axons in chimeras and in several neural culture paradigms.
Chapter 5
I investigate the requirement for the transcription factor Pax6 in the dorsal
thalamus for the development of the thalamocortical tract. I show that in vitro, explants
of tau-GFP labelled dorsal thalamus project axons that respond appropriately to target
tissues encountered by the thalamocortical tract but that dorsal thalamus isolated from
Pax6Sey/Sey embryos which lack Pax6 function do not. These experiments demonstrate an
autonomous requirement for Pax6 in the dorsal thalamus for thalamocortical tract
projection. Finally, I propose further experiments to address some of the questions
raised by this work.
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CHAPTER 2
GENERATION OF EMBRYONIC STEM CELLS AND TRANSGENIC MICE
EXPRESSING A TAU TAGGED GREEN FLUORESCENT PROTEIN
SUMMARY
Chapter 2 describes the generation of lines of transgenic ES cells and mice
expressing a tau tagged GFP transgene and observations on the consequences of
transgene expression.
First I wanted to assess the properties of tau-GFP fusion proteins as fluorescent
markers when inserted into the mammalian expression vector pCAGiP. Fusion cDNAs
comprising tau cDNA coding sequences fused in frame at their 5' or 3' ends to GFP
cDNA coding sequences were inserted into pCAGiP to generate pTP3 and pTP6
respectively. These constructs expressed fusion proteins in which tau was tagged at its
amino terminus (GFP-tau expressed from pTP3) or its carboxyl terminus (tau-GFP
expressed from pTP6) with GFP when introduced into mammalian cells. The properties
of these fusion proteins were compared to each other and to untagged GFP (plasmid
pTP5). This showed that tau-GFP and GFP-tau exhibited similar labelling properties in
HEK293 cells and in ES cells before and after differentiation into neurons with
processes being well labelled and with the label being excluded from the interphase
nucleus. Neither tau-GFP fusion showed decreased fluorescence compared to untagged
GFP and although untagged GFP did label processes in neurons derived from ES cells, it
was less easy to detect these processes than when they were labelled with either tau
tagged GFP. I concluded that both fusions offered sufficient advantages over untagged
GFP to merit their use as a marker in the transgenic mice for use in the experiments
described in Chapter 5.
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The expression construct pTP6 was then introduced into ES cells and transgenic
lines assessed for their suitability in generating transgenic mice according to their tau-
GFP fluorescence in ES cells before and after differentiation into neurons. No major
differences were observed between the lines tested. Three tau-GFP expressing ES lines
were selected for the generation of transgenic mice resulting in two lines of transgenic
mice (TgTP6.3 and TgTP6.4) and the consequences of transgene expression in these two
lines was evaluated. Characterisation of the expression of tau-GFP in these lines and
their application in a variety of experiments is described in the following chapters.
INTRODUCTION
As described in Chapter 1, there are several methodologies for the production of
transgenic animals. My aim was to generate transgenic mice expressing a tau-GFP
transgene ubiquitously for use in experiments such as those described in Chapters 4 and
5. Using gene targeting was an unattractive option as this approach would involve
detailed and time consuming identification and characterisation of a ubiquitously
expressed gene (see Chapter 1). A more attractive approach was to use a promoter that
conferred ubiquitous expression in transgenic mice. The CAG promoter is constructed
from the human cytomegalovirus immediate early enhancer (HCMVIEE) coupled to the
chicken p-actin promoter and first intron (CBA) to drive transgene expression. This
promoter was designed to be active in a wide variety of mammalian cell types when
introduced as a random integration event (Niwa et al., 1991) and has subsequently
proved to be able to drive widespread transgene expression in transgenic mice (Okabe et
al., 1997, Hadjantonakis et al., 1998, Pratt et al., 2000a, Kawamoto et al., 2000). The
generation of an expression construct in which tau-GFP transgene expression is driven
by the CAG promoter is more straightforward than the generation of gene targeting
constructs. This approach does however suffer from the potential drawback that, as the
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transgene is introduced into the genome as a random integration event, transgene
expression will be influenced by unpredictable position effects.
The GFP variant I chose to use was 'mgfp6' (Siemerring et ah, 1996, Zernicka-
Goetz et al., 1996, Zernicka-Goetz et ah, 1997). This GFP comprises several amino acid
substitutions into the wild-type amino acid sequence which confer thermostability at
37°C and enhanced fluorescence as described in Chapter 1. I was primarily concerned
with tau-GFP expression in neural structures (see Chapter 1). Tagging the GFP with tau
protein was anticipated to improve the quality of labelling, particularly of axons, by
anchoring GFP to the microtubule containing cytoskeleton as described in Chapter 1. A
preliminary description of the labelling properties of tau-GFP is presented in this
Chapter with a more detailed description in Chapter 3. The generation of transgenic
mice via germline transmission of embryonic stem cells allows for the evaluation of
transgenic ES cell lines before transgenic mice are generated. ES cells can be induced to
differentiate into neurons in vitro allowing an assessment of neuronal labelling
properties of tau-GFP fusions for various transgenic ES cell lines. For this reason the
expression vector I used (pCAGiP) contained an internal ribosome entry site (IRES)
(Mountford and Smith, 1995) coupling transgene expression to a puromycin resistance
gene to facilitate isolation of ES clones stably transfected with the tau-GFP expression
construct by virtue of their puromycin resistance
MATERIALS AND METHODS
Molecular biology materials and ES cell culture materials used in this Chapter
are listed in Appendix A and B respectively. Chimeras for germline transmission were
generated by Jenny Nichols. Data on growth and viability of transgenic mice gathered
by Margaret Keighren and John West are presented in Appendix C. Confocal imaging
was performed as described in Chapter 3.
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Preparation of competent E. coli
Competent E. coli cells, strain DH5a were prepared by harvesting an
exponentially proliferating DH5a culture grown in 500ml LB medium (absorption at
600nm (A600) of 0.4-0.6 measured using a Jenway spectrophotometer). The cells were
chilled on ice and washed twice by centrifugation at 2000g for 10 minutes at 4°C
followed by resuspension in ice cold 50mM CaCl2 and finally resuspended in 50ml of
ice cold competent cell freezing mix (CCFM). Competent DH5a cells were stored as
0.5ml aliquots at -70°C until use.
Transformation of £. coli with plasmid DNA
Competent DH5a cells were thawed on ice and an lOOpl aliquot mixed with
DNA (10 to 100 ng) in a 15ml vented universal tube on ice. After a further 30 minutes
on ice the cells were heat shocked in a 42°C water bath for exactly 2 minutes. 2 volumes
(1001) of LB medium was then added to the mixture which was then incubated at 37°C
in a shaking incubator for 30 minutes to 1 hour. The cells were then plated on LB agar
plates containing 50g/ml ampicillin and incubated overnight at 37°C until colonies were
visible to the naked eye. Clones were then streaked onto fresh LB-agar plates and the
resulting colonies expanded in liquid culture for plasmid DNA extraction. These
volumes were adjusted as required to scale up or down the transformation.
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Plasmid DNA
All plasmid DNA was propagated in the E. coli strain DH5a. Liquid cultures of
DH5a were grown in LB medium and colonies were grown on LB-agar plates. Plasmids
were characterised by restriction digest using appropriate restriction enzymes and the
products visualised on ethidium bromide stained agarose gels (generally 1% agarose)
following electrophoresis. Tau and GFP fusion sequences were confirmed by DNA
sequencing. Unless otherwise stated, standard procedures (Sambrook et ah, 1989) were
used throughout for handling bacteria and plasmids and manufacturer's guidelines were
followed for the use ofkits and enzymes.
Glycerol stocks for cryopreservation of E. coli
For long term storage of bacterial clones, glycerol was added to liquid bacterial
cultures to a final concentration of 15% and 0.5ml aliquots were stored at -70°C. Clones
were recovered by streaking out onto fresh LB-agar plates containing 50pg/ml
ampicillin.
DNA ligation
DNA fragments were ligated together using T4 DNA ligase according to the
manufacturer's guidelines. Competent DH5a were transformed with the ligation
reaction and recombinant plasmids recovered. In some cases DNA was modified by
phosphorylation, dephosphorylation or blunt-ending prior to ligation. If required:
oligonucleotides were phosphorylated in the presence of polynucleotide kinase; plasmid
DNA was dephosphorylated using calf intestinal alkaline phosphatase; DNA fragments
with 5' overhangs were blunt ended using Sequenase.
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DNA site directed mutagenesis
Site directed mutagenesis was performed essentially as described for the
QuikChange™ site directed Mutagenesis kit (Stratagene, 200518) to introduce a BspHl
site into pMGFP6. Pfu polymerase (2.5 units) was used to amplify pMGFP6 (50ng)
using oligonucleotides GFPBSPFI1.1 and GFPBSPH1.2 (125ng) in a reaction volume of
50pl. Following 30 seconds at 95°C the reaction was subjected to 14 cycles of 95°C for
30 seconds, 50°C for 1 minute and 68°C for 8 minutes in a thermal cycler. The reaction
was then digested with the methylation sensitive restriction enzyme Dpnl to destroy the
original DNA which was methylated at Dpnl sites by propagation in DH5a but not
unmethylated DNA synthesised by Pfu polymerase. Competent DH5a were transformed
with the reaction and resultant plasmids extracted and analysed.
DNA sequencing
Manual DNA sequencing was performed using the Sequenase 2.0 kit. A list of
the sequencing primers used for sequencing tau GFP fusion constructs are listed in
Appendix A. In some cases, plasmid DNA was sequenced commercially by MWG
Biotech.
Mouse Genomic DNA extraction
Mouse tail tips (approx 0.5cm long) were digested overnight in 500pl tail tip
lysis buffer (TTLB) containing lOOpg/ml Proteinase K and then mixed with 500pl
PCIA (phenol: chloroform: isoamyl alcohol 50:49:1) for 20 minutes, centrifuged at
16000g for 5 minutes and the upper aqueous layer removed to a fresh tube. A further
500pl PCIA was added to the recovered aqueous layer and the process repeated
resulting in two rounds of PCIA extraction. DNA was precipitated by the addition of
1/10 volumes of sodium acetate pH5.5 and 2 volumes of 96% ethanol to the recovered
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Mouse tail tip DNA was digested with the appropriate restriction enzyme and
separated on an 0.8% SeaKem LE agarose gel. Following staining with ethidium
bromide and imaging on a transilluminator, the gel was treated with 0.25M HC1 for 30
minutes, denatured in Southern denaturing solution for 1 hour and neutralised in
Southern neutralising solution for 1 hour. The DNA was transferred to a positively
charged nylon membrane by capillary action in 20xSSC overnight, rinsed in 3xSSC,
crosslinked with ultraviolet light (1200mJ) and baked at 120°C for 30 minutes.
32P labelled probe preparation and hybridisation
Plasmid DNA was digested with the appropriate restriction enzyme, subjected to
agarose gel electrophoresis, and the desired fragment identified and extracted from the
gel. The HiPrime Kit (Roche) was used to produce 32P labelled probe from this DNA
fragment using random hexanucleotide priming. The probe was hybridised to the nylon
filter in Church solution at 65°C overnight. After washing twice in Church wash at 65°C
the filter was exposed to X-ray film at -70°C which was developed after an appropriate




pMGFP6 (a gift from J. Haseloff, Fig. 2.1 A) was digested with Kpnl and Sacl
and the 0.8kb fragment containing mgfp6 sequence extracted after agarose gel
electrophoresis and the ends blunted using Sequenase2.0. BstXl oligonucleotide linkers
BST-P1 and BST-P2 were phosphorylated using polynucleotide kinase, annealed, and
ligated to the blunt-ends of mgfp6 prior to ligation into BstXl digested pCAGGS-
BstXl(+SVori) (Fig. 2.ID) as described by Aruffo et al., 1987. This plasmid was
digested with EcoRl and the 0.8kb fragment containing mgfp6 sequence was ligated to
EcoRl digested pCAGiP (a gift from I Chambers, Fig. 2.IE) to generate pTP5 (Fig.
2.2A).
pTP3 (GFP-tau fusion)
The Sacl site in pMGFP6 (a gift from J. Haseloff, Fig. 2.1 A) 3' to mgfp6
sequence was converted to an EcoRl site by digestion with Sacl, dephosphorylation
with calf intestinal alkaline phosphatase, and ligation to annealed SAC1/ECOR1
oligonucleotides which had been phosphorylated using polynucleotide kinase. A BspHl
site was introduced into the 3' end of the MGFP6 sequence using the oligonucleotides
GFPBSPH1.1 and GFPBSPH1.2 for Pfu polymerase PCR site directed mutagenesis.
The resulting plasmid, pMGFP6.BSPHl (which contains two BspHl sites in the
pBluescript SK backbone in addition to the one I introduced into the mgfp6 sequence),
was digested to completion with EcoRl, purified, subjected to partial digestion with
BspHl, and the 3.5kb product recovered. A 1.3kb Ncol/EcoRl fragment of
pEn2+3+1234 (a gift from G. Lee, Fig. 2.1C) containing human tau sequence htau40 was
ligated into the 3.5kb EcoRl /BspHl (partial) pMGFP6.BSPHl backbone to generate a
2.1kb in frame GFP-tau fusion sequence in pMGFP6CHTAU. Oligonucleotides
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KPN1CAG and BSTX1CAG were phosphorylated with polynucleotide kinase and
annealed to the 2.1kb Kpnl fragment of pMGFP6CHTAU containing the GFP-tau
fusion sequence. Unbound oligonucleotide were removed using a Chromaspin-400
column (Clontech K1303-1) according to the manufacturers instructions and the 2.1kb
fragment ligated into BstXl digested pCAGGS-BstXl(+SVori) (Fig. 2.ID) as above.
This plasmid was digested with EcoRl and the 2.1kb fragment containing mgfp6chtau
fusion sequence was ligated into EcoRl digested pCAGiP (a gift from I. Chambers, Fig.
2.IE) to generate pTP3 (Fig. 2.2B). The GFP-tau fusion cDNA sequence is shown in
Fig. 2.3 A,B.
pTP6 (tau-GFP fusion)
The Asp718 site in pMGFP6 (a gift from J. Haseloff, Fig. 2.1A) 5' to mgfp6
sequence was converted to a Bglll site by digestion with Asp718, dephosphorylation
with calf intestinal alkaline phosphatase, and ligation to annealed ASP718/BGL2
oligonucleotides which had been phosphorylated using polynucleotide kinase to
generate pMGFP6.BGL2. The 0.7kb Bgl2/Sacl fragment of pMGFP6.BGL2 containing
mgfpb sequence was then inserted into the 4.2kb BamHl/Sacl fragment of ptauLacZ
(Callahan and Thomas, 1994, Fig. 2.IB) to generate an in frame fusion between bovine
tau and mgfp6 sequences in pBTAUNMGFP6. Oligonucleotides KPN1CAG,
SAC1CAG, and BSTX1CAG were phosphorylated with polynucleotide kinase and
annealed to the 2.1kb Kpnl /Sac 1 fragment of pBTAUNMGFP6 containing the tau-GFP
fusion sequence. Unbound oligonucleotide were removed using a chromaspin-400
column (Clontech K1303-1) according to the manufacturers instructions and the 2.1kb
fragment ligated into BstXl digested pCAGGS-BstXl(+SVori) (Fig. 2.ID) as above.
This plasmid was digested with EcoRl and the 2.1kb fragment containing btaunmgfp6
fusion sequence was ligated into EcoRl digested pCAGiP (a gift from I. Chambers, Fig.
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2.IE) to generate pTP6 (Fig. 2.2C). The tau-GFP fusion cDNA sequence is shown in
Fig. 2.3 C,D.
Embryonic stem cell culture
Routine culturing of ES cells
All procedures were performed using sterile technique in a tissue culture area
dedicated solely to the handling of germline competent ES cells. ES cells were cultured
without a feeder layer as described by Smith (1991) without antibiotic in 10ml GMEM
medium containing -mercaptoethanol and 10% foetal calf serum (GMEM+FCS) plus
Leukemia Inhibitory Factor (LIF). Tissue culture flasks and plates were gelatinised by
rinsing with a 0.1% solution of swine skin gelatin dissolved in PBS.
The ES cells were passaged every two to three days as they approached
confluence. The protocol below describes passaging ES cells growing in a tissue culture
flask with a 25cm2 growing area (T25 flask). These volumes and cell numbers were
adjusted accordingly for larger or smaller cultures. Passage was accomplished by
aspirating the medium, rinsing the cells with phosphate buffered saline (PBS), and
adding 1ml of TVP (a 0.025% trypsin solution). The cells were incubated at 37°C until
they started to detach from the substrate and the flask was tapped sharply on the bench
to dislodge the cells. The trypsinisation was stopped by the addition of 5ml
GMEM|3+FCS. The cells were further dissociated by triturating using a 5ml plastic
pipette before centrifugation at 2000g for 3 minutes and resuspension of the cell pellet in
10ml GMEMp+FCS+LIF. Cells were counted using a hemocytometer. A confluent T25
flask typically yielded lxlO7 cells. Approximately lxlO6 cells in 10 ml
GMEMP+FCS+LIF were returned to a fresh gelatinised T25 flask. Cells were cultured
in a humidified incubator at 37°C with 5% C02 and all solutions and media were
prewarmed to 37°C before use.
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Freezing and Thawing ES cell clones
ES cells grown to confluence in a T25 were trypsinized as described above and
resuspended in 8.5ml of GMEMJ3+FCS+LIF to which 1ml dimethyl sulphoxide
(DMSO) was slowly added. The cells were pelleted by centrifugation at 2000g for 3
minutes and gently resuspended in 1ml freezing mixture consisting of
GMEM(3+FCS+LIF+10% DMSO (final concentration of lxlO7 cells/ml). Aliquots of
0.5ml were placed in cryo-tubes which were inserted into a polystyrene rack at -70°C
overnight. The polystyrene packing ensured that the vials were cooled slowly enough to
ensure good cryopreservation. The vials could then be stored indefinitely in the vapour
phase of liquid nitrogen (-180°C) in a cryo-bank. These volumes were adjusted
accordingly when freezing larger or smaller cultures.
ES cells were recovered by rapidly thawing the vials in a 37°C water bath and
quickly transferring their contents to 9.5ml of warm GMEMp+FCS+LIF. The cells were
pelleted by centrifugation at 2000g, resuspended in 10ml GMEMp+FCS+LIF to remove
traces of DMSO, pelleted again, and resuspended in 4ml growth medium for culture in 6
well plates. In some cases thawing the cells into a smaller culture (for example a 12-well
plate) facilitated recovery of clones. Clones were expanded by passage into successively
larger cultures.
Retinoic acid induced neuronal differentiation of ES cells
The protocol used was a combination of the '-4/+4' protocols described by Bain
et al., (1997) and Li et al., (1998) with minor modifications. Confluent ES cells growing
in a T25 flask (approximately lxlO7 cells) were dissociated gently to generate small cell
clumps rather than fully dissociated cells. This was achieved by reducing time of TVP
treatment and the amount of triturating the cells were subjected to during resuspension.
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The cells were then washed twice in 10ml GMEMp+FCS to remove traces of LIF which
would otherwise inhibit differentiation. The washed cells were resuspended in 10ml
GMEMp+FCS and transferred to a 9cm bacterial grade sterile dish (not tissue culture
treated plastic). Under these conditions the ES cells aggregated to one another to form
embryoid bodies (EBs). The EBs were agitated daily to discourage them from
aggregating together or adhering to the bottom of the dish. Fresh medium was supplied
every second day using a method that selectively enriched the culture for EBs while
depleting un-aggregated cells and debris. This was accomplished by swirling the dish to
concentrate the EBs in the centre and transferring them to a 30ml universal which was
allowed to stand for 5 minutes allowing the EBs to settled to the bottom. The medium
(mainly containing single cells and debris that had not sunk to the bottom) was then
carefully aspirated off the EB pellet and replaced with fresh GMEMp+FCS and the EBs
transferred to a fresh 10cm dish. All trans retinoic acid (RA) was included in the
medium from the fourth day in culture until the eighth day. The RA stock was diluted
into growth medium to give a final concentration of 10"6M.
After eight days the EBs were collected, rinsed twice in PBS and incubated with
TVP at 37°C until cells could be seen detaching from the EBs. The digestion was
stopped by addition of 5ml GMEMP+FCS and the EBs further dissociated by pipetting
up and down ten times with a 5ml plastic pipette. The partly dissociated EBs were
allowed to stand for 5 minutes to allow undissociated clumps to fall to the bottom. The
supernatant (containing dissociated cells) was carefully removed and the cells counted
with a hemocytometer. The cells were pelleted and resuspended in DMEM/F12 medium
containing N2 and B27 supplements to a final concentration of 3xl05 cells/ml.
The 'ES neurons' were cultured in Nunc 4 well dishes that had been treated with
poly-D-Lysine (PDL) and Laminin. PDL in PBS (0.001%) was added to tissue culture
plates for 15 minutes at room temperature and aspirated before washing three times with
82
PBS. Laminin in cold PBS (2g/ml) was then added to the tissue culture plates for 20
minutes and removed just prior to plating cells. Approximately 3xl05 cells were plated
in each well in a volume of 1 ml. The dishes were returned to the incubator and cultured
for 1 to 3 days until recognisable neuronal morphology became apparent.
Electroporation of ES cells
Preparation of DNA for electroporation
For each electroporation, lOOg of CsCl2 gradient purified plasmid DNA was
linearised with an appropriate restriction enzyme in a 500pl volume. An aliquot was
electrophoresed on an agarose gel to confirm that the digest had reached completion.
The linearised plasmid was precipitated by addition of 50pl 3M Sodium Acetate pH5.5
and 1ml ethanol at -20°C followed by centrifugation at 16000g for 5 minutes to pellet
the DNA. The DNA pellet was washed twice in 70% ethanol and transported to the ES
cell culture area in 100% ethanol. Inside the tissue culture hood most of the ethanol was
removed by aspiration and the remainder allowed to evaporate. These steps ensured the
sterility of plasmid DNA solution prior to its introduction into ES cells. Once dry, the
DNA was dissolved in lOOpl PBS overnight at 4°C in a sealed tube (final concentration
lmg/ml). This step was necessary as the DNA dissolved slowly in PBS.
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Preparation of ES cells for electroporation
ES cells were grown to near confluence in a 175cm2 (T175) gelatinised tissue
culture flask in GMEMP+FCS+LIF. The cells were fed by replacing the culture medium
with fresh medium 3-4 hours before electroporation. The ES cells were then trypsinized,
resuspended in growth medium, counted using a hemocytometer (a single T175 flask
typically yielded 5x107 cells), washed twice with PBS to remove traces of growth
medium, and resuspended in ice cold PBS at a final density of 1.43x107 cells/ml.
Selection of stable transfectants
DNA (1001 at lmg/ml) and ES cells (700pl containing lxlO7 cells) were
transferred to a sterile ice cold electroporation cuvette with a plugged glass Pasteur
pipette and mixed by gently pipetting up and down. The cuvette was placed in a Gene-
Pulser II and electroporated at 0.8kV, 3pF with a time constant of 0.1s. The cells were
then added to 20ml GMEMp+FCS+LIF (5x10s cells/ml). Volumes of 1ml (5X103 cells)
or 2ml (lxlO6 cells) were added to the required number of gelatinised 10cm diameter
tissue culture dishes containing 10ml ofprewarmed GMEMP+FCS+LIF which had been
prepared the previous day and stored in the incubator. Control plates containing the
same numbers of cells which had not undergone electroporation were also set up. The
plates were then returned to the incubator overnight. The medium was replaced with
selection medium (GMEMp+FCS+LIF containing 2pg/ml puromycin) about 40 hours
after the electroporation. This was to allow time for expression of antibiotic resistance
by transfected cells. Selection medium was replaced every two days until stably
transfected puromycin resistant ES clones appeared.
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Picking and expanding ES cell clones
Once ES cells were visible to the naked eye (typically after 10 to 12 days) their
positions were marked on the underside of the dish. The medium was aspirated off, the
cells rinsed twice with PBS and the clones left just covered with PBS. Individual clones
were dislodged from the plate using a yellow pipette tip and transferred into 50pl TVP
in a 96-well plate. After incubation at 37°C for 5 minutes the cells were dissociated by
pipetting up and down six times and transferred to 2ml GMEMp+FCS+LIF+Puromycin
in a 24-well (ungelatinised) plate. As ES cells became confluent they were expanded by
passaging into larger cultures.
Germline transmission of ES cells
ES cells were injected into C57BL/6 blastocysts and reintroduced into pseudo-
pregnant females by Jenny Nichols (Edinburgh University) using standard procedures
(Hogan et al., 1994). Chimeric offspring were identified by coat colour and test-crossed
to wild type animals to establish germline transmission.
Mouse genetics
The E14Tg2a ES cell line used for germline transmission were derived from
129/Ola strain (Hooper et al., 1987) so the initial genotype of the TgTP6.3 and TgTP6.4
transgenic mice was 129/Ola. Animals used throughout this study were derived by
backcross breeding onto outbred CD1 background (Banton and Kingman, UK) and
inbred C57BL/6 background (Banton and Kingman, UK). The results reported here used
animals which had been back-crossed for four or less generations so represent TgTP6.3
and TgTP6.4 alleles on mixed 129/Ola, C57BL/6, and CD1 background.
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Quantifying GFP fluorescence by FACS
ES cells were dissociated as for passage, resuspended in PBS containing 1%
Bovine Serum Albumin (BSA), and green fluorescence profiles obtained using
fluorescence activated cell sorter (Becton Dickinson, Rutherford, NJ) operated by
Andrew Sanderson (Edinburgh University)
RESULTS
Construction of expression vectors
The expression constructs pTP3 (Fig. 2.2B), pTP5 (Fig. 2.2A) and pTP6 (Fig.
2.2C) consisted of a GFP-tau (Fig 2.3 A,B), untagged GFP, or tau-GFP (Fig. 2.3 C,D)
cDNA sequences inserted between the EcoRl sites of pCAGiP (Fig. 2.1 E) respectively.
The GFP variant used for all these experiments was mgfp6 (Siemering et al., 1996,
Zernika-Goetz et al., 1996, Zernika-Goetz et al., 1997) as this version has enhanced
fluorescence and thermostability at 37°C compared to wild-type GFP (see Chapter 1).
The tau-GFP fusion in pTP6 was made using a bovine tau clone extracted from a
tau-LacZ fusion plasmid ptau-LacZ which successfully labelled axons in fruitfly
(Callahan & Thomas, 1994) and transgenic mice (Mombaerts et al., 1996) using a
BamHl site at the junction between tau and LacZ sequences. This BamHl site was
ligated to a Bgl2 site which I introduced into the 5' end of the mmgfp6 clone by ligating
an oligonucleotide containing a Bgl2 site into the Asp718 site of the mgfp6 plasmid.
This generated an in frame fusion.
The GFP-tau fusion in pTP3 was made using a human tau clone (htau40) which
had an Ncol site engineered into its start ATG codon (a kind gift from G. Lee). This
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Figure 2.1
Plasmids used in this study. (A to D) Simplified plasmid maps showing the
plasmids used as starting materials. GFP, tau, and LacZ coding sequences are
indicated by green, red, and blue arrows respectively. (A) pMGFP6 from which
MGFP6 coding sequence was obtained, (B) ptauLacZ from which bovine tau
coding sequence was obtained, (C) pEn2+3+1234 from which human tau coding
sequences were obtained, (D) pPHCAGGS-BstXl(+Svori) and (E) Mammalian
'CAG promoter' expression vector pCAGiPuro. 'CAG promoter' expression is
driven by human cytomegalovirus immediate early enhancer (HMVCIEE) coupled
to chick P-actin promoter and first intron (CBA promoter) with bovine growth
hormone polyadenylation signal (bGHpA). The cDNA to be expressed is inserted
between EcoRl sites. The internal ribosome entry site (IRES) between the inserted
cDNA and the puromycin resistance gene (Puro) allows expression of both from
the same bicistronic transcript. pMGFP6, ptauLacZ, pPHCAGGS-BstXl(+Svori)
and pCAGiPuro are pBluescript SK (Stratagene) derivatives and pEn2+3+1234 is













Plasmid maps of GFP and tau tagged GFP expression vectors generated during
this study. (A) pTP5 in which mgfp6 cDNA is inserted into pCAGiP. (B) pTP3 in
which mgfp6-htau40 fusion cDNA is inserted into pCAGiP. (C) pTP6 in which














Tau tagged GFP fusion genes generated during this study. (A,C) show schematics
of (A) GFP-tau and (C) tau-GFP fusion cDNAs with restriction sites used for
mapping marked (mgfp6 sequence coloured green and tau sequence coloured red).
Scale in base pairs (bp). (B,D) Nucleotide and amino acid sequences of (B) GFP-
tau and (D) tau-GFP fusion proteins. Nucleotide sequences (upper) are numbered
and amino acid sequences (lower) are shown using single letter code. MGFP6
amino acids are coloured green with substitutions to wild-type GFP sequence
resulting in improved thermostability and fluorescence bold and underlined. (B)
human and (D) bovine tau amino acid sequences are coloured red with the four






500 1000 1500 2000





































961 + + + + + + 1020
VPGKQAAAQPHTEI PEGTTA
Figure 2.3
T GAAGAAGCAGGCATT GGAGACAC C CC CAGCCT GGAAGACGAAGCT GC T GGT CACGT GAC
EEAGIGDTPSLEDEAAGHVT
CCAAGCTCGCATGGTCAGTAAAAGCAAAGACGGGACTGGAAGCGATGACAAAAAAGCCAA




GGGCCAGGC CAACGCCACCAGGATT CCAGCAAAAACCC CGCCCGCT CCAAAGACACCAC C
1201 + + + + + + 1260
GQANATRI PAKTPPAPKT PP
CAGCTCTGGTGAACCTCCAAAATCAGGGGATCGCAGCGGCTACAGCAGCCCCGGCTCCCC
1261 + + + + + + 1320
SSGEPPKSGDRSGY SS PGSP
AGGCACTCCCGGCAGCCGCTCCCGCACCCCGTCCCTTCCAACCCCACCCACCCGGGAGCC
1321 + + + + + + 1380
GTPGSRSRTPSLPTPPTREP
CAAGAAGGTGGCAGTGGT CC GTACT CCACCCAAGT CGCCGT CT TCC GCCAAGAGCC GCCT
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CTCATTAGGCAACATCCATCATAAACCAGGAGGTGGCCAGGTGGAAGTAAAATCTGAGAA
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1741 + + + + + + 1800
L D F K D R VQSKIGSLDN ITHV
CC C TGGCGGAGGAAATAAAAAGAT T GAAAC C CACAAGCT GACCTT C CGC GAGAACGCCAA
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GT CT C CACGGCAT CT CAGCAATGT CT CC TC CACC GGCAGCAT CGACAT GGTAGACT CGC C
1921 + + + + + + 1980
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CCAGCTCGCCACGCTAGCTGACGAGGTGTCTGCCTCCCTGGCCAAGCAGGGTTTGTGA
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Figure 2.3
CCAAGTGTGGCTCATTAGGCAACATCCATCATAAGCCAGGAGGTGGCCAAGTGGAAGTGA
1081 + + + + + + 1140
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T H V P G G GNKKIETHKLTFRE
AGAACGCCAAAGCCAAGACCGACCACGGGGCGGAGATCGTGTCCGGGGATCTAGTACCGG
1261 + + + + + + 1320
NAKAKTDHGAEIVSGDLVPV
TAGAAAAAATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAAT
1321 + + + + + + 1380
EKMSKGEELFTGVVPILVEL
TAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAA
1381 + + + + + + 1440
DGDVNGHKFSVSGEGEGDAT
CATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGC
1441 + + + + + + 1500
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CAACCCTGGTCACCACCCTGACCTACGGCGTGCAGTGCTTCTCCCGTTACCCTGATCATA
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TGAAGCGGCACGACTTCTTCAAGAGCGCCATGCCTGAGGGATACGTGCAGGAGAGGACCA
1561 + + + + + + 1620
KRHDFFKSAMPEGYVQERTI
TCTTCTTCAAGGACGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAGGGAGACA
1621 + + + + + + 1680
FFKDDGNYKTRAEVKFEGDT
CCCTCGTCAACAGGATCGAGCTTAAGGGAATCGATTTCAAGGAGGACGGAAACATCCTCG
1681 + + + + + + 1740
LVNRIELKGIDFKEDGNILG
GCCACAAGTTGGAATACAACTACAACTCCCACAACGTATACATCATGGCCGACAAGCAAA
1741 + + + + + + 1800
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AGAACGGCATCAAAGCCAACTTCAAGACCCGCCACAACATCGAAGACGGCGGCGTGCAAC
1801 + + + + + + 1860
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1861 + + + + + + 1920
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1921 + + + + + + 1980
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Figure 2.4
Ethidium bromide stained agarose gels showing restriction digests of (A)
pCAGiP, (B) pTP5, (C) pTP3 and (D) pTP6: EcoRl (lane 1), Ncol (lane 2),
HindiII (lane 3), Sail (lane 4), EcoRl and Ncol (lane 5), EcoRl and HindiII (lane
6), EcoRl and Sail (lane 7) and Ncol and Sail (lane 8). EcoRl excises cDNAs
inserted into pCAGiPuro (faint 0.8kb EcoRl fragment in (B) lane 1, 2.1kb EcoRl
fragments in (C) lane 1 and (D) lane 1). The marker lane (M) contains lkb ladder
molecular weight marker (Gibco BRL: 10787-018) with fragment sizes in kb

































































































was fused to a BspHl site which I introduced into the 3' end of the mgfp6 clone by site
directed mutagenesis to generate an in frame fusion. Restriction digests ofpCAGiP,
pTP3, pTP5, and pTP6 are shown in Fig. 2.4.
Comparison of different tau-GFP fusions
Transient transfection of HEK293 cells with these constructs established that
whereas the untagged GFP was distributed throughout the cell, the tau-GFP and GFP-
tau fusions were excluded from the nucleus. These results are shown in Fig. 2.5. These
experiments confirmed that the expression constructs were functional.
ES cells (Sox2 line, Li et al., 1998) were electroporated with pTP3, pTP5, and
pTP6 which had been linearised with Seal which cuts within the ampicillin resistance
gene and puromycin resistant stably transfected clones were isolated and expanded for
analysis. FACS profiles of proliferating ES cells grown in the presence of LIF were
obtained for two independent clones for each plasmid (Fig. 2.5). These showed that
clones transfected with all three constructs exhibited similar levels of GFP fluorescence.
These ES cells were induced to differentiate into neurons by aggregating them into
embryoid bodies (EBs) and exposure to retinoic acid (Bain et ah, 1995, Li et ah, 1998).
The EBs were dissociated and cultured for 2 days until cellular processes were visible.
These were then assessed by eye using epifluorescence microscopy (FITC filter set) and
imaged on an inverted confocal microscope while the cultures were still alive to assess
the quality of process labelling. This showed that processes were labelled by both tagged
and untagged GFP but that processes expressing either tau tagged GFP version were
easier to detect than those expressing untagged GFP. The images presented in Fig. 2.5
demonstrate this. It should be noted that for unknown reasons, the neural
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Figure 2.5.
Comparing labelling properties of various tau tagged GFP proteins. (A to G)
FACS profiles collected in the FITC (green) channel of (A) untransfected ES cells
and ES cells stably transfected with (B,C) pTP3, (D,E) pTP5, or (F,G) pTP6. Note
broadly similar profiles for tau tagged and untagged GFP. (H,I) show bright field
and green fluorescence confocal images of untransfected cells respectively. (J to
U) Fluorescence images and confocal micrographs of (J,N,R) HEK293 cells and
(K to M, O to Q and S to U) ES cells after differentiation into neurons expressing
(J to M) untagged GFP from pTP5, (N to Q) GFP-tau from pTP3 and (R to U) tau-
GFP from pTP6. In HEK293 cells, GFP labels the whole extent of the cell
whereas tau-GFP and GFP-tau are excluded from the nucleus. In ES cell neurons,
tau-GFP and GFP-tau label neural processes more clearly than untagged GFP
(compare fine filaments seen in O and S to more diffuse label in K). When
examined under bright field the ES neurons shown in O, S, and K all contained
bundles of processes of similar appearance. Comparison of bright field and
fluorescence images of individual processes show that tau tagged GFP labelled
processes (compare P to Q and T to U) are easier to detect than those labelled with











differentiation protocol was less successful with the Sox2 ES cells (Li et al., 1998) used
in these experiments than for the E14Tg2a ES cell line (Blooper et al., 1987)
subsequently used for generation of transgenic mice (see below and compare Fig. 2.5H
to Fig. 2.5 L,P, and T) even when the two lines were subjected to the differentiation
protocol in parallel. Viewing the cells through tissue culture plastic also adversely
affected the fluorescent signal (compare Figs 2.5 and 2.6 in this chapter to Fig. 3.5 in
Chapter 3 for ES cells exhibiting similar levels of fluorescence but imaged through a
plastic culture well or through a glass coverslip respectively). These factors combine to
reduce the quality of the images presented in this Chapter but the conclusion is clear as
both tagged and untagged GFP versions were assessed under the same conditions.
These results show that the tau-GFP labelling generated by stable transfection
with pTP6 successfully labelled cell processes and was not obviously disadvantageous
to the cell. The pTP6 construct linearised by Seal was introduced into the germline
competent ES cell line E14Tg2aSc4 (a subclone of the E14Tg2a ES cell line (Hooper et
al., 1987)). Ten puromycin resistant clones were selected at random without checking
their fluorescent properties and expanded for analysis.
FACS profiles of proliferating ES cells grown in the presence of LIF were
obtained for nine of these ten independent clones (Fig. 2.6). This showed that all clones
exhibited similar levels of GFP fluorescence.
Seven of these ES clones were induced to differentiate into neurons by
aggregating them into embryoid bodies (EBs) and exposure to retinoic acid (Bain et al.,
1995, Li et al., 1998). The EBs were dissociated and cultured for 2 to 3 days until long
cellular processes were visible. These were then assessed by eye using epifluorescence
microscopy (FITC filter set) and imaged on an inverted confocal microscope while the
cultures were still alive to assess the quality of process labelling (Fig. 2.7). These
experiments established that all clones exhibited similar levels of fluorescence and, after
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differentiation into neurons, their processes were clearly fluorescent. There appeared to
be no non-expressing cells in either the Sox2 ES cells stably expressing pTP3, pTP5 or
pTP6 or in the E14Tg2aSc4 ES cells stably expressing pTP6 either before or after neural
differentiation indicating that the CAG promoter was able to drive ubiquitous transgene
expression at least in ES cells and in neurons derived from these ES cells.
Generation of tau-GFP expressing transgenic mice
According to the assays described above, all tau-GFP expressing E14Tg2aSc4
clones stably transfected with pTP6 appear equally suitable for generation of transgenic
mice. Three (E14Tg2aSc4TP6.3, E14Tg2aSc4TP6.4 and E14Tg2aSc4TP6.6) were
chosen for injection into blastocysts, transfer to pseudopregnant females and production
of chimeras. Two of the ES lines (E14Tg2aSc4TP6.3 and E14Tg2aSc4TP6.4) generated
chimeras as judged by coat colour and these were test crossed to determine whether
germline transmission had been accomplished. Examination of coat colour of these test
cross offspring showed that ES lines E14Tg2aSc4TP6.3 and E14Tg2aSc4TP6.4 had
successfully contributed to the germline and I named these lines 'TgTP6.3' and
'TgTP6.4' respectively. Examination of ear punches under epifluorescence microscopy
(FITC filter set) confirmed that some of the offspring did possess green fluorescent ears
indicating that the tau-GFP transgene had been successfully transmitted and was
expressed in these transgenic lines.
The fluorescent (transgenic) offspring were test-crossed to wild-type mice and
the progeny were tail tipped. Tail tips were assessed for fluorescence prior to extraction
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Figure 2.6
Comparing tau-GFP labelling in undifferentiated ES cells stably transfected with
pTP6. FACS profiles collected in the FITC (green) channel of (A) untransfected
ES cells and (B to J) nine ES lines (B to J show profiles for clones
E14Tg2aSc4TP6.1 to E14Tg2aSc4TP6.9 respectively) stably expressing tau-GFP.
All nine clones exhibit similar fluorescence properties with the vast majority of
cells being green. Note that the exact shape of the FACS profile was not constant
for a particular ES clone (compare G to G' profiles which were collected from




























Comparing tau-GFP labelling in ES cells stably expressing pTP6 which have been
differentiated to generate 'ES neurons' and cultured to allow neural processes to
develop. Bright field and green fluorescence confocal images show (A,B)
untransfected ES neurons and (C to W) tau-GFP expressing ES neurons.
Comparison of bright field and fluorescence images showed that in all clones
examined, all ES neurons expressed tau-GFP in their processes (compare C to D,
F to G, I to J, L to M, O to P, R to S, U to V). A high power view of each culture
is shown in the right hand column (E, H, K, N, Q, T, and W). The ES cell lines
were as follows (A,B) E14Tg2aSc4, (C to E) E14Tg2aSc4TP6.1, (F to H)
E14Tg2aSc4TP6.2, (I to K) E14Tg2aSc4TP6.3, (L to N) E14Tg2aSc4TP6.4, (O to
Q) E14Tg2aSc4TP6.5, (R to T) E14Tg2aSc4TP6.6, (U to W) E14Tg2aSc4TP6.7.





of DNA. The DNA was digested with EcoRl (which should release a 2.1kb fragment
containing the tau-GFP fusion cDNA from pTP6, see Fig2.4 D) and subjected to
agarose gel electrophoresis and southern blotting onto a nylon membrane. The blots
were then hybridised to a 32P labelled 738bp pMGFP6 EcoRl fragment (see Fig. 2.4 B)
and hybridising bands detected by autoradiography. For both TgTP6.3 and TgTP6.4
lines, all animals which exhibited green fluorescent tails and ears also exhibited a 2.1kb
EcoRl fragment hybridising to the mgfp6 probe (Fig. 2.8). This experiment showed that
the transgene was expressed in all animals carrying a copy of the transgene and that
there was no evidence for position effects silencing the transgene (see Chapter 1), at
least in the ears and tail.
Deleterious effects of TgTP6.3 and TgTP6.4 transgenes
TgTP6.3 Heterozygotes
In the course of breeding the TgTP6.3 line it was observed that transgenic
animals were frequently smaller than their non-transgenic littermates and that from the
time of weaning until reaching maturity (3-6 weeks of age) transgenic TgTP6.3 animals
appeared to be under-represented in litters. This prompted an examination of whether
the TgTP6.3 or TgTP6.4 transgenic alleles adversely affected growth and survival. The
embryos and adults used for these counts were obtained by crossing TgTP6.3
heterozygote mice to non-transgenic mice. This cross should result in transmission of
the transgene to half the progeny (Mendelian ratio Tg/-: -/- of 1:1 for a Tg/- x -/- cross).
Any viability disadvantage (or advantage) conferred by the transgene results in deviation
from this 1:1 ratio. The comparison of littermates controls for variation in viability or
weight reflecting epigenetic factors such as nursing and animal husbandry. These results
are depicted graphically in Fig. 2..9.
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Figure 2.8
Southern blots showing that TgTP6.3 and TgTP6.4 transgene is present in green
fluorescent animals from each line. Each blot represents southern blot results for a
litter of (A) TgTP6.3 or (B) TgTP6.4 animals generated by mating a heterozygous
transgenic animal to a wild-type animal. The numbers above the gel represent the
lane number. Below is indicated if examination of tail tips before DNA extraction
for southern blot revealed that the animal was 'g' fluorescent or 'ng' not
fluorescent. This showed that all animals containing the 2.1kb EcoRl fragment
hybridising the GFP probe were fluorescent for both TgTP6.3 (lanes 2, 3 and 4 in
(A)) and TgTP6.4 lines (lanes 2, 4 and 6 in (B)). These results are typical of those
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For animals aged between 3 and 6 weeks (P21 to P42), the mean number of
transgenic animals (2.3 animals per litter) was less than the mean number of non-
transgenic animals (4.1 animals per litter) for 42 litters counted. This difference in
average number of animals per litter was statistically significant (Mann-Whitney Rank
Sum Test, PO.OOl). To see whether this reduced viability could be traced to before
birth, litters of mid to late gestation embryos (E13.5-E16.5) were examined. This
showed that there was no significant difference (Mann-Whitney Rank Sum Test)
between the mean number of transgenic (5.7 embryos per litter) and non-transgenic (4.9
embryos per litter) at this stage of development for 34 litters counted. A yj test
confirmed that there were significantly fewer TgTP6.3 tau-GFP+ animals surviving to
between three and six weeks than their tau-GFP" littermates (95 versus 172, x2=21.5,
P<0.05) but that there was no survival difference at El5 (193 versus 168, x2=l-9,
P>005). The yj was used to test the null hypothesis that equal numbers of tau-GFP+ and
tau-GFP" animals survived to each time-point. Although showing no reduction in
viability, TgTP6.3 transgenic embryos were on average 10% lighter than non-transgenic
embryos at this stage of development. Weighing El4.5 embryos from two litters showed
a significant difference between transgenic (mean weight of 434mg, n=17) and non-
transgenic (mean weight of 471mg, n=10) E15.5 embryos (P<0.05, t-test). A single
TgTP6.3 allele therefore resulted in a slight reduction in embryonic weight and a
predisposition to postnatal death. It should be emphasised that many TgTP6.3
heterozygotes did reach adulthood and were fertile.
This aspect of the TgTP6.3 transgene has been examined in more detail in
collaboration with John Wests' laboratory and the results of this collaboration are
presented in Appendix C rather than in this section as this data was not acquired by me.
Survival and weight of transgenic and non-transgenic animals were compared at
99
Figure 2.9
Heterozygotes for the TgTP6.3 transgene exhibit reduced embryonic growth
survival to adulthood compared to their non-transgenic littermates, whereas
TgTP6.4 heterozygotes do not. (A) Survival of TgTP6.3 and TgTP6.4 animals
during embryonic and postnatal development. The graph shows the mean number
of tau-GFP+ and tau-GFP" animals per litter. Animals were counted during
embryogenesis (between E14 and El6) and postnatally (between 3 and 6 weeks of
age). These litters were generated by mating a TgTP6.3 or TgTP6.4 heterozygote
with a non-transgenic animal so half of the progeny should inherit the tau-GFP
transgene. Deviation from a 1:1 tau-GFP+:tau-GFP" ratio therefore implies that the
tau-GFP transgene is deleterious (or advantageous) for viability. There was no
evidence that there were significantly fewer (or more) tau-GFP+ animals than tau-
GFP" animals per litter for TgTP6.3 E14 to E16 embryos or for postnatal TgTP6.4
animals of 3 to 6 weeks of age (Mann-Whitney Rank Sum Test, P>0.05) but
significantly fewer (*) TgTP6.3 tau-GFP+ animals survived to 3-6 weeks of age
than their tau-GFP" littermates (Mann-Whitney Rank Sum Test, P<0.05). These
results show that the TgTP6.3 transgene confers a reduced postnatal viability
phenotype in heterozygotes. The litter sizes were not normally distributed so error
bars cannot be shown. (B) This graph shows that the mean weight of TgTP6.3 tau-

















various ages. These experiments confirmed and expanded on results presented in this
Chapter and showed that animals heterozygous for the TgTP6.3 transgene were
generally slower to gain weight and more likely to die during postnatal life than their
non-transgenic littermates.
TgTP6.3 Homozygotes
One third of fluorescent males resulting from a mating between TgTP6.3
heterozygotes would be predicted to be TgTP6.3 homozygotes (Mendelian ratio Tg/Tg:
Tg/-'.-/- of 1:2:1 for a Tg/- x Tg/- cross, with a ratio of 1:2 for Tg/Tg: Tg/-). Mating of
homozygous TgTP6.3 males with wild type females should yield only TgTP6.3
heterozygotes (Tg/Tg x -/- cross yields only Tg/- progeny). In collaboration with John
West, male and female TgTP6.3 heterozygotes were crossed and 20 fluorescent male
progeny from these intercross litters were test crossed to wild-types and their progeny
examined. None of these males transmitted the transgene to 100% of their progeny
indicating that none of them were homozygous for the TgTP6.3 transgene. The observed
frequency of TgTP6.3 homozygotes reaching sexual maturity (0%) was significantly
different to the expected frequency (33.3%) indicating that the TgTP6.3 transgene is a
homozygous lethal (y2 = 10, P<0.005). The %2 was used to test the null hypothesis that 1
in 3 fertile green fluorescent males were TgTP6.3 homozygotes.
TgTP6.4 Heterozygotes
Unlike the TgTP6.3 line, the differences between the numbers of TgTP6.4
transgenic animals and their non-transgenic littermates in a litter at the time of weaning
was not statistically significant (Mann-Whitney Rank Sum Test) with mean numbers of
transgenic and non-transgenic in a litter being 3.0 and 3.8 respectively for 22 litters
counted. The TgTP6.4 tau-GFP+ and tau-GFP" animals appeared to survive equally well
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to between three and six weeks (67 versus 84, %2-2.13, P>0.05). The x2 was used to test
the null hypothesis that equal numbers of tau-GFP+ and tau-GFP" animals survived to
each time-point. This suggests that the adverse effects on viability of the TgTP6.4
transgene, if any, were more mild than those for the TgTP6.3 transgene.
DISCUSSION
This chapter describes the generation of a panel of expression constructs for
evaluating the suitability of tau tagged GFP as a marker in transgenic mice and the
production of ES cells and transgenic mice expressing tau-tagged GFP. Tagging GFP
with tau at either the C- or N-terminus did not result in a reduction in GFP fluorescence.
Both fusion proteins exhibited similar subcellular distributions suggesting that the GFP
tag did not disrupt the subcellular localisation of tau. The properties of tau-GFP
subcellular localisation is more fully addressed in the next chapter but the results
presented in this chapter suggest that tau tagged GFP is a better marker of cellular
processes than untagged GFP.
One possible concern in using cells or tissues from these mice is that ectopic
expression of tau-GFP might compromise cell function. As discussed in Chapter 1, there
is mixed evidence for adverse consequences associated with ectopic expression of tau
protein in transgenic mice. Ectopic expression of a tau-GFP fusion protein might disrupt
cell function by in some way interfering with microtubule assembly or predisposing
transgenic animals to neural pathological disorders resembling Alzheimer's disease.
Differences between the methodologies employed to generate different transgenic mice
ectopically expressing tau make it difficult to predict the phenotype of novel strains.
This thesis reports the generation of two lines of transgenic mice ectopically expressing
a tau tagged GFP. These lines do not exhibit the same pattern of tau-GFP expression. As
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described more fully in the following chapter, the TgTP6.3 line exhibits apparently
ubiquitous tau-GFP expression whereas in the TgTP6.4 line tau-GFP expression is
largely absent from large proportions of the CNS while being widely expressed in non-
neural tissues. The two lines also differ in the effect that transgene expression has on
postnatal growth and viability. The TgTP6.3 allele affects growth and viability in a
dosage dependent manner. TgTP6.3 heterozygotes are predisposed to grow more slowly
and die before reaching adulthood whereas homozygous animals never reach adulthood.
TgTP6.4 heterozygotes do not appear to suffer from reduced viability. The same tau-
GFP expression construct therefore participates in two distinct alleles. The TgTP6.3
allele confers a homozygous lethal semi-dominant phenotype whereas the TgTP6.4
allele does not.
As discussed in Chapter 1, examination of existing tau overexpressing transgenic
mice suggests that increasing dosage of tau has increasingly adverse consequences. It
could be that the higher levels of tau-GFP in the CNS of developing TgTP6.3 mice
compared to TgTP6.4 mice accounts for the more severe phenotype. A similar argument
could be used to explain why TgTP6.3 homozygotes might have a more severe
phenotype than TgTP6.3 heterozygotes. It is also possible that differences between the
TgTP6.3 and TgTP6.4 alleles reflects sequence alterations to different genomic loci
associated with the two different transgene integration events, with the TgTP6.3
integration event presumably disrupting gene(s) involved in growth and viability. It is
not possible to resolve these issues without more detailed information on the nature of
the transgene integration event and more data on tau-GFP expression patterns and
dosage in these animals. In this context it would be interesting to examine the
phenotypes of transgenic mice generated from the other tau-GFP expressing ES cell
lines. Adverse effects associated with mutagenic transgene integration events are likely
to be highly variable between independent transgenic lines as each line is likely to have
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a different transgene integration site. Adverse affects associated with tau-GFP
expression might be expected to be less variable between independent tau-GFP
expressing transgenic lines although the potential for variability in the patterns of
transgene expression in different transgenic lines resulting from position effects would
complicate this type of analysis.
It cannot be ruled out that further subtle cell type specific phenotypes will be
identified with more detailed analysis. Experiments using these ES cells and animals
should be designed with controls for possible effects of the transgene in whatever
system is being studied.
These transgenic mice were produced via the generation of ES cells ubiquitously
expressing tau-GFP protein. The use of the bicistronic expression vector pCAGiPuro in
which tau-GFP expression was linked to puromycin resistance allowed for selection of
stably expressing clones with puromycin so obviating screening for fluorescent clones.
The similar fluorescence of all clones picked confirms the success of this strategy. It was
also possible to screen the ES cells for likely suitability in generating a useful transgenic
mouse. In this case I was interested in marking neurons, so took advantage of the
potential of ES cells to differentiate into neurons in vitro (Bain et al.t 1995, Li et al.,
1998). If there were ES clones which switched off tau-GFP during the differentiation, or
had for some reason become incompetent to differentiate, then these could be discarded
at this stage. In this study, all clones could be induced to differentiate into cells with
neuronal morphology that expressed tau-GFP in their processes and three were picked
for generation of transgenic mice. Surprisingly, of two lines generated only one
(TgTP6.3) exhibited strong tau-GFP expression in the brain although tau-GFP was
expressed in other tissues in both. The incomplete success of this screening strategy
emphasises the care that must be taken in extrapolating from neurons derived from ES
cells to the full repertoire of neuronal subtypes present in the brain.
104
Because the transgene was introduced as a random integration event, it is
unknown how many copies of the transgene were present in the TgTP6.3 and TgTP6.4
lines. As I was primarily concerned with characterisation and exploitation of the
transgenic lines, I decided that determination of the transgene copy number was not
central to this study and I did not pursue it further.
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CHAPTER 3
CHARACTERISATION OF TAU-GFP EXPRESSION
SUMMARY
Chapter 3 describes the characterisation of tau-GFP expression in the TgTP6.3
and TgTP6.4 lines of transgenic mice whose generation was described in Chapter 2.
This analysis shows that the TgTP6.3 line does express tau-GFP ubiquitously in neural
structures whereas the TgTP6.4 line does not. In the TgTP6.3 line, tau-GFP is expressed
in pre-implantation embryos and throughout subsequent development so is suitable as a
source of cells for the cell mixing experiments of planned in Chapter 1 and described in
Chapters 4 and 5. The subcellular distribution of tau-GFP was investigated by analysing
sections of developing brain and cultured cells and tissues. This showed that tau-GFP
was excluded from the interphase nucleus and concentrated in cellular processes and
axon tracts. During mitosis, tau-GFP labelled the mitotic spindle.
INTRODUCTION
The primary motive behind generating these transgenic lines was to obtain
embryonic tau-GFP labelled thalamocortical axons for use in in vitro models of
thalamocortical tract formation (see Chapters 1, 4, and 5). A secondary aim was to
achieve ubiquitous tau-GFP expression so that the transgenic line could be exploited
more generally as a universal source of tau-GFP labelled cells. The characterisation of
tau-GFP expression described here therefore concentrates on developmental stages and
neural structures relevant to thalamocortical tract formation although other structures
and developmental stages are also described.
MATERIALS AND METHODS
Materials used for primary cell culture, tissue processing and imaging are listed
in Appendix B. ES culture is described in Chapter 2. Characterisation of pre-
implantation development and the adult brain was a joint study with Linda Sharp.
Dissociation of embryonic brain
Tissues were dissected from E14.5 brains (TgTP6.3, TgTP6.4, or their non-
transgenic littermates) in ice cold oxygenated EBSS and dissociated with papain
solution (containing DNase) at 37°C for 45 minutes followed by triturating with a flame
polished glass Pasteur pipette to generate a single cell suspension. Cells were washed
twice by centrifugation at 300g for 5 minutes and the cell pellet gently resuspended in
EBSS containing 10% ovomucoid inhibitor and DNase. Cells for FACS were then
resuspended in PBS containing 1% bovine serum albumin. Cells for primary culture
were gently layered over 100% ovomucoid inhibitor solution and centrifuged at 70g for
5 minutes. The upper (cell containing) layer was recovered, centrifuged at 300g for 5
minutes, cells resuspended in EBSS and counted before pelleting at 300g for 5 minutes
and resuspension in serum free culture medium at an appropriate concentration.
Quantification of GFP fluorescence by FACS analysis
Embryonic brain tissues from E14.5 TgTP6.3 and TgTP6.4 embryos or their
non-transgenic littennates were dissociated. White blood cells were isolated from whole
blood by hypotonic lysis of red blood cells in 0.2% NaCl. Blood was centrifuged at
220g for 3 minutes, the cell pellet resuspended in 0.2% NaCl on ice for 30 seconds and
an equal volume of 1.67% NaCl added. This process was then repeated to further enrich
for white blood cells which can osmoregulate so do not lyse in 0.2% NaCl. Dissociated
cells were subject to FACS as described in Chapter 2.
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Tissue processing for Vibratome sections.
Embryos or tissues were fixed in ice cold 4% paraformaldehyde in phosphate
buffered saline (PBS) overnight and embedded in 4% low melting point agarose.
Sections (200pm) were cut on a Vibratome in ice cold PBS or water. Some sections
were counterstained with the DNA stain propidium iodide (PI) before mounting in 1:1
glycerol:PBS containing 10% Vectashield.
Primary neural cell culture
Dissociated cells were plated onto poly-D-lysine coated glass coverslips at a
density of 2000-4000 cells/nrm2 and cultured in serum free medium at 37°C in a
humidified incubator containing 5% C02. After 2-3 days in culture the cells were fixed
by immersion in ice cold 4% paraformaldehyde in PBS for 30 minutes and transferred to
PBS. Some were counterstained with PI before quickly rinsing in water (to prevent salt
crystals forming) and mounting in 1:1 glycerokPBS containing 10% Vectashield.
Confocal microscopy
Cells and tissues were imaged using a Leica TCS NT confocal system and
associated software with DMIRBE (inverted) or DMRE (compound) microscope in a
confocal facility run by Linda Sharp. Bright field images were collected in the
transmitted channel. GFP was detected in the FITC (green) channel. In some cases
sections were counterstained with PI which was detected in the TRITC (red) channel.
Generally, serial optical sections were collected and combined.
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Visualising mitotic machinery in fixed and live tau-GFP ES cells
The tau-GFP expressing ES cell line E14Tg2aSc4TP6.3 from which the
TgTP6.3 transgenic line was derived was used for these experiments. For live imaging,
ES cells were cultured on poly-D-lysine and gelatine coated Willco thin glass bottomed
35mm dishes in a climate controlled chamber (5% C02, 37°C, humidified) on the stage
of an inverted microscope. For chromosomal staining, ES cells were grown on gelatin
coated plastic, fixed for 15 minutes in 4% paraformaldehyde in PHEM buffer (Schliwa
and van Blerkom, 1981) at room temperature, and permeabilised with 0.1% TritonXlOO.
Cells were then stained in a solution of propidium iodide containing 4pg/ml RNase, and
mounted in 100% Vectashield. Confocal images were collected using an oil immersion
lens.
RESULTS
Tau-GFP labelling in TgTP6.3 and TgTP6.4 heterozygotes
Quantification by FACS analysis
FACS was used to quantify the tau-GFP expression in TgTP6.3 and TgTP6.4
embryonic brain at the time of thalamocortical tract formation. Tissues from non-
transgenic littermates were used as controls (Fig. 3.1). Structures dissected from E14.5
brain were dissociated into single cell suspensions for FACS. The protocol used resulted
in the removal of cellular processes, so that, these values effectively represent the tau-
GFP labelling of the cell body. The structures analysed in isolation were hippocampus,
cerebral cortex, ventral telencephalon, and dorsal thalamus. FACS profiles were also
obtained for whole brain and mid- and hind- brain combined.
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Figure 3.1
(A to K) FACS profiles showing tau-GFP fluorescence in cells isolated from
various regions of TgTP6.3 and TgTP6.4 embryonic brain. (A,H) Dissociated
whole brain from E14.5 non-transgenic littermates of TgTP6.3 and TgTP6.4
embryos respectively used to establish baseline fluorescence. (B to G) show FACS
profiles of E14.5 TgTP6.3 embryonic brain regions. (I to N) show FACS profiles
of E14.5 TgTP6.4 embryonic brain regions. The regions examined were: (B,I)
whole brain; (C,J) hippocampus; (D,K) cerebral cortex; (E,L) ventral
telencephalon; (F,M) dorsal thalamus; and (G,N) mid- and hind-brain combined.
Note that A', B' and F shown above Table 3.1 are the same profiles as A, B, and I
respectively with the fluorescent ranges Ml, M2, and M3 used to categorise cells
into the bins listed in Table 3.1 marked. (O to R) FACS profiles showing tau-GFP
fluorescence of white blood cells isolated from (P) TgTP6.3 adult, (R) TgTP6.4
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Table 3.1
Green fluorescence properties of cells dissociated from E14.5 TgTP6.3 and
TgTP6.4 embryonic brain (with non-transgenic littermate cells used to define the
non-fluorescent baseline). The FACS profiles illustrated in Fig. 3.1 were
quantified by assigning cells to one of three bins: Ml comprised of 'all fluorescent
cells' defined as having fluorescence greater than the majority of non-transgenic
cells; M2 comprised of'weakly fluorescent cells' defined as having fluorescence
intermediate between the majority of non-transgenic (non-fluorescent) cells and
the majority of TgTP6.3 (strongly fluorescent) cells; M3 comprising of'strongly
fluorescent cells' defined as the fluorescent range exhibited by the majority of
TgTP6.3 cells. M1=M2+M3. The ranges contained within these bins are marked
on panels A', B', and I' representing the FACS profiles obtained from non-
transgenic, TgTP6.3 and TgTP6.4 whole brain respectively (these profiles are the
same as figures A, B, and I in Fig. 3.1). The table shows the % cells within each
bin for TgTP6.3, TgTP6.4 and non-transgenic cells extracted from the tissues
listed. These figures show that for all tissues examined, the vast majority of
TgTP6.3 cells exhibit similar high fluorescence properties and that the TgTP6.4
cells are either 'non-fluorescent' or 'weakly fluorescent'. Note that the proportion




Genotype % cells in each bin
E14.5 tissue 'non-
fluorescent'
M 1 M2 M 3
WT whole brain 98.8 0.6 0.6 0.0
TgTP6.3 whole brain 0.1 99.9 13.5 87.6
hippocam pus 0.3 99.7 1 1.9 88.9
cerebral cortex 0.2 99.8 1 1.8 89.2
ventral
telencephalon
0.2 99.8 24.5 76.9
dorsal
thalam us
0.4 99.6 8.7 91.5
midbrain and
hindbrain
0.2 99.8 24.0 77.3
WT whole brain 98.6 0.7 0.6 0.1
TgTP6.4 whole brain 73.9 26.1 23.5 2.7
hippocampus 46.0 54.0 47.2 7.0
cerebral cortex 60.3 39.7 36.5 3.5
ventral
telencephalon
72.5 27.5 24.6 3.1
dorsal
thalam us
55.2 44.8 40.1 5.0
m idbrain and
hindbrain
58.2 41.8 37.2 4.8
For comparison of tau-GFP expression in developing TgTP6.3 and TgTP6.4
brains, fluorescence was divided into three bins ('Ml', 'M2' and 'M3') comprising of
cells with fluorescence: (Ml) greater than the majority of non-transgenic cells; (M2)
greater than the majority of non-transgenic cells and less than the majority of TgTP6.3
cells; (M3) the range seen in the majority of TgTP6.3 cells (M1=M2+M3). Table 3.1
shows the proportions of cells in each category.
Most TgTP6.4 cells from the regions of the developing brain examined exhibit
indistinguishable fluorescence as non-transgenic cells. The vast majority of the
remaining TgTP6.4 cells were more weakly fluorescent than the equivalent TgTP6.3
cells. Although it cannot be ruled out that some non-neural cells (for example blood
vessels and membranes) contaminated the preparations of dissociated cells, it is unlikely
that such contamination could account for the intermediate (bin M2) fluorescence seen
in the TgTP6.4 FACS profiles judging from the intense tau-GFP labelling seen in these
cell types in the TgTP6.4 brain (see Fig. 3.3 B,C).
Although the TgTP6.3 brain cells generated FACS profiles with a single peak,
these profiles were not perfect bell-shaped curves. This suggests that each population
actually consists of subpopulations of cells with distinct (though similar) fluorescence
properties whose individual profiles overlap to generate a composite profile. This may
reflect subtle cell type specific differences in the activity of the transgene promoter or in
tau-GFP structure or stability. The TgTP6.4 FACS profiles bore even less resemblance
to a bell shaped curve than the TgTP6.3 profiles indicating a continuum of fluorescence
intensities ranging from non-fluorescent to levels approaching those seen in the TgTP6.3
cells. This suggests that the CAG promoter in the TgTP6.4 line is more sensitive to cell
type specific effects than it is in the TgTP6.3 line, presumably this is a position effect
reflecting the properties of integration site (as discussed in Chapter 2).
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FACS analysis of white blood cells from TgTP6.3 and TgTP6.4 adult
heterozygotes showed that TgTP6.3 white blood cells were all fluorescent compared to
white blood cells from non-transgenic controls. Unlike in brain tissues, however, there
were clearly two distinct populations (see the two fluorescent peaks in Fig. 3.1 P)
presumably corresponding to two subpopulations of TgTP6.3 blood cells with distinct
fluorescent properties. In contrast, many TgTP6.4 white blood cells exhibited the same
fluorescence as non-transgenic controls and the remainder exhibited a range of
fluorescence intensities which overlapped with those seen for the TgTP6.3 white blood
cells but did not resolve into two distinct subpopulations (see Fig. 3.1 R).
Spatial and temporal labelling pattern
The onset of detectable paternal transgene expression was determined as the
stage of development at which GFP fluorescence could be detected in approximately
half of the embryos obtained from a cross between heterozygous (Tg/-) males and wild-
type (-/-) females (Mendelian ratio Tg/-:-/- of 1:1 for a Tg/- x -/- cross). Examination of
preimplantation TgTP6.3 embryos showed that transgenic embryos could first be
distinguished from their non-transgenic littermates at the 8-cell stage (Fig. 3.2 A to D).
All embryos younger than the 4-cell stage had a similar fluorescent appearance
indicating that paternal transgene expression was not detectable before the 4-cell stage.
The onset of maternal TgTP6.3 expression could not be determined by this method as all
eggs and early embryos from TgTP6.3 females were highly fluorescent due to
maternally expressed tau-GFP regardless of whether the embryos themselves were
transgenic (not shown). Interestingly, sperm from TgTP6.3 heterozygote males were not
detectably more fluorescent than sperm from non-transgenic males (not shown).
Examination of Vibratome sections of TgTP6.3 embryos and post-natal animals
indicated that tau-GFP was widely expressed throughout the developing brain.
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Following the onset of tau-GFP expression in the preimplantation embryo (Fig. 3.2 A to
D), expression continues to be widespread in TgTP6.3 blastocysts (Fig. 3.2 E,F), in
developing embryos throughout the remainder of gestation (Fig. 3.2 G to K) and in the
adult brain (Fig. 3.2 L,M).
TgTP6.4 embryos exhibited strong and widespread tau-GFP expression in many
non-neural tissues but tau-GFP was almost undetectable in a large proportion of the
CNS. At El0.5 TgTP6.4 heterozygotes do express tau-GFP but the head structures do
not appear to be as fluorescent as is seen in TgTP6.3 embryos (compare TgTP6.4
embryo in Fig. 3.3 A to an equivalent TgTP6.3 embryo in Fig. 3.2 G). Examination of
coronal sections of E14.5 TgTP6.4 forebrain show that the majority of the fluorescence
resided in the membranes surrounding the brain and in blood vessels embedded in
neural tissue. Almost no fluorescence was detectable in the neural tissue itself (see
figure 3.3 B, C and compare to equivalent sections of TgTP6.3 embryos in Fig. 3.2 I,
also see Fig. 3.4 E).
Non-uniform distribution of tau-GFP fluorescence in embryonic brain
Although FACS analysis (Fig. 3.1 and Table 3.1) showed that all TgTP6.3
embryonic brain cells (or at least their cell bodies) expressed similar levels of tau-GFP,
the intensity of tau-GFP labelling was not uniform across all regions of the developing
brain. Certain regions were more intensely labelled with GFP fluorescence than others
(Fig. 3.2). As discussed below, this can at least partly be attributed to the subcellular
distribution of tau-GFP. As tau-GFP label is excluded from the interphase nucleus,
structures exhibiting a high nuclear packing density appear more weakly labelled than
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Figure 3.2
Confocal images showing widespread tau-GFP expression throughout
development of TgTP6.3 heterozygotes and in the adult brain. (A) Bright field and
(B) green fluorescent images of the same field showing that at the 8-cell stage tau-
GFP is expressed throughout two transgenic embryos with no expression
detectable in four non-transgenic littermates. (C) Bright field and (D) green
fluorescent images of one of these fluorescent 8-cell embryos are also shown. (E)
Bright field and (F) green fluorescent images of the same field showing that at the
blastocyst stage (E3.5) tau-GFP is expressed throughout two transgenic embryos
with no expression detectable in a third non-transgenic littermate. (G)
Wholemount of a transgenic El 0.5 embryo showing expression throughout head
and body. (H,I) E14.5 embryo showing (H) sagittal section through whole embryo
(similar orientation to (G)) and (I) coronal section through the head at the level of
the forebrain. (J,K) El9.5 brain showing (J) sagittal section and (K) coronal
section of forebrain. (L,M) Adult brain showing (L) sagittal section and (M)
coronal section of left hemisphere. Note that the posterior end of the embryo in
(H) and rostral-most brain region in (L) are missing from these sections. In all
cases, tau-GFP expression appears throughout all embryonic tissues. Dorsal
thalamus (dt), cerebellum (cb), cerebral cortex (cc) and carotid artery (ca), are





Confocal images showing limited tau GFP expression throughout development of
TgTP6.4 heterozygotes. (A) E10.5 embryo. (B, C) Coronal sections through head
of E14.5 embryo at the level of the forebrain. Note that although eye and brain
tissue is weakly labelled, blood vessels are labelled as is surrounding non-neural




regions with more cytoplasm (including fibre tracts and the lens of the eye). TgTP6.3
tissues whose nuclei have been stained with PI (Fig. 3.4 C,D and F to M) illustrate this.
Tau-GFP efficiently labels long cellular processes
In using a tau-GFP fusion transgene I anticipated labelling microtubule
containing structures, notably the long cellular processes which connect cells in the
CNS. To test whether this had been successfully accomplished I looked at tau-GFP
localisation in cultured cells and in fibre tracts. El6 cortex was dissociated into single
cells, plated onto coverslips, and imaged after time in culture. Tau-GFP was present in
the cytoplasm where it efficiently filled cellular processes (compare Fig. 3.4 A, B). To
evaluate the TgTP6.3 transgene as a marker of fibre tracts I chose the thalamocortical
axon tract (Fig. 3.4 E) as an example (Auladell et al., 2000). As described in Chapter 1,
the thalamocortical tract consists of axons connecting the dorsal thalamus (dt) with the
cerebral cortex (cc). The thalamocortical tract passes ventrally through the ventral
thalamus (vt), makes a sharp lateral turn (avoiding the hypothalamus (ht)) and enters the
ventral telencephalon (vtel) through the internal capsule (ic), before turning dorsally into
the intermediate zone (iz) of the cerebral cortex. The thalamocortical fibre tract is
highlighted by tau-GFP label with particularly strong staining seen in the internal
capsule and intermediate zone (Fig. 3.4 E). The direction of fibres is apparent although
individual fibres are hard to resolve (Fig. 3.4 F,H). There was strikingly reciprocity
between the localisation of tau-GFP and cell nuclei (compare Fig. 3.4 C, F, and H to D,
G, and I). Apparent 'holes' in tau-GFP labelling correspond to the nuclei of cells stained
red with propidium iodide (compare tau-GFP label in Fig. 3.4 C with propidium iodide
staining in Fig. 3.4 D, see also Fig. 3.3 J to M).
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Figure 3.4
Tau-GFP label reveals neural processes and is excluded from the nucleus in
TgTP6.3 transgenic mice. (A) Bright field and (B) green fluorescent images of
dissociated E16 cortical cells cultured on coverslips. Tau-GFP efficiently labels all
the neural processes which can be detected by bright field microscopy. (C) Green
fluorescence and (D) PI stained nuclei in Vibratome sections of El 6 cortex.
Apparent 'holes' in the tau-GFP labelling correspond to the location of nuclei
showing that tau-GFP is excluded from the nucleus. (E) Coronal Vibratome
section of transgenic embryonic brain illustrating the thalamocortical axon
pathway which connects the dorsal thalamus (dt) and cerebral cortex (cc). Note the
intense green fluorescence of the fibre tract in the ventral thalamus (vt), internal
capsule (ic), and intermediate zone (iz) of the cerebral cortex indicating that the
entire tract is efficiently labelled. (F,H) Green fluorescence and (G,I) PI staining in
Vibratome sections of E16 brain showing (F,G) intermediate zone (coronal
section) and (H,I) internal capsule(sagittal section). Note the reciprocity of tau-
GFP and propidium iodide staining which accounts for the intense labelling in
fibre tracts compared to regions of high nuclear packing density. (J to K) Merged
tau-GFP and PI fluorescence images of El 8.5 brain showing (J) the anterior
commissure, (K) the corpus callosum, and (L) the optic nerve (all sections in a
coronal plane). Note that these fibre tracts (marked with an 'f) exhibit
concentrated green fluorescent label and were of lower nuclear packing density
than adjacent tissue. (M) the carotid artery (ca). Note also the extremely intense
green fluorescence of the carotid artery wall in M ( M is a higher magnification of
the carotid artery indicated in Fig. 3.2 K). Bar in (A to D and J to M); 20pm, (E);
500pm, (F to I); 100pm.
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Figure 3.4
Intense tau-GFP labelling was also apparent in other fibre tracts in TgTP6.3
brain including the anterior commissure, corpus callosum, and optic nerve (see Fig. 3.4
J, K, and L respectively). For unknown reasons, blood vessels were intensely fluorescent
(this feature was also seen in the TgTP6.4 line as shown in Fig. 3.2 B,C). Fig. 3.4 M
shows a high power magnification of the carotid artery (ca) indicated in Fig. 3.2 K. The
artery wall is intensely fluorescent.
Tau-GFP labels mictrotubule-containing structures
As described in Chapter 1, tau is a microtubule binding protein. I expected that
the ability of tau-GFP to bind to microtubules would provide a means to visualise the
microtubule component of the cytoskeleton. In living cells these subcellular details are
otherwise inaccessible.
The microtubule component of the cytoskeleton plays an important role in cell
function throughout the cell cycle with microtubules existing in a constant state of
dynamic instability. During interphase, microtubules radiating from a single microtubule
organising centre (MTOC) fill the cytoplasm and bundle together to form the core of
developing processes. At the onset of mitosis, the MTOC replicates to generate two
daughters, which migrate to opposing poles of the cell. The microtubules reorganise to
generate the mitotic spindle, a structure which co-ordinates the equal segregation of
chromosomes to the daughter cells.
To confirm that tau-GFP labels a variety of microtubule containing structures, I
examined live preparations of tau-GFP expressing cells from TgTP6.3 transgenic mice
and the E14Tg2aSc4TP6.3 ES cell line from which the mice were derived. A single
optical section through live ES cells (Fig. 3.5 A) shows a subcellular fibrous tau-GFP
labelling pattern in the cytoplasm. Live interphase cells from embryonic heart exhibit
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Figure 3.5
Confocal imaging of tau-GFP in living cells allows visualisation of subcellular
structures and reveals the filamentous microtubule network. (A to C) Tau-GFP
labelling of living interphase cells. (A) Filamentous tau-GFP labelling in live ES
cells. (B) Tau-GFP labelling radiates from a single point in embryonic heart cells
(see also cell in top left-hand corner of A). (C) Tau-GFP labels growing processes
in cultured neurons. (D to K) Tau-GFP labels the mitotic machinery in dividing
ES cells. (D to G) In fixed cells representing key stages of mitosis tau-GFP
labelling can be seen as green spots that correspond to the expected position
occupied by the MTOCs. Chromosomes are stained red. The location of the spots
of tau-GFP label relative to the chromosomes matches the location occupied by
the MTOCs after they: (D) replicate during prophase to coincide with
chromosome condensation and the onset of mitosis; (E) flank the chromosomes as
they line up along the plane of division (equator) during metaphase; and (F,G)
segregate to the opposite poles of the cell occupied by the MTOCs at anaphase. (H
to K) Confocal images selected from time-lapse footage of a live tau-GFP
expressing ES cell undergoing mitosis. The position of tau-GFP labelling matches
the position occupied by the mitotic spindle as the cell divides. (H,I) Intense tau-
GFP labelling can be seen perpendicular to and symmetrically arranged around the
plane of cell division as the cell undergoes metaphase. (J,K) The cell proceeds (J)
through anaphase and (K) telophase to generate two daughter cells (the lower
daughter cell is not included in this optical section). Pairs of yellow bars (H to K)
mark the plane of cell division. Note that the mitotic spindle appears much more
strongly labelled in live cells (H,I) than in fixed cells at comparable stages of
mitosis (E,F). Images in (A, D to G, I to K) are single optical sections chosen to
emphasise subcellular detail. Bar in (A, C to K); 5pm, (B); 10pm.
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Figure 3.5
GFP labelling radiating from a single intensely labelled point into the cytoplasm (Fig.
3.5 B). Neural cells which have been dissociated and cultured exhibit long evenly
labelled processes, with a particularly strong GFP signal extending from their base (Fig.
3.5 C).
During mitosis tau-GFP labels the mitotic machinery. Representative examples
of fixed cells (chromosomes stained red with the DNA stain propidium iodide) are
shown (Fig. 3.5 D to G). At the start of mitosis the MTOCs replicate as the
chromosomes condense (Fig. 3.5 D). The chromosomes then congregate along the plane
of division (equator) to form the metaphase plate which is flanked (at the poles) by the
MTOCs between which the mitotic spindle is formed (Fig. 3.5 E) before segregating
towards the MTOCs along the mitotic spindle (Fig. 3.5 F). Mitosis concludes as the
daughter cells separate each with a complete set of chromosomes associated with a
MTOC (Fig. 3.5 G).
The pattern of tau-GFP labelling described above is consistent with tau-GFP
labelling microtubules during interphase and mitosis with particularly strong labelling
seen at the MTOC. The tau-GFP does not associate with the chromosomes themselves
as propidium iodide and tau-GFP label do not co-localise (Fig. 3.5 E to G).
Time-lapse footage of a tau-GFP expressing ES cell undergoing cell division
shows that tau-GFP permits visualisation of the mitotic machinery as mitosis proceeds.
Images selected from this time-lapse footage are shown (Fig. 3.5 H to K). Tau-GFP
labels an oval structure reminiscent of the mitotic spindle (Fig. 3.5 H,I) in a cell, which
goes on to divide (Fig. 3.5 J,K). A strong signal corresponds to the microtubule rich
midbody which forms at the constriction between daughter cells (Fig. 3.5 K). Tau-GFP
label is excluded from the chromosomes, which can therefore be visualised (particularly
clear in Fig. 3.5 J but also apparent in Fig. 3.5 H,I).
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These patterns of tau-GFP labelling resemble the distribution of microtubules
within the cell during different phases of the cell cycle (Waters et al., 1993) and are
consistent with the localisation of ectopically expressed tau protein reported by others
(Ludin and Matus, 1998, Kaech et al., 1996, Preuss and Mandelkow, 1998, Mills et al.,
1998, Rodriguez et al., 1999) where tau decorates the microtubule component of the
cytoskeleton.
DISCUSSION
The TgTP6.3 line exhibits widespread tau-GFP expression throughout
development and data presented in this Chapter confirm that at El4.5, during the period
of thalamocortical tract development, expression is uniform and ubiquitous throughout
the brain. This is in marked contrast to the TgTP6.4 line which exhibits much weaker
tau-GFP expression in neural structures with most cells being apparently unlabelled.
Analysis of white blood cells extracted from TgTP6.3 and TgTP6.4 heterozygous adults
showed that the expression properties seen in neural tissue were mirrored in the blood.
TgTP6.3 white blood cells were all fluorescent, although two fluorescent populations
were discernible, whereas many TgTP6.4 white blood cells appeared to be non-
fluorescent. The TgTP6.4 line is therefore unsuitable for my purposes and the remainder
of this study concentrates on the evaluation and exploitation of the TgTP6.3 line.
Since transgenic mice ubiquitously expressing untagged GFP are already
available (Okabe et al., 1997, Hadjantonakis et al., 1998, Kawamoto et al., 2000), it is
important to emphasise the benefits of each labelling system. Untagged GFP diffuses
throughout the cell freely so a labelled cell generates a uniform fluorescent signal,
although the cell body tends to fluoresce much more strongly than thin processes. Axons
of cells transfected with soluble GFP are less easy to detect than those of cells
transfected with tau tagged GFP (see Chapter 2, Rohm et al, 2000). Tau tagged GFP
122
decorates the microtubule component of the cytoskeleton and is excluded from the
interphase nucleus (this Chapter, Ludin and Matus, 1998, Kaech et ah, 1996, Preuss and
Mandelkow, 1998, Mills et ah, 1998, Rodriguez et ah, 1999). This allows cellular
features to be visualised in cells expressing tau-GFP which are less clear in cells
expressing soluble GFP. For example, cell division can be tracked by watching the
fluorescent signal generated by tau-GFP decorating the mitotic machinery, and
alterations in microtubule organisation are also associated with other processes such as
cell death (Mills et ah, 1998) and migration. A potential benefit of tau tagged GFP over
untagged GFP is that the tagged version is anchored to the cytoskeleton so is less likely
to diffuse out of cells during tissue processing resulting in loss of signal and increased
background. This problem was reported for a line of transgenic mice expressing GFP
where live preparations had to be perfused to wash away leaking GFP (Van den Pol and
Ghosh, 1998). In my experiments, tau-GFP expressing cells and tissues are cultured in
contact with unlabelled tissue without any obvious deterioration of signal caused by
GFP leaking (see Chapters 4 and 5) and the tau-GFP label remains detectable in fixed
tissue preparations after immunostaining for several other proteins (data not shown).
Tau tagged GFP therefore appears to be a more robust label than soluble GFP with the
advantage of illuminating the microtubule component of the cytoskeleton.
Fixation of tau-GFP labelled cells using the methods employed in this study does
not obviously result in a decrease in GFP fluorescence since labelled and unlabelled
cells and their processes could easily be distinguished in live and fixed preparations (see
Chapters 4 and 5). Fixation, even when using protocols specifically developed to
preserve microtubule structure (Schliwa and van Blerkom, 1981, Waters et ah, 1993),
does however appear to alter the subcellular distribution of tau-GFP. For example,
comparison of tau-GFP labelling of the mitotic machinery in fixed and live cells reveals
that whereas in live cells the mitotic spindle is very clearly labelled, in fixed cells it
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appeared much fainter and the clearest fluorescent features are the MTOCs between
which the spindle forms. In general, fixation appears to cause tau-GFP label to become
'hazy' compared to the sharply defined tau-GFP labelling seen in live cells, but does not
result in significant deterioration in the quality of labelling above the subcellular level.
Of particular importance for the exploitation of these mice for the experiments
described in Chapters 4 and 5, the tau-GFP is efficiently transported down cellular
extensions and therefore labels axons and fibre tracts.
The ability of tau-GFP to decorate microtubules allows the visualisation of the
microtubule containing cytoskeleton at a subcellular level. In proliferating cells
expressing tau-GFP, I show that the pattern of tau-GFP labelling can be used to identify
phases of the cell cycle. The breakdown of the nuclear envelope is indicated by tau-GFP
label, excluded from the nucleus during interphase, filling the cell. This alteration in
subcellular distribution might also reflect phosphorylation of tau-GFP occuring at the
onset of mitosis as phosphorylation reduces the affinity of tau for microtubules (Fig. 1.9,
page 62). The MTOCs are strongly labelled allowing their replication and movement to
be tracked and the formation and orientation of the mitotic spindle is also apparent.
Intense GFP labelling corresponds to the structure separating the daughter cells (the
midbody) at the end of mitosis. Although not addressed in such detail as cell division in
this study, the indications are that changes in microtubule structure associated with cell
differentiation, migration, and death, should also be apparent.
Although the transgene is ubiquitously expressed, the subcellular localisation of
tau-GFP causes certain anatomical features to be highlighted. In the brain for example,
fibre tracts appear bright, regions of high nuclear density appear dim, and blood vessels
and membranes (which are richly supplied with blood vessels) also appear bright. These
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features can be used to provide fluorescent anatomical landmarks which are useful when
targeting brain regions for dissection or injection.
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CHAPTER 4
EVALUATION OF TgTP6.3 CELLS AND TISSUES IN MIXING EXPERIMENTS
SUMMARY
Chapter 4 describes applications of TgTP6.3 mice as a source of cells in a
variety of cell mixing paradigms. TgTP6.3<->non-transgenic chimeras are examined at
the blastocyst stage and after development into late gestation embryos. In other
experiments TgTP6.3 and non-transgenic embryonic neural cells and tissues are
combined in culture to evaluate the extent to which neural cell morphology and axons of
labelled cells can be distinguished against a background of unlabelled cells and tissues.
These experiments demonstrated that TgTP6.3 cells and tissues could readily be
detected against a background of unlabelled cells and tissues and that the TgTP6.3 line
was suitable as a source of cells for the experiments described in Chapter 5.
INTRODUCTION
As described in Chapter 1, my primary motive for generating transgenic mice
ubiquitously expressing a tau-GFP transgene was as a source of cells and tissues for use
in an investigation of the genetic control of thalamocortical tract formation. Before
embarking on these experiments (described in Chapter 5) I performed some 'proof of
concept' cell mixing experiments with cells and tissues derived from the TgTP6.3 line.
The aim of these experiments was to establish whether the tau-GFP labelled cells could
be readily detected after mixing with un-labelled cells and the extent to which cell
morphology and axons of labelled cells was revealed by the tau-GFP label.
TgTP6.3<->non-transgenic chimeras generated by aggregation of 8-cell TgTP6.3
and non-transgenic embryos were examined at various stages of development. In the
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developing chimera, TgTP6.3 and non-transgenic cells 'compete' to contribute to
various structures (see Rossant and Spence, 1998) and analysis of these chimeras was
anticipated to indicate if the tau-GFP expressing cells were differently competent to
contribute to various structures compared to non-transgenic cells. This type of analysis
has been used to show that cells lacking Pax6 function do not contribute to certain
developing eye structures (Quinn et ah, 1996, Collinson et ah, 2000).
The examination of TgTP6.3 brains described in Chapter 3 established that tau-
GFP expression was uniform and ubiquitous at the time of thalamocortical tract
formation and that fibre tracts, including the thalamocortical tract, were strongly
labelled. These results strongly suggested that tau-GFP labelled the full extent of cell
morphology but because all the cells were 'green' it was conceivable that unlabelled tau-
GFP expressing fibres might not be detected against a labelled background. Tau-GFP
expressing cells and tissues were cultured with non-expressing cells and tissues to test
the extent to which fibres were labelled and could be detected against an unlabelled
background.
MATERIALS AND METHODS
Materials used for cell culture, tissue processing, and preparation of specimens
for microscopy in this Chapter are listed in Appendix B. Chimeras were produced by
Margaret Keighren and Gillian MacKay. Vibratome sectioning, dissociated cell culture,
and mounting for confocal microscopy were performed as described in Chapter 3.
Organotypic explant and seeding co-cultures were performed as described in Chapter 5.
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Aggregation chimeras
Chimeras were produced as described by Tarkowski (1961) and reviewed in
Rossant and Spence, (1998). 8 cell stage transgenic and non-transgenic embryos were
aggregated to produce chimeras. Some of these were allowed to develop in vitro into
blastocysts. These were then imaged while still growing in culture medium in a climate
controlled chamber (5% C02, 37°C, humidified) on the stage of an inverted confocal
microscope. Others were transferred to pseudo-pregnant females and allowed to develop
into El4.5 chimeric embryos before harvesting their brains for Vibratome sectioning
and imaging.
RESULTS
Tau-GFP labelled cells are detectable in cell mixing experiments
I anticipated that a major application of TgTP6.3 mice is as a universal source of
tau-GFP labelled cells. I next assessed their properties in three types of cell mixing
paradigm in which transgenic and non-transgenic cells were combined in vivo in
chimeras or in vitro in primary neural culture.
Chimeras
The production of chimeras allows analysis of cellular interactions throughout
development (Rossant and Spence, 1998). As the onset of tau-GFP expression occurs in
the first few days after fertilisation, I wanted to test whether TgTP6.3 and non-
transgenic cells could be distinguished in early embryos. TgTP6.3<-»non-transgenic
chimeras produced by aggregating 8 cell stage transgenic and non-transgenic embryos
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Figure 4.1
Tau-GFP labelled cells are easily detected after mixing with non-transgenic cells
in TgTP6.3<-»non-transgenic chimeras . (A,B) Blastocyst stage aggregation
chimeras between transgenic and non-transgenic embryos. These chimeras were
generated by G. MacKay and M. Keighren. Fluorescent confocal images show (A)
a balanced chimera and (B) an unbalanced chimera in which most of the cells are
of transgenic origin. In each case the position of labelled cells can easily be
mapped. The nuclear exclusion of tau-GFP facilitates the counting of labelled
cells. (C to K) Vibratome sections illustrating tau-GFP fluorescence in E14.5
TgTP6.3<-»non-transgenic chimeras. (C to E) shows a chimeric eye at (D) low
power and (E) a higher magnification of the retina. Note the sectoring of tau-GFP
labelled cells into columns in (D,E). (F to H) shows chimeric dorsal telencephalon
(G) at low power and (H) at higher magnification of the ventricular and
intermediate zones of the cerebral cortex. Note the sectoring of tau-GFP labelled
cells into columns in (G) and tau-GFP labelled axons in the intermediate zone in
(H). (I to K) shows (J) the thalamocortical tract in a chimeric embryo (similar
section to that shown in Fig 3.4 E on page 118) with (K) a higher power
magnification of the dorsal thalamus. (C,F and I) show PI staining of the section
shown in (D,G and J) does not reveal gross differences in cytoarchitecture between
regions enriched for tau-GFP or non-expressing cells. Bars in (A,B); 20pm, (C, D,
F, G, I, J); 100pm, (E, H, K); 25pm.
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Figure 4.1
were cultured and imaged while still alive. Fluorescent images of two such chimeras
undergoing blastocoel formation, in which labelled and unlabelled cells have become
intermingled, are shown in Fig. 4.1. In one chimera (Fig. 4.1 A) numbers of transgenic
and non-transgenic cells are balanced and in the other (Fig. 4.IB) transgenic cells are
more abundant than non-transgenic cells. Note that the tau-GFP label allows the nuclear
position of expressing cells within the chimera to be mapped. Non-expressing cells
derived from the non-transgenic embryo appear as gaps in the green fluorescence.
TgTP6.3<->non transgenic chimeras allowed to develop into E14.5 embyos show
that tau-GFP expressing cells contribute to a variety of developing forebrain structures
including the eye (Fig. 4.1 C to E), the cerebral cortex (Fig. 4.1 F to H), and the
thalamocortical tract (Fig. 4.1 I to K). This showed that TgTP6.3 cells were not grossly
discriminated against (or for) with respect to generation of structures involved in
thalamocortical tract formation. This analysis was not performed in sufficient
quantitative detail (see Quinn et al, 1996, Collinson et ah, 2000) to conclude whether the
tau-GFP expressing cells contributed to exactly the same extent as non-transgenic cells.
Dissociated cell co-culture
Co-culture of dissociated cells is often used to investigate how the behaviour of
one cell population is influenced by proximity to another. To test the use of my cells in
this type of experiment, dissociated cells from transgenic and non-transgenic embryonic
cerebral cortex were mixed and cultured after plating onto coverslips. Bright field
images of such a co-culture show a tangle of cellular processes where it is very difficult
to assign a particular process to a particular cell (Fig. 4.2 A). This is resolved by
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Figure 4.2
Tau-GFP labelled cells are easily detected after mixing with non-transgenic cells
in brain in primary neural co-culture. (A) Bright field and (B) fluorescent confocal
images of a mixed co-culture of dissociated transgenic and non-transgenic cortex.
Note that the morphology of cells expressing tau-GFP is clearly marked by green
fluorescence, nuclei are stained red with PI to aid comparison of fields. (C to E)
Confocal images of organotypic co-culture of tau-GFP expressing thalamus with
non-transgenic ventral telencephalon. (C,D) Green fibres can clearly be seen as
they enter unlabelled tissue(dotted lines in (C)) with higher magnification in (D).
(E,F) Visualisation of tau-GFP labelled cells which have integrated into unlabelled
tissue during (E) organotypic co-culture and (F) after seeding of tau-GFP labelled
cortical cells onto an unlabelled cortical slice (greyscale of fluorescent image). Bar
in (A, B); 10pm, (C), 500pm, (D); 200pm, (E, F); 20pm.
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Figure 4.2
examining the fluorescence image, where tau-GFP clearly marks the morphology of
transgenic cells and allows the course of their processes to be traced (Fig. 4.2B, nuclei
counterstained red mark positions of cell bodies of both expressing and non-expressing
cells).
Organotypic explant and seeding co-cultures
Organotypic co-culture is often used to investigate how axons generated by one
tissue respond when challenged with the environment supplied by a second tissue.
Axons in organotypic co-culture typically travel longer distances than is seen in cultures
of dissociated cells and I wanted to confirm that tau-GFP labelling was efficient over
longer distances. In vivo, thalamocortical axons travel from the thalamus to the cortex
via the ventral telencephalon. In vitro, thalamic explants innervate explants of ventral
telencephalon (see Chapter 5). Explants of transgenic E14.5 thalamus were cultured with
explants of non-transgenic ventral telencephalon. After 3 days in culture the explants
were fixed and imaged. Tau-GFP labelled fibres, which have grown into the unlabelled
explant, were clearly visible (Fig. 4.2C) and at higher power individual fibres could be
clearly resolved (Fig. 4.2D). In some of these cultures labelled cells migrated into
unlabelled tissues and integrated into them (Fig. 4.2E). Tau-GFP labelled cells are also
easily detected after seeding onto slices of non-transgenic cortex and sprouting of
processes in culture (Fig. 4.2F).
DISCUSSION
Experiments in which tau-GFP expressing cells and tissues derived from
TgTP6.3 heterozygote embryos are cultured with non-expressing cells or tissues
demonstrate the experimental potential of these mice in cell mixing experiments.
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Labelled cells and their processes can be visualised by fluorescence microscopy in live
and fixed preparations and their behaviour mapped.
Long term cell mixing experiments such as transplants and chimeras where
labelled cell populations must remain identifiable for weeks or months after the
experiment is started demand that the label must be stable. TgTP6.3 cells fit these
criteria since tau-GFP expression is ubiquitous both in ES cells before and after
differentiation in vitro and in all cells from transgenic mice derived from these ES cells.
A cell carrying the transgene and its descendants should therefore be detectable
indefinitely.
These tau-GFP expressing ES cells and TgTP6.3 transgenic mice can be used as
a source of labelled cells of any cell type for use in short or long term cell mixing
experiments or to establish cell lines. Transgenic 'donor' cells and tissues can be
visualised in exquisite detail after mixing and culture with non-transgenic 'host' tissues
demonstrating the value of my cells in cell mixing applications. These include the
development of neural transplantation technologies (Isacson et al., 1995, Scheffler et al.,
1999, Svendsen and Smith, 1999, Mezey et al., 2000, Brazelton et al., 2000). Genetic
modifications to the labelled cells can be achieved by manipulating the ES cells or by
breeding the transgenic mice to place the tau-GFP transgene on different genetic
backgrounds (see Chapter 5).
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CHAPTER 5
PAX6 IS REQUIRED AUTONOMOUSLY BY THALAMOCORTICAL AXONS
SUMMARY
Chapter 5 describes the identification of an autonomous requirement for Pax6
within the dorsal thalamus for thalamocortical tract projection. To perform these
experiments I developed an in vitro assay for thalamocortical tract navigation. By using
tau-GFP expressing embryonic dorsal thalamic explants, I was able to see the green
fluorescent axons as they navigated through unlabelled tissues.
INTRODUCTION
As described in Chapter 1, the thalamus fails to make appropriate cortical
connections in mouse embryos lacking Pax6 function. Thalamic axons become stalled in
the ventral telencephalon. Axon tracing studies in rat embryos lacking Pax6 function
(Pax6rSey/rSey) show that rather than growing through the internal capsule towards the
cerebral cortex, thalamocortical axons become stalled in the ventral telencephalon
forming a characteristic mushroom shaped structure composed of stalled axons (Kawano
et ah, 1999 and Fig. 1.4 B on page 38). Mouse Pax6Sey/Sey embryos exhibit similar
thalamocortical defects in the absence of Pax6 function (Pratt et ah, 2000b). A
comparison of the timetables of Pax6 expression and thalamocortical tract formation
reveals several sites at which Pax6 might influence thalamocortical tract projection (Fig.
1.4 A,B,C note that Fig. 1.4 B represents a stage of development after the time Pax6 has
become down-regulated in the dorsal thalamus). The failure of the tract to form might
reflect an autonomous requirement of thalamocortical axons for Pax6 (source defect), a
requirement for Pax6 in cells lining the thalamocortical tract (pathway defect), or a
combination of the two.
134
MATERIALS AND METHODS
Materials used for primary cell culture, tissue processing, and mounting for
microscopy are listed in Appendix B. Vibratome sectioning and confocal microscopy
were performed as described in Chapter 3.
Primary culture of embryonic neural cells and tissues
Brains from E14.5 wild type or mutant embryos were collected in ice cold
oxygenated EBSS prior to processing for slices or dissociation and cultured in serum
free medium as described below. The culture strategies are outlined in Fig. 5.2.
Organotypic co-cultures
Explants were prepared from El4.5 embryonic brains using the methods and
reagents described by Lotto and Price, (1999a,b) and Pratt et al., (2000a,b). Organotypic
explants (300 pm thick) containing the regions of interest (dorsal thalamus, cerebral
cortex, ventral telencephalon or hypothalamus) were dissected from coronal slices of
E14.5 brains obtained using a tissue chopper (as illustrated in Fig. 5.4 A-D) and
arranged on collagen-coated inserts. Dorsal thalamic explants were from tau-
GFP:Pax6+/+ or tau-GFP:Pax6Sey/Sey embryos; other tissues were from Pax6+/+ or
Pax6Sey/Sey embryos that did not carry the transgene. Dorsal thalamus was recognised
under transmitted and epifluorescence illumination, guided by anatomical landmarks
known to correspond to gene expression boundaries defining the dorsal thalamus in both
wild-types and mutants (Fig. 5.4 A-E; described in Results). The left and right dorsal
thalamus were left joined dorsally in culture and their cut edges (red dotted lines in Fig.
5.4 B,D, just anterior to the border between dorsal and ventral thalamus) were placed
against different tissues on each side. To recreate the topography of intact brain as much
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as possible, these cut edges of dissected thalamus were placed in contact with either the
medial edge of dissected ventral telencephalon or the dorsal edge of dissected
hypothalamus (Fig. 5.4B,D see also Fig. 5.2). Following culture for 3 days in serum-free
medium, cultures were fixed in ice-cold 4% paraformaldehyde in phosphate PBS,
stained with the nuclear counterstain T0-PR03 and mounted in 1:1 glycerohPBS
containing 10% Vectashield. Images of the cultures were obtained by combining serial
optical sections acquired with a Leica confocal microscope. The following co-culture
combinations were tested: Pax6+/+ ventral telencephalon with either tau-GFP:Pax6+/+
thalamus (n=25) or tau-GFP:Pax6Sey/Sey thalamus (n=21); Pax6+/+ cortex with either tau-
GFP:Pax6+/+ thalamus (n=21) or tau-GFP:Pax6Sey/Sey thalamus (n=21); Pax6+/+
hypothalamus with either tau-GFP:Pax6+/+ thalamus (n=6) or tau-GFP:Pax6Sey/Sey
thalamus (n=6); Pax6Sey/Sey ventral telencephalon with tau-GFP:Pax6+/+ thalamus (n=4).
In some cases cultures were viewed under epifluorescence while still growing or fixed
for imaging at various time points to establish the time course of innervation.
Seeding experiments
Seeding was based on the method originally described by Emerling and Lander
(1994) for seeding thalamic cells onto slices of cerebral cortex with the modifications
described below. Embryonic thalamic cells were dissociated from thalamus using a
papain dissociation system. Thalamus was dissected from El4.5 tau-GFP:Pax6+/+ or
tau-GFP:Pax6Sey/Sey brains in ice cold oxygenated EBSS and incubated in papain
solution (containing DNase) at 37°C for 45 minutes followed by triturating with a flame
polished glass Pasteur pipette to generate a single cell suspension. Cells were washed
twice by centrifugation at 300g for 5 minutes and gentle resuspension of the cell pellet
in EBSS containing 10% ovomucoid inhibitor. The cell suspension was then layered
over 100% ovomucoid inhibitor, centrifuged at 70g for 5 minutes, and the upper layer
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containing dissociated cells recovered. Cells were then counted and the volume adjusted
to give a suspension of 3x106 cells/ml in serum free culture medium.
300 pm thick coronal slices of Pax6+/+ El4.5 brain were obtained using a tissue
chopper and incubated in thalamic cell suspension for 1 hour with occasional agitation.
After this time, slices were carefully washed by serial transfer through three changes of
culture medium using a wide bore flame polished glass Pasteur pipette. Slices were then
arranged on a collagen coated filter and cultured for 3 days prior to fixation, T0PR03
staining, and imaging on a confocal microscope.
The following seeding combinations were tested: tau-GFP:Pax6+/+ thalamic
cells seeded onto Pax6+/+ forebrain slice (n=6) or tau-GFP:Pax6Sey/Sey thalamic cells
seeded onto Pax6+/+ forebrain slice (n=6). After time in culture the forebrain slices often
spread out and became distorted making it difficult to identify structures. The results in
Fig 5.6 A to D show results from two cultures of each type in which the dorsal thalamus,
hypothalamus, and ventral telencephalon could be readily identified.
Mice
Embryos for these experiments were generated by crossing pigmented mixed
background: 129 strain (Hooper et ah, 1987)/ C57BL/6 strain (Bantom and Kingman,
UK) and/or 'Edinburgh-derived Small eye' background (Kaufman et ah, 1995, Roberts,
1967) males to albino Swiss strain females (in house colony). Some of these animals
were heterozygous for the loss of function 'Small eye' (Pax6Sey/+) mutant Pax6 allele
(Hill et ah, 1991). This produced embryos with the required Pax6 genotype with
pigmented eyes which facilitated genotyping El4.5 embryos from their eye phenotype.
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As described by Kaufman et al. (1995), Pax6+/+ embryos have a perfectly round iris,
Pax6Sey/+ embryos have a distorted iris, and Pax6Sey/Sey embryos have no eyes
RESULTS
Anatomy of tau-GFP:Pax6Sey/Seyembryonic brain
Vibratome sections of TgTP6.3 heterozygotes (tau-GFP :Pax6+/+) were
compared to tau-GFP:Pax6Sey/Sey at E13.5. A selection of these are shown in Fig. 5.1.
The gross disturbances in forebrain morphology characteristic of small-eye
homozygotes are apparent in the tau-GFP:Pax6SeylSey embryos showing that expression of
the tau-GFP transgene does not grossly affect the small-eye phenotype. Fig. 5.1 A and B
shows that the thalamocortical tract is clearly visible in transgenic mice expressing tau-
GFP on a wild-type background {tau-GFP:Pax6+/+). Axons originate from the dorsal
thalamus, enter the ventral thalamus and turn at the hypothalamus into the ventral
telencephalon, which they penetrate to reach the cortex. This tract is not seen in tau-
GFP:Pax6Sey/Sey embryos (Fig. 5.1 C to F). A mushroom shaped tau-GFP labelled
structure resembling the conformation adopted by stalled thalamocortical axons (see
Fig. 1.4B on page 38) is however apparent (Fig. 5.1 C and D).
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Figure 5.1
(A to G) Green fluorescent images of coronal sections of E14.5 tau-GFP:Pax6+/+
and tau-GFP:Pax6Sey/Sey brains. (A,B) tau-GFP:Pax6+/+ embryo showing strong
tau-GFP labelling of thalamic axons as they turn sharply to avoid the
hypothalamus and enter the ventral telencephalon to form the internal capsule (*).
(C-G) tau-GFP:Pax6Sey/Sey embryos exhibit defective tract formation. C, E, G show
a rostral (C) to caudal (G) series. (C,D) mushroom shaped tau-GFP staining
structure in rostral tau-GFP:Pax6Sey/Sey ventral telencephalon. (E,F) the strong tau-
GFP label seen in tau-GFP:Pax6+/+ embryos is lacking from the position normally
occupied by the internal capsule (*). (B, D, F) are magnified views of the boxed
areas in (A, C, E) respectively. (H) Composition of litters generated from tau-
GFP:Pax6'/SeyxPax6+/Sey crosses counted at El4.5. Pax6 genotype was assessed by
examination of eye phenotype and tau-GFP status by examination under
epifluorescence. These results show that the TgTP6.3 transgene does not
drastically alter the expected Mendelian ratio (1:2:1) of Pax6+/+:









Analysis of thalamocortical tract projection in vitro
Time course
In order to determine the time course of thalamic axon outgrowth into target
tissues, several explant cultures were set up and observed live at daily intervals using
epifluorescence or fixed after 1, 2 or 3 days in culture processed for imaging on a
confocal microscope. Typical innervation of a cerebral cortex explant by tau-GFP dorsal
thalamic axons is shown in Fig. 5.3 A to F. This experiment shows that between 1 and 2
days in culture were sufficient for extensive axon outgrowth and the establishment of
the major features of innervation seen after 3 days.
Pax6+/+ versus Pax6Sey/Sey
The aim of these experiments was to test whether or not axons from dorsal
thalamus in Pax6Sey/Sey embryos are able to respond to growth and/or guidance signals
along their path to the cortex. To test the ability of thalamic axons to innervate tissue
encountered along the normal thalamocortical pathway, explants of El4.5 tau-
GFP:Pax6+/+ and tau-GFP:Pax6Sey/Sey thalamus were cultured in contact with wild-type
ventral telencephalon, hypothalamus or cerebral cortex (Fig. 5.4 F-M; results are shown
on a grey-scale, which makes axons clearer). Dorsal thalamic explants were removed
from sections appearing similar to that shown in Fig. 5.4 A,C, as illustrated in Fig. 5.4
B,D. Analysis of Pax6 (Fig. 5.4 E) and other gene expression patterns (Stoykova et ah,
1996, Warren and Price, 1997, Kawano et ah, 1999, Pratt et ah, 2000b) helped to define
tissue landmarks and to make accurate dissections.
Dorsal thalamus from tau-GFP:Pax6+/+ embryos produced prolific outgrowth
into wild-type ventral telencephalon, extending well over half-way through the
telencephalic explants in 76% of cultures (typical examples are shown in Fig. 5.4 F,G).
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Figure 5.2
Schematic showing how tau-GFP labelled and unlabelled tissues are combined in
tissue culture for the explant co-culture and seeding experiments described in the
text. For explant co-cultures, tau-GFP expressing dorsal thalamus (dt) is combined
with non-expressing cerebral cortex (cc), ventral telencephalon (vtel), or
hypothalamus (ht) and the extent of innervation of unlabelled explants by tau-GFP
labelled fibres is assessed. For seeding cultures, tau-GFP expressing dorsal
thalamus is dissociated and seeded onto a slice of unlabelled forebrain and the
extent to which labelled cells adhere and grow on particular regions is assessed.




























In 62% of these cultures large numbers of thalamic axons often curved quite sharply in a
dorsal direction. These features, illustrated in figure 5.4 F,G are reminiscent of the in
vivo trajectory of thalamic axons as they grow through the internal capsule and turn
dorsally towards the neocortex (Fig. 5.4 A, Fig. 1.2 on page 19). In marked contrast,
none of the cultures of tau-GFP:Pax6Sey/Sey dorsal thalamus with wild-type ventral
telencephalon showed these features. In 60% of these cultures, thalamic axons did enter
the medial part of the ventral telencephalon, but in almost all these cases (86%) not even
a single thalamic axon reached anywhere near halfway through the telencephalic
explant. A typical example is shown in Fig. 5.4 H. In none of these cultures, nor in the
14% of cases where longer thalamic axons were seen (Fig. 5.4 I illustrates the culture in
which there was most growth), was there any evidence of a consistent turning of the
thalamic axons in a dorsal direction. Observations of tau-GFP labelled wild-type and
Pax6Sey/Sey axons in some of these cultures during their 3 days in vitro revealed that the
major features of innervation were established quickly, within 1-2 days of the start of
culture, and there was less progression between 2 and 3 days. It is unlikely, therefore,
that the defective innervation from the tau-GFP:Pax6Sey/Sey thalamic explants can be
explained simply by a slowing of development.
In all cultures where tau-GFP:Pax6+/+ dorsal thalamus was placed next to wild-
type hypothalamus, thalamic axons coursed around its edge and failed to innervate it
(Fig. 5.4 J), in agreement with previous findings on the repulsive nature of the
hypothalamus for dorsal thalamic axons (Braisted et al., 1999). The same result was
obtained in all cases where tau-GFP:Pax6Sey/Sey dorsal thalamic explants were used (Fig.
5.4 L). When tau-GFP:Pax6+/+ dorsal thalamus was placed with wild-type cortex, most
cultures showed large numbers of thalamic axons wrapping around its edges and upper
and lower surfaces (Fig. 5.4 K). This pattern has been described before and is due
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Figure 5.3
Time course of thalamic innervation in culture. Panels show green fluorescent
images of tau-GFP expressing E14.5 thalamus cultured with cerebral cortex and
imaged after (A,B) 1 day , (C,D) 2 days or (E,F) 3 days. (B,D,F) are higher power
magnifications of (A, C, E) respectively. The major features of innervation are
established between 1 and 2 days in culture. Each time point shows a different
culture. Greyscale presentation of fluorescent images are shown with tau-GFP
expressing thalamus and axons appearing grey (adjacent tau-GFP" tissue outlines
can be discerned). Bars in (A, C, E); 500pm
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Figure 5.3
to the inability of the early cortical layers to receive thalamic innervation (Molnar and
Blakemore, 1991, Goetz et al., 1992). In 95% of these cultures, thalamic axons extended
distances equivalent to at least halfway round the circumference of the cortical explants.
When tau-GFP:Pax6Sey/Sey dorsal thalamus was cultured with wild-type cortex, the
pattern of thalamic axonal growth was similar to that with tau-GFP:Pax6+/+ dorsal
thalamus (Fig. 5.4 M), although in many cases it appeared that there were fewer
thalamic axons.. In 92% of these cultures large numbers of axons extended distances
equivalent to well over halfway round the circumference of the cortical explants, as
occurred with the tau-GFP:Pax6+/+ dorsal thalamus.
Several observations indicate that the inability of the Pax6Sey/Sey dorsal thalamus
to generate normal innervation of ventral telencephalon is not caused by a non-specific
inability to grow. First, Pax6Sey/Sey dorsal thalamic explants are capable of producing
many long axons when co-cultured with wild-type cortex, as do Pax6+/+ thalamic
explants (Rennie et al., 1994). The apparent reduction in the numbers of mutant thalamic
axons in these co-cultures is compatible with previous observations that mutant dorsal
thalamus contains fewer neurons (proliferation in the early mutant diencephalon is
reduced: (Warren and Price, 1997) although it could conceivably be due to a defective
response by some thalamic neurons to cortex-derived growth-promoting factors.
Second, analysis of nuclear morphology with T0-PR03 showed that under all
conditions used here almost all cells remain viable in both Pax6+/+ and Pax6Sey/Sey dorsal
thalamic explants. Third, in other experiments in which El4.5 dorsal thalamic explants
were dissociated and cultured for 3 days in serum-free medium, Pax6+/+ and Pax6Sey/Sey
cells survived and grew neurites equally well (Edgar et al., 1999). Therefore, the
inability of the Pax6Sey/Sey dorsal thalamus to generate normal ventral telencephalic
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Figure 5.4
Pax6Sey/Sey thalamic explants exhibit defective tract formation, as shown by
organotypic co-culture of tau-GFP:Pax6'/+ or tau-GFP:Pax6Sey/Sey dorsal thalamic
(dt) explants with Pax6+/+ explants of ventral telencephalon (vtel), hypothalamus
(ht), or cerebral cortex (cc). (A,C) Green fluorescent images of coronal sections of
El4.5 tau-GFP:Pax6+/+ and tau-GFP:Pax6Sey/Sey brains similar to those from which
explants were dissected. (A) tau-GFP:Pax6+/+ embryo showing strong tau-GFP
labelling of thalamic axons as they turn sharply to avoid the hypothalamus and
enter the ventral telencephalon to form the internal capsule (*). (C) tau-
GFP:Pax6Sey/Sey embryo, showing that the strong tau-GFP label seen in tau-
GFP:Pax6+/+ embryos is lacking from the position normally occupied by the
internal capsule (*). (B,D) Schematic representations of sections shown in A,C
with red dotted lines indicating locations of cuts used to isolate from coronal slices
the tissues used in these experiments (dt, vtel, ht and cc). Panels (A-D) show only
one side but note that the left and right dorsal thalamus were left joined dorsally in
culture and their cut edges, just anterior to the border with ventral thalamus, were
placed against different tissues on each side. The border between the ventral and
dorsal thalamus, as defined by tissue landmarks and the expression of genes such
as Dlx2 and Pax6, is shown with a blue line. (E) In situ hybridisation on a 200
pm-thick Vibratome section (pink counterstain) of a Pax6Sey/Sey E14.5 embryo
corresponding to the section in C,D, showing expression of Pax6 (purple) in the
thalamus, where it acts as a marker of ventral thalamus even in the mutants
(Stoykova et al., 1996; Warren and Price, 1997), and telencephalon. (F-M)
Representative examples of co-cultures of (F,G,J,K) tau-GFP:Pax6+/+ thalamus or
(H,I,L,M) tau-GFP:Pax6Sey/Sey thalamus with (F-I) Pax6+/+ ventral telencephalon,
(J,L) Pax6+/+ hypothalamus or (K,M) Pax6+/+ cerebral cortex. Greyscale
presentation of fluorescent images are shown with tau-GFP expressing thalamus
and axons appearing grey (adjacent tau-GFP" tissue outlines can be discerned). (N)
Schematic showing Pax6+/+ and Pax6Sey/Sey thalamocortical cells. The red X
indicates an autonomous defect of the Pax6Sey/Sey thalamocortical growth cone that
prevents it from responding appropriately to growth and guidance cues in the
ventral telencephalon. Fig. 5.4 E was taken from Pratt et al., 2000b. All images to





The nature of the ventral telencephalon in Pax6Sey/Sey embryos. Organotypic co-
culture of tau-GFP:Pax6+/+ dorsal thalamic explant with explant of Pax6Sey/Sey
ventral telencephalon. Greyscale presentation of fluorescent image shown with
tau-GFP expressing thalamus and axons appearing grey (adjacent tau-GFP" tissue
outline can be discerned). Note large numbers of thalamic fibres penetrating the
ventral telencephalon. Bar, 200pm.
Figure 5.6
Seeding experiment in which dissociated (A, B) tau-GFP:Pax6+/" or (C, D) tau-
GFP:Pax6Sey/Sey thalamic cells were seeded onto Pax6+/+ forebrain slices and
imaged after time in culture. Panels (A-D) are centred on the region occupied by
the internal capsule(*). Note that many more Pax6+/+ cells adhere to the internal
capsule than Pax6Sey/Sey cells. Panel E shows tau-GFP:Pax6Sey/Sey cells adhering to a
different forebrain region. F is a cartoon of a forebrain slice showing the position
of the internal capsule (*) on which panels (A to D) are centred and the
approximate location of the panel shown in E. Greyscale presentation of
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innervation is likely to be due to its inability to respond to growth and guidance cues in
that region.
Although the main focus of this work was the dorsal thalamus and its axons, I
carried out a few experiments to gain a better idea of the status of the ventral
telencephalon in the mutants. In cultures of tau-GFP:Pax6+/+ dorsal thalamus with
Pax6Sey/Sey ventral telencephalon I observed prolific innervation by long axons, indicating
that the mutant ventral telencephalon does not lack the ability to stimulate and receive
dorsal thalamic innervation (Fig. 5.5 A). Innervation did not appear normal, however,
and many axons turned in abnormal ways in the mutant ventral telencephalon (compare
Fig. 5.5 with Fig. 5.4 F,G). Although the Pax6Sey/Sey ventral telencephalon may be
permissive for incoming thalamic axons, it is quite possible that defects in this region
contribute to the lack of thalamocortical innervation in small eye homozygotes.
When wild-type dorsal thalamic cells were seeded onto coronal wild type brain
slices they adhered to the internal capsule (Fig. 5.6 A,B; marked with *). The
thalamocortical tract projects through this structure at the junction between ventral
thalamus and ventral telencephalon. When the experiment was repeated with mutant
thalamic cells, this adhesion was lost (Fig. 5.6 C,D). This result was not due to general
lack of viability of the Pax6Sey/Sey thalamic cells in my culture as they did adhere to and
grow on other regions of the slice (Fig. 5.6 E). This supports the findings from the
explant cultures that Pax6 is required in dorsal thalamic cells to program their adhesive
properties, specifically their ability to project into the ventral telencephalon.
DISCUSSION
The thalamocortical tract fails to form normally in Pax6Sey/Sey mice. In wild type
(.Pax6+/+) embryos the tract projects from the dorsal thalamus and travels through the
ventral thalamus, avoids the hypothalamus, turns sharply into the ventral telencephalon
147
(forming the internal capsule) and then reaches its target in the cerebral cortex (Tuttle et
ah, 1999, Braisted et ah, 1999, Auladell et ah, 2000). In Pax6Sey/Sey mice, the dorsal
thalamus does project a tract but it fails to enter the cortex and appears to become stalled
en route from the ventral thalamus to the ventral telencephalon (Kawano et ah, 1999,
Pratt et ah, 2000b).
A comparison of timetables for Pax6 gene expression in developing forebrain
(Stoykova et ah, 1996, Grindley et ah, 1997, Mastick et ah, 1997, Warren and Price,
1997, Kawano et al, 1999) and thalamocortical tract formation (Tuttle et ah, 1999,
Braisted et al, 1999, Auladell et ah, 2000) suggests several locations at which Pax6
could influence the developing thalamocortical tract (Fig. 1.4 on page 38). Pax6 is
expressed at many points along the thalamocortical pathway at times coinciding with
critical events in thalamocortical tract formation, including the dorsal thalamus where
Pax6 expression coincides with neurogenesis between E10 and E13 (Angevine, 1970)
and the ventral thalamus, the hypothalamus, the ventral telencephalon and the cerebral
cortex which also express Pax6. The failure of the thalamocortical tract to form in the
absence of Pax6 could reflect a requirement for Pax6 at one or more of these locations.
Pax6 and formation of the dorsal thalamus
Previous studies of the embryonic diencephalon in Pax6Sey/Sey mice showing
relatively normal anterior to posterior (A-P) expression patterns of Dlx, Otx, Emx, and
Wnt genes, Proxl, Gbx2, Mashl and Pax6 have indicated that diencephalic A-P
patterning is not greatly disturbed (Stoykova et al., 1996, Warren and Price, 1997,
Grindley et al., 1997). These gene expression studies have suggested that the embryonic
Pax6Sey/Sey diencephalon possesses correlates of the histogenetic regions that in wild-
types give rise to major diencephalic structures. Despite obvious distortions in the shape
of the embryonic Pax6Sey/Sey diencephalon (Warren and Price 1997, Stoykova et al., 1996)
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which may in part be due to defects of cell proliferation in this region (Warren and
Price, 1997) morphological features reminiscent of those that distinguish diencephalic
regions in wild-types have been described. Equivalents of prosomeres 1-3 and their
main components, the ventral and dorsal thalamus and the pretectum, have been
identified on the basis of gene expression and morphology in the mutants and named
according to their wild-type counterparts (Stoykova et ah, 1996, Mastick et ah, 1997,
Warren et al., 1997, Kawano et ah, 1999, Pratt et ah, 2000b).
The alterations in the expression patterns of several genes (Hbnf, VMAT2,
Liml/Lhxl, and Nkx2.2) are superimposed on these structures and reflect a failure of the
Pax6Sey/Sey dorsal thalamus to differentiate normally in the absence of Pax6 expression
(Pratt et ah, 2000b). These molecular patterning defects indicate that the differentiation
program of the Pax6Sey/Sey dorsal thalamus is disrupted during the period when it fails to
make appropriate connections with the cerebral cortex.
Pax6 and dorsal thalamic tract projection
From observations of the Pax6Sey/Sey brain alone, it is conceivable that the
thalamocortical tract defect results from an autonomous defect in the dorsal thalamus
itself, or from defects in the environment through which the thalamocortical axons
navigate, or a combination of the two. To address this issue, I show that explants of
mutant dorsal thalamus are defective in their ability to project a tract capable of correct
navigation through wild type ventral telencephalon. This defect may be limited to this
specific aspect of thalamocortical growth since Pax6Sey/Sey thalamic axons innervate wild-
type cortex and avoid wild-type hypothalamus, as do wild-type thalamic axons. This
provides direct evidence that Pax6 expression is required within the dorsal thalamus
itself, regardless of whether Pax6 expression is also required at other locations. This
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experiment could not rule out the possibility that these axon navigation properties were
programmed non-autonomously by Pax6 prior to explant preparation.
Because my thalamic explants contained some ventral thalamus and epithalamus
as well as dorsal thalamic tissue, it is formally possible that these results could be
explained by the lack of essential signalling to axons en passant (Wang and Tessier-
Lavigne, 1999). This possibility would demand that adjacent tissues instruct axons
leaving the dorsal thalamus in ventral telencephalic navigation. The zli or the ventral
thalamus would be possible candidates for this type of interaction (Mastick et al., 1997;
Braisted et ah, 1999; Tuttle et ah, 1999). The evidence, however, is against such a
possibility. Wild-type thalamic explants in my cultures exhibit similar features of axon
outgrowth to those reported in cultures using dorsal thalamic explants prepared from
embryonic brain at similar ages but with surrounding tissues removed. These features
include avoidance of the hypothalamus, attraction towards the ventral telencephalon and
penetration of the cortex (Molnar and Blakemore, 1991, Goetz et ah, 1992, Braisted et
ah, 1999, Braisted et ah, 2000). Since these 'pure' dorsal thalamic explants have been
isolated from potential instruction by cells lying outside the dorsal thalamus, such
instructions are unlikely to be important for these features of thalamocortical formation.
The design and interpretation of the explant experiments depend on correct
identification of the dorsal thalamus in a mutant brain. Given the disturbed anatomy of
the Pax6Sey/Sey diencephalon, it was critical that in spite of these abnormalities the dorsal
thalamic explants isolated from the Pax6+/+ and Pax6Sey/Sey brain were 'equivalent'. The
Pax6Sey,Sey embryo does possess a structure corresponding to the dorsal thalamus which
can be identified by its morphology and gene expression patterns (see above), and which
does project axons. The problem of equivalence reduces to choosing explants in which
axons projecting from Pax6Sey/Sey and Pax6+/+ dorsal thalamus have equal opportunities to
interact with target tissues. The major defect in thalamocortical tract formation in
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mutants appears to occur as axons attempt to navigate from the ventral thalamus into the
ventral telencephalon (Kawano et al., 1999, Pratt et ah, 2000b). There is no evidence
that axons originating from the dorsal thalamus become stalled in the ventral thalamus
or that they fail to avoid the hypothalamus. I therefore selected explants that centred on
the dorsal thalamus but also contained some ventral thalamic and epithalamic tissue.
This ensured that dorsal thalamus was present and enabled me to position explants to
recreate the topography of the intact brain more accurately than if I had attempted to
dissect smaller pieces of tissue with resulting loss of anatomical landmarks. Since the
ventral thalamus/ ventral telencephalon transition zone, where thalamocortical defects in
the Pax6Sey/Sey mice occur, was absent from our thalamic explants, axons from tau-
GFP:Pax6Sey/Sey or tau-GFP:Pax6+/+ thalamic explants were able to navigate to the edge
of the thalamic explant where they were confronted by the target tissue. The observation
that thalamic axons responded to the target tissues in ways reminiscent of their
behaviour in vivo supported the accuracy of my culture system.
The explant experiments showed that there is an autonomous requirement for
Pax6 within the dorsal thalamus. The dorsal thalamus is a complex structure and it is
possible that Pax6 expressing cells not projecting axons to the cortex influence the
properties of thalamocortical cells. An analogous role for Pax6 occurs in the tract of the
post-optic commissure (Mastick et al., 1997) and en passant interactions (Wang and
Tessier-Lavigne, 1999) might influence thalamocortical axons. Dissociation isolates the
thalamic cell from non-autonomous signals, which might otherwise be supplied by the
dorsal thalamus. When thalamic cells were seeded onto slices of brain the Pax6Sey/Sey
thalamic cells did not adhere to the internal capsule which was clearly an attractive
substrate for Pax6+/+ thalamic cells. This fitted nicely with the results of the explant co-
cultures above, which showed that Pax6 was required within the dorsal thalamus for
tract projection into the ventral telencephalon. Pax6 is therefore required to program
151
these adhesive properties and this requirement is not dependant on continued contact
with other cells in the dorsal thalamus. This experiment could not rule out the possibility
that these adhesive properties were irreversibly programmed non-autonomously by Pax6
prior to dissociation.
The seeding experiments described here produced a clear result but suffered
from several limitations. Firstly, culturing whole forebrain slices resulted in loss of
definition due to the culture spreading out and this made identification of structures of
interest difficult (the central location of the internal capsule made it the easiest to
locate). Secondly, the whole forebrain slice is a complex environment and it would be
interesting to assess adhesion of thalamic cells to individual forebrain structures such as
internal capsule, hypothalamus and cerebral cortex in isolation. This would minimise
problems in subsequent identification of structures. Thirdly, I assessed a mixture of
adhesion, growth and survival of seeded cells and it would be interesting to assess
adhesion of thalamic cells after shorter periods before they had time to grow and
migrate. It would be interesting to perform seeding experiments with cells isolated
before the tract starts to project (E10 to E13) while they are still expressing Pax6.
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Pax6 and the ventral telencephalon
The Pax6Sey/Sey ventral telencephalon maintains normal expression patterns of
Netrinl (Pratt et al., 2000b) a molecule implicated in thalamocortical tract formation
(Braisted et al., 2000) and is permissive to wild-type thalamic axons. Therefore,
although it is possible that defects in the ventral telencephalon contribute to the lack of
thalamocortical innervation in Pax6Sey/Sey embryos, I find no evidence that such defects
can account for the Pax6Sey/Sey thalamocortical phenotype wholly.
Pax6 and regulation of cell surface properties
The cerebral cortex, like the dorsal thalamus, exhibits Pax6 expression in
ventricular zone cells during neurogenesis and downregulates Pax6 expression in
postmitotic cells. The expression of Pax6 in proliferating cortical neurons influences
their postmitotic gene expression patterns and cell surface properties with the
maintenance of this genetic pattern becoming independent of the presence of Pax6
(Warren et al., 1999). Work on the developing cerebral cortex has implicated Pax6 in
regulating members of the cadherin family of cell adhesion molecules (Stoykova et al.,
1997) and the trk family of neurotrophin receptors (Warren et al., 1999). In vitro
aggregation assays (Stoykova et al., 1997) and transplantation experiments (David Price
unpublished observations) have established that the adhesive properties of cortical cells
are altered in Pax6Sey/Sey embryos. Roles for Pax6 in regulating adhesive properties have
been elegantly demonstrated in the eye by analysis of Pax6v' <-> Pax6+/+ chimeras
(Quinn et al., 1996, Collinson et al., 2000). Pax6 has also been implicated in axon
pathfinding in the tract of the postoptic commissure (Mastick et al., 1997) and the spinal
cord (Ericson et al., 1997, Osumi et al., 1997) as well as in the thalamocortical tract
(Tuttle et al, 1999, Kawano et al., 1999). Consistent with its roles elsewhere in the CNS,
Pax6 probably controls thalamocortical tract formation by regulating the cell surface
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properties of thalamocortical cells and influencing the navigation choices made by their
growth cones.
Clarification of the molecular mechanisms of Pax6 action will be
facilitated as the tally of molecules implicated in thalamocortical tract formation
increases. At present these include cell surface receptors DCC, Neogenin, Robol,
Robo2, RPTP5, Sema6A and LAMP, and secreted molecules Netrinl, Slitl and Slit2
(Ringsted et al., 1999, Braisted et al., 2000, Tuttle et al., 1999, Mann et al., 1998,
Leighton et al., 2001). These signalling systems may not act in isolation. For example,
Robol and DCC (receptors for Slit2 and Netrinl) form a complex which controls
commissural axon crossing of the vertebrate midline via a receptor mediated silencing
mechanism (Stein and Tessier-Lavigne, 2001) and similar interactions may also operate
in thalamocortical axons. A recent study by Braisted et al., (2000) has demonstrated that
Netrinl promotes the growth of thalamocortical axons through the ventral telencephalon
and so it is possible that abnormalities in Pax6Sey/Sey embryos may be contributed to by
defects of receptors mediating its attractant effects, DCC and Neogenin. Both are
expressed in the normal dorsal thalamus. Preliminary evidence, however, suggests that
DCC is still expressed in the dorsal thalamus of Pax6Sey/Sey embryos (Pratt et al., 2000b).
As thalamocortical tract defects are less severe in loss-of-function Netrinl mutants than
in Pax6Sey/Sey embryos and blocking Netrinl in vitro does not abolish thalamic axon
attraction to ventral telencephalon (Braisted et al., 2000), it is hard to explain the small
eye defects on the basis of a loss of Netrinl responsiveness alone. Other perhaps as yet
unidentified signalling systems are likely involved.
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Conclusion
The requirement for Pax6 in the dorsal thalamus is lifted by the time its cells
become postmitotic. It is possible that Pax6 has direct effects on the expression of cell
surface molecules involved in receptor/ligand interactions, cell adhesion or axon
pathfinding before it is downregulated. On the other hand, findings that the defective
responses of Pax6Sey/Sey dorsal thalamic axons coincide with persistent changes in the
expression patterns of regulatory genes other than Pax6 from the early stages of dorsal
thalamic development (Pratt et ah, 2000b) allows the possibility that these defects result
indirectly from the early absence of Pax6 in this region. Genes such as Liml/Lhxl or
Nkx2.2 whose expression is influenced by Pax6 may have more direct effects, for
example up- or downregulating the expression of effector molecules. Whether direct or
indirect, I conclude that Pax6 plays an essential role in the development of the dorsal
thalamus and the ability of its axons to respond to key growth and guidance cues.
Future work
Presumably Pax6 influences the development of thalamocortical axons by
transcriptional regulation of genes involved in axon navigation. Identification of
transcriptional targets would show the extent to which Pax6 directly regulates the
transcription of cell surface molecules as opposed to controlling the transcription of
regulatory molecules (for example other transcription factors) which in turn influence
axon navigation properties.
Gene expression profiling provides a means for identifying Pax6 targets by
identifying genes whose transcription is sensitive to Pax6 activity. Levels of particular
transcripts could be compared between thalamocortical cells isolated from Pax6+/+ and
Pax6~/~ embryos at various stages of thalamocortical development. Pax6 expression
could be artificially induced (or inhibited) to identify genes whose transcription is
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sensitive to Pax6. These profiling studies could be used to perform selected screens, for
example screening the panel of genes recently implicated in axon navigation by a gene
trap screen (Leighton et ah, 2001) or to search random libraries of mouse transcripts for
novel genes. Genes whose expression levels have already been shown to be influenced
by Pax6 (or not) could be utilised as controls in such experiments.
A complementary approach to understanding Pax6 function is to catalogue
Pax6Sey/Sey thalamocortical axon defects at the cellular and subcellular levels. For
example it is unknown whether properties such as thalamocortical axon fasciculation
and branching or growth cone complexity or collapse are altered in the Pax6 mutant.
The use of in vitro assays including neuron-turning assays, membrane stripe assays and
primary co-culture experiments (including the co-culture assays described above) allows
the measurement of these properties. In vitro systems can be used to assess the roles of
candidate effector molecules by manipulating their availability to the thalamocortical
axon and observing its response.
Hopefully these two approaches will be synergistic. The characterisation of
genes under the direct and indirect transcriptional control of Pax6 will supply candidates
whose roles in Pax6Sey/Sey thalamocortical tract phenotype can be tested and identification
of Pax6Sey/Sey subcellular phenotypes may suggest classes of molecule for gene
expression profiling. This knowledge will be useful in the wider context of
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MOLECULAR BIOLOGY MATERIALS AND REAGENTS
General-purpose molecular biology reagents were purchased from Sigma UK, Fisher
UK, and BDH/Merck, UK.
Agarose for gel electrophoresis
Seakem LE Agarose (Flowgen: 50000)
Bacterial culture media and antibiotics
LB tablets (Sigma: L-7275)
1 tablet dissolved in 50ml water and sterilised by autoclaving.
LB-Agar (Sigma: L-2897)
35g added to 11 water and dissolved and sterilised by autoclaving.
Competent cell freezing mix (CCFM)
lOOmM KC1, 50mM CaCl2, 10% Glycerol, lOmM potassium acetate pH7.5
Ampicillin (Roche: 835 242):
50mg/ml stock dissolved in 50% ethanol stored at -20°C and diluted 1000-fold
to working concentration of 50pg/ml in LB or LB-Agar at temperatures not
exceeding 50°C.
Enzymes for molecular biology
DNA Restriction enzymes.
These were purchased from Roche or Amersham Pharmacia Biotech and used
according to manufacturers guidelines.
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DNA modifying enzymes
Cloned Pfu polymerase (Stratagene: 600153)
Sequenase v2.0: (Amersham Pharmacia Biotech: US70770)
T4 DNA ligase (Roche: 481 220)
Polynucleotide Kinase (Roche: 174 645)
Calf intestinal alkaline phosphatase (Roche: 713 023)
Other enzymes
Proteinase K (Roche:745 723)
Lysozyme (Roche: 107 255)
Molecular Biology Kits
DNA extraction & purification
Ultraclean mini plasmid prep kit (Mo Bio Laboratories: 12300-100)
Plasmid midi kit (Qiagen: 12143)
Qiaex II gel extraction system (Qiagen: 20021)
Manual DNA sequencing
Sequenase v 2.0 (Amersham Pharmacia Biotech: US70770).
35S-ATP for manual sequencing was purchased from ICN.
DNA labelling
High Prime DNA labelling kit (Roche: 1585584)
Oligonucleotides
Purchased from Genosys, MWG-Biotech, or Oswel.
'Adapters'
Used to convert Asp718 to Bgl2 'ASP718/BGL2': GTACTAGATCTA
Used to convert Sacl site to EcoRl site 'SAC1/ECOR1': GAATTCAGCT
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Site directed mutagenesis
Used to introduce BspHl site into pMGFP6
' GFPB SPH1.1': TTACACATGTCATGAATGAACTAT
'GFPBSPH 1.2': ATAGTTCATTCATGACATGTGTAA





















Mouse genomic DNA extraction
Tail tip lysis buffer (TTLB)
200mM Tris pH8, 200mM NaCl, 5mM EDTA, 0.2% SDS
Southern Blotting and hybridisation
32P-a-dCTP for radiolabeled probe preparation was purchased from ICN.
Southern denaturing solution: 0.5M NaOH
Southern neutralising solution: 0.5M Tris, 3M NaCl, pH7.0
20xSSC: 3M NaCl, 0.3M sodium citrate
Church Solution: 0.5M NaP04, 7% SDS, ImM EDTA, 1% BSA, pH7.2
Church Wash: 40mM NaP04, 1% SDS, ImM EDTA, pH7.2
Nylon membrane (positively charged): Roche: 1 417 240
178
APPENDIX B
ES AND PRIMARY CULTURE, TISSUE PROCESSING AND IMAGING.
Tissue culture plasticware
Flasks
25cm2 culture area (T25) flasks (Iwaki:3100-025)
75cm2 culture area (T75) flasks (Iwaki:3110-075)
175cm2 culture area (T175) flasks (Iwaki: 3120-150)
Plates
0.32 cm2 culture area (96 well) plate (Iwaki:3860-096)
1.9 cm2 culture area/well (4 well) plate (Nunc:176740A)
2.0 cm2 culture area/well (24 well) plate (Iwaki: 3820-024)
3.8 cm2 culture area/well (12 well) plate (Iwaki: 3815-012)
9.4 cm2 culture area/well (6 well) plate (Iwaki: 3810-006)
Dishes
79 cm2 tissue culture (10 cm diameter) dish (Iwaki: 3020-100)
Bacterial grade (9 cm diameter) dish (Sterilin: 101VR20)
Sterile plastic pipettes
5ml pipette (Iwaki: LX5ML)
10ml pipette (Iwaki: LX10ML)
25ml pipette (Iwaki: LX25ML)
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Solutions and reagents for ES culture
Starting materials
All solutions and reagents were prepared and used under sterile conditions.
lOx GMEM (BHK21 Medium (lOx) Glasgow MEM) (Gibco BRL: 12541-025)
L-Glutamine 200mM (Gibco BRL: 25030-032)
MEM non-essential amino acids lOOx (Gibco BRL: 11140-035)
Sodium Pyruvate MEM lOOmM (11360-039)
Sodium Bicarbonate (BDH/Merck: 10247)
Gelatin (Type A from porcine skin) (Sigma: G-1890)
Foetal calf serum (FCS) (Globepharm: Batch F16784).
FCS batches were tested in CGR for ability to support ES cell culture.




DMSO Analar (BDH/Merck: 103234L)
PBS tablets (Oxoid: BR14) 1 tablet dissolved in 100ml water.
Leukemia Inhibitory Factor (LIF): Produced in house by Centre for Genome
Research, Edinburgh University. Aliquots (0.5ml) stored at -20°C at lOOOx
working strength.
Preparation of GMEM+FCS (400ml)
Sterile water: 340ml
1 OxGMEM: 40ml
Sodium Bicarbonate (7.5%): 13.2ml
MEM non-essential Amino Acids: 4ml
L-Glutamine (200mM): 4ml
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Sodium Pyruvate (lOOmM): 4ml





ES neuron culture media and reagents
all-trans Retinoic Acid (Sigma: R2625)
1 OmM Stock prepared in DMSO and stored in the dark at -20°C until use.
DMEM/F12 without L-Glutamine (Gibco BRL: 21331-046)
Neurobasal medium (Gibco BRL: 21103-049)
N2 supplement (Gibco BRL: 17502-048)
B27 supplement (Gibco BRL: 17504-044)
Electroporation of ES cells
GenePulser II (Biorad, USA)
0.4cm Electroporation cuvette (Biorad: 1652088)
The cells and DNA were electroporated as close as possible to 4°C.
Primary neural culture
Stock solutions for serum free culture medium*
Antibiotics: Gentamycin (lOOmg) Kanamycin (200mg) added to 20ml sterile
double deionised water, filter sterilised and stored in 1ml aliquots at -20°C.
Putrescene: 100pM stock (161.1mg/100ml in sterile double deionised water,
filter sterilised and stored in 4ml aliquots at -70°C).
Progesterone: 20p.M stock (6.29mg/100ml ethanol stored in 1ml and then 50pl
aliquots at -70°C).
Na2Se03: 30pM stock (5.2mg/100ml in sterile double deionised water, filter
sterilised and stored in 50pl aliquots at -70°C).
L-glutamine: 0.2M stock (6.344g/100ml in sterile double deionised water, filter
sterilised and store in 2ml and then 50pl aliquots at -70°C).
Preparation of serum free culture medium
Prepared by mixing the following reagents together under sterile conditions and
stored for not more than two weeks at 4°C until use. Medium was warmed and
equilibrated in a 37°C humidified incubator containing 5% C02 for at least one
hour prior to use.
100ml F12 (Hams) (Sigma: N4888)
100ml Dulbecco's modified Eagles' medium (DMEM) (Sigma: D5671)
lmg Insulin (Sigma: 16634. Final concentration 5pg/ml)
2mg apo-transferrin (Sigma: T1147. Final concentration 10pg/ml)
3ml HEPES buffer (Sigma: H0887)
0.24g Na^CCf, (Sigma: S5761. Final concentration 0.12mg/ml)
3ml antibiotics stock* (Gentamycin + Kanamycin) (Sigma: G1264 + K1377)
2ml putrescene stock* (Sigma: P5780. Final concentration 16.11pg/ml)
20pl progesterone stock* (Sigma: P8783. Final concentration 6.29ng/ml)
20pl Na^eCh stock* (Sigma: S5261. Final concentration 5.2ng/ml)
2ml L-glutamine stock* (Sigma: G2128. Final concentration 25pg/ml)
'EBSS' medium used during embryonic brain dissection
Prepared by mixing the following reagents together under sterile conditions and
stored for not more than two weeks at 4°C until use.
100ml Earle's balanced salt solution lOx (EBSS) (Sigma: E-7510)
0.22g Na2HC03 (Sigma: S5761. Final concentration 22mg/ml)
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0.065g Glucose (Sigma: G-7021. Final concentration 6.5mg/ml)
900ml double deionised water.
EBSS was oxygenated by bubbling with 95% 02 and chilled on ice prior to use.
Dissociation of cells from embryonic brain
Tissue was dissected and subjected to dissociation using the Papain Dissociation
System (Worthington Biochemical Corporation: LK003160) exactly as described
by the manufacturer unless otherwise stated in the text.
Dissociated cell culture substrate
Laminin lmg/ml (Sigma: L2020)
Poly-D-Lysine lmg/ml (Sigma: P7280)
Preparation of slices of embryonic brain for organotypic culture
Slices were cut on a Mcllwain Tissue Chopper (The Mickle Laboratory
Engineering Company). Brains were transferred from ice cold oxygenated EBSS
to a small piece of sterile filter paper on the Teflon stage and sliced. Slices were
then separated from one another and manipulated in ice cold oxygenated EBSS.
Organotypic culture substrate
The explants were grown in 6-well plates on collagen coated inserts (Costar:
3492) in about 2.2 ml serum free culture medium, this volume was carefully
adjusted so that the slices were just covered by the meniscus before cultures were
returned to the incubator.
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Preparing specimens for imaging
Vibratome (Technical Products International Inc, USA; Vibratome Series 1000).
Embryonic brains were fixed, agarose (4%) embedded, and sectioned at 4°C with
Vibratome settings; Amplitude = 8 and Speed = 4.
Fixation
Cells and tissues were routinely fixed at 4°C in PBS containing 4%
paraformaldehyde (pH7.0). For improved preservation of microtubule structure
cells were fixed at room temperature in PHEM buffer (Schliwa and Blerkom,
1981) containing 4% paraformaldehyde (pH6.9).
PHEM buffer: 60mM PIPES (Merck: 441204M), 25mM HEPES (Sigma:
H9136), lOmM EGTA (Aldrich: 23,453-2), 2mM MgCl2 (Fisher: M/0600/53),
pH6.9.
Glassware
Glass slides and coverslips were purchased from BDH/ Merck
Thin 'glass bottomed' 35mm dishes (Willco Wells B.V., The Netherlands:
HBSt-3522) used for imaging live cultures on an inverted confocal microscope.
Staining and mounting
Vectashield (Vector laboratories: H-1000)
T0PR03 (Molecular probes, 642/661)
Propidium Iodide (Sigma, P4170)
Fixed preparations were mounted in 1:1 glycerokPBS containing 10%
Vectashield (or in 100% Vectashield). Coverslips were sealed with Aquamount
(BDH: 362262H). Thin strips of plastic were placed between the slide and the




POSTNATAL DEVELOPMENT OF TAU-GFP TRANSGENIC MICE
SUMMARY
As described in Chapter 2, postnatal TgTP6.3 heterozygotes were more likely to
die between P21 and P42 than their non-transgenic littermates and a small but
significant reduction in embryo weight was evident during late prenatal development in
TgTP6.3 embryos (Fig. 2.9 on page 100). The data presented in Appendix C was
gathered by Margaret Keighren and Jean Flockhart in collaboration with John West and
provides a more detailed picture of weight gain and viability during postnatal
development.
RESULTS
Weight gain of transgenic male and female TgTP6.3 heterozygotes compared to
their non-transgenic littermates is shown in Fig. CI.
Viability of transgenic male and female TgTP6.3 heterozygotes compared to
their non-transgenic littermates is shown in Table CI.
CONCLUSION
Male and female TgTP6.3 heterozygotes are slower to put on weight than their
non-transgenic male and female littermates respectively. Although similar numbers of
transgenic and non-transgenic animals survive to P21 (time of weaning) there is
significantly greater mortality suffered by TgTP6.3 animals before they reach P42
(adulthood). The significance of these findings is discussed in Chapter 2.
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Figure C.1
Weight gain of TgTP6.3 heterozygotes (tau-GFP+) compared to their non-
transgenic (tau-GFP') littermates. The progeny of Tg/- x -/- crosses were
categorised according to tau-GFP status and sex and weighed at 7 day intervals.
The graphs show mean animal mass (grams) plotted against postnatal age (days)
for each category. Females (upper panel) and males (lower panel). Males and
females were treated separately as males put on weight more rapidly and are larger
than females. Tau-GFP+ and tau-GFP" results are plotted in green and black
respectively. These results show that both male and female TgTP6.3 heterozygotes
put on weight more slowly than their tau-GFP" littermates although the trajectory
of weight gain is similar in both cases.
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Figure C.1
Postnatal growth of TgTP6.3 females and their non-transgenic littermates
Postnatal growth of TgTP6.3 males and their non-transgenic littermates
Mean weight of tau-GFP"
Mean weight of tau-GFP+ (TgTP6.3 heterozygotes)
Table C.1
Postnatal viability of TgTP6.3 heterozygotes (tau-GFP+) compared to their non-
transgenic (tau-GFP") littermates. The progeny of Tg/- x -/- crosses were
categorised according to tau-GFP status and the sex and number of animals in
each category surviving to P21 (time of weaning) and P42 (adulthood) were
tabulated.
There was no significant difference between the numbers of tau-GFP+ and tau-
GFP" animals surviving to P21 (121 and 133 respectively, x= 0.57, P>0.05).
There was a significant difference between the numbers of tau-GFP+ and tau-GFP
animals which had died before reaching P42 (15/106 and 3/130 respectively, x2=
4.42, P<0.05).
No significant differences in viability were seen between males and females.
The x was used to test the null hypothesis that there was no difference between
tau-GFP+ and tau-GFP" populations at each time point.
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Table C.1







Dead Alive Dead Alive
tau-GFP" M ND ND 77 1 76
tau-GFP+ M ND ND 55 6 49
tau-GFP" F ND ND 56 2 54
tau-GFP+ F ND ND 66 9 57
tau-GFP" M+F ND ND 133 3 130
tau-GFP+ M+F ND ND 121 15 106
Grand
Total
266 12 254 18 236
The numbers of tau-GFP+ and tau-GFP" animals surviving to P21 (weaning) and P42
(adulthood) were counted (ND=not determined).
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SUMMARY
The transcription factor Pax6 is widely expressed
throughout the developing nervous system, including most
alar regions of the newly formed murine diencephalon.
Later in embryogenesis its diencephalic expression
becomes more restricted. It persists in the developing
anterior thalamus (conventionally termed "ventral"
thalamus) and pretectum but is downregulated in the body
of the posterior (dorsal) thalamus. At the time of this
downregulation, the dorsal thalamus forms its major
axonal efferent pathway via the ventral telencephalon to
the cerebral cortex. This pathway is absent in mice lacking
functional Pax6 (small eye homozygotes: Sey/Sey). We
tested whether the mechanism underlying this defect
includes abnormalities of the dorsal thalamus itself. We
exploited a new transgenic mouse ubiquitously expressing
green fluorescent protein tagged with tau, in which axonal
tracts are clearly visible, and co-cultured dorsal thalamic
explants from Pax6+/+ or Pax6Sey/Sey embryos carrying the
transgene with wild-type tissues from other regions of the
forebrain. Whereas Pax6+/+ thalamic explants produced
strong innervation of wild-type ventral telencephalic
explants in a pattern that mimicked the thalamocortical
tract in vivo, Pax6SeylSey explants did not, indicating a
defect in the ability of mutant dorsal thalamic cells to
respond to signals normally present in ventral
telencephalon. Pax6Sey/Sey embryos also showed early
alterations in the expression of regulatory genes in the
region destined to become dorsal thalamus. Whereas in
normal mice Nkx2.2 and Liml/Lhxl are expressed ventral
to this region, in the mutants their expression domains are
throughout it, suggesting that a primary action of Pax6 is
to generate correct dorsoventral patterning in the
diencephalon. Our results suggest that normal
thalamocortical development requires the actions of Pax6
within the dorsal thalamus itself.
Key words: Confocal microscopy, Diencephalon, Dorsoventral
patterning, Green fluorescent protein; Liml/Lhxl, Nkx2.2,
Organotypic co-cultures, Small eye mice, Tau, Thalamocortical
axons. Transgenic mice
INTRODUCTION
The forebrain (prosencephalon) develops from the anterior-
most region of the neural tube. Recent studies have revealed
that the underlying organisation of the prosencephalon and of
more caudal segmented regions of the neural tube may share
common properties. On the basis of tissue morphology and
patterns of gene expression, the Prosomeric Model (Puelles
and Rubenstein, 1993; Rubenstein et ah, 1994) was generated
to provide a framework for understanding the morphological
development of the prosencephalon. The Prosomeric Model
subdivides the forebrain into six transverse domains called
prosomeres, lying perpendicular to the anteroposterior (AP)
axis of the neural tube, and four longitudinal histogenic
domains, lying parallel to the AP axis of the neural tube (from
dorsal to ventral: roofplate, alar plate, basal plate and
floorplate). The diencephalon develops in prosomeres 1-3 (pl-
p3; pi is the most posterior), which are identified by
morphological constrictions in the tissue and the expression
domains of regulatory genes including Pax6, Dlx2 and Wnt3
(Bulfone et al., 1993; Puelles and Rubenstein, 1993; Stoykova
and Gruss, 1994). The pretectum forms in pi, the dorsal
thalamus in p2 and the ventral thalamus in p3. In relation to
the AP axis of the CNS, which bends sharply in the brain, the
dorsal thalamus develops posterior to the ventral thalamus. In
this report, we retain the conventional nomenclature of "ventral
thalamus" and "dorsal thalamus" wherever possible, although
we sometimes apply the synonymous terms "anterior
thalamus" and "posterior thalamus" (e.g. where the terms are
embedded in a discussion of the ventral and dorsal longitudinal
domains in the neural tube). The dorsal thalamus is a pivotal
forebrain structure, receiving sensory inputs from the periphery
and communicating via thalamocortical axons with the
cerebral cortex.
The mechanisms that pattern the diencephalon and control
the later development of structures such as the dorsal thalamus
and its thalamocortical connections are poorly understood. In
this study, we tested the role of the transcription factor, Pax6,
in these processes. Pax6 contains two DNA-binding motifs,
a paired domain and a paired-like homeodomain. The
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spatiotemporal pattern of its expression, extending from
embryonic day 8.5 (E8.5) until adulthood in many structures
including the diencephalon, suggests that it plays a role in key
stages of forebrain development (Walther and Gruss, 1991;
Mansouri et al., 1994; Stoykova and Gruss, 1994). Mutations
of Pax6 result in the small eye (Sey) phenotype (Hill et al.,
1991). Homozygotes (Pax6Sey,Sey) show defects in numerous
forebrain structures, including the diencephalon, and die
shortly after birth (Hogan et al., 1986; Schmahl et al., 1993;
Quinn et al., 1996; Stoykova et al., 1996; Caric et al., 1997;
Grindley et al., 1997; Mastick et al., 1997; Warren and Price,
1997). Previous studies of the expression domains of
regulatory genes have indicated that AP patterning of the
diencephalon is relatively normal and that the dorsal thalamus
is present in Pax6Sey/Sey embryos (Stoykova et al., 1996;
Grindley et al., 1997; Mastick et al., 1997; Warren and Price,
1997). Kawano et al. (1999) have shown that, despite the
presence of the dorsal thalamus in homozygous small eye rat
embryos, thalamocortical connections do not form. Dorsal
thalamic axons normally traverse the ventral thalamus and
ventral telencephalon to reach the cerebral cortex whereas in
the mutants they traverse the ventral thalamus but not the
ventral telencephalon.
It has been suggested that the absence of thalamocortical
axons in Pax6Sey/Sey embryos is due to abnormalities of Pax6-
expressing cell clusters that lie along their path and would
normally guide them (Kawano et al., 1999). The full extent of
dorsal thalamic abnormalities in the absence of Pax6 has never
been clearly defined, however, and it is equally possible that
Pax6Sey/Sey dorsal thalamic axons have an intrinsic inability to
respond to appropriate growth and guidance factors. We tested
this hypothesis by taking dorsal thalamic explants from
Pax6Sey/Sey embryos in which all the cells were marked with
green fluorescent protein (GFP) tagged with tau and
confronting them with wild-type ventral telencephalon, the
region through which thalamocortical axons normally grow.
The results indicated autonomous defects in the responses of
dorsal thalamic axons to ventral telencephalic factors. Normal
dorsal thalamus downregulates Pax6 expression at the time
when thalamocortical axons start to form (Puelles and
Rubenstein, 1993; Stoykova and Gruss, 1994; Stoykova et al.,
1996; Mastick et al., 1997; Warren and Price, 1997; Kawano
et al.. 1999; Auladell et al., 2000; our unpublished
observations), and we went on to examine whether other
regulatory genes might act as intermediates between Pax6 and
the responsiveness of the dorsal thalamus. We describe an early
abnormality in dorsoventral (DV) patterning of the Pax6Sey/Sey
thalamus that may underlie defects in the responses of
thalamocortical axons.
MATERIALS AND METHODS
Generation of transgenic mice expressing tau-GFP
Transgenic mice carrying a ubiquitously expressed GFP tagged with
tau were generated. The GFP variant mmgfp6 cDNA (a gift from J.
Haseloff; Siemering et al., 1996; Zernika-Goetz et al., 1997) was
fused at its 5' end to the 3' end of a cDNA encoding bovine tau
(Callahan and Thomas, 1994). The fusion cDNA was inserted into the
mammalian expression vector, pCAGiP (a gift from I. Chambers),
allowing the CAG promoter to drive expression of tau-GFP and
puromycin resistance (Niwa et al., 1991). This construct was
introduced into embryonic stem cells and the transgenic mouse line
TgTP6.3 was derived by germline transmission. In these animals tau-
GFP is expressed throughout the developing CNS including thalamus
(Pratt et al., 2000). The tau tag tethers GFP to the microtubule-
containing cytoskeleton, resulting in clear labelling of axons including
those of the thalamocortical pathway (Fig. 2A).
Breeding
Embryonic development was assumed to have begun at midnight on
the night of mating. Experiments were carried out on E10.5, El 1.5,
E12.5, E13.5, E14.5 E15.5, E17.5 and E19.5 embryos from matings
between Pax6Sey/+ mice, some of which carried the tau-GFP transgene
(generating tau-GFP:Pax6+/+ or tau-GFP:Pax6Sey/Sey embryos).
Pax6Sey/Sey embryos were easily distinguished by their absence of eyes
and shortened snout (Hill et al., 1991). Age-matched controls were
Pax6+/+ littermates from these matings and embryos from matings
between Pax6+/+ mice, some of which carried the tau-GFP transgene.
Organotypic cocultures
Cultures were carried out following methods in Lotto and Price
(1999). Organotypic explants (300 pm thick) containing the regions
of interest (dorsal thalamus, cerebral cortex, ventral telencephalon or
hypothalamus) were dissected from coronal slices of E14.5 brains (as
illustrated in Fig. 2A-D) and arranged on collagen-coated inserts
(Costar, UK). Dorsal thalamic explants were from tau-GFP:Pax6+/+
or tau-GFP:Pax6Sey/Sey embryos; other tissues were from Pax6+/+ or
Pax6Sey/Sey embryos that did not carry the transgene. Dorsal thalamus
was recognized under transmitted and epifluorescence illumination,
guided by anatomical landmarks known to correspond to gene
expression boundaries defining the dorsal thalamus in both wild-type
and mutants (Fig. 2A-E; described in Results). The left and right
dorsal thalamus were left joined dorsally in culture and their cut edges
(red dotted lines in Fig. 2B,D, just anterior to the border between
dorsal and ventral thalamus) were placed against different tissues on
each side. To recreate the topography of intact brain as much as
possible, these cut edges of dissected thalamus were placed in contact
with either the medial edge of dissected ventral telencephalon or the
dorsal edge of dissected hypothalamus (Fig. 2B,D). Three days after
being placed in serum-free medium, cultures were fixed in ice-cold
4% paraformaldehyde in phosphate-buffered saline (PBS), stained
with the nuclear counterstain TO-PR03 (Molecular Probes, USA) and
mounted in 1:1 glycerokPBS containing 10% Vectashield (Vector
Laboratories, UK). Images of the cultures were obtained by
combining serial optical sections acquired with a Leica confocal
microscope. The following co-culture combinations were tested:
Pax6+/+ ventral telencephalon with either tau-GFP:Pax6+/+ thalamus
(n=25) or tau-GFP:Pax6Sey/Sey thalamus (n=21); Pax6+/+ cortex with
either tau-GFP:Pax6+/+ thalamus (n=21) or tau-GFP:Pax6Sey/Sey
thalamus (n=21); Pax6+/+ hypothalamus with either tau-GFP:Pax6+/+
thalamus («=6) or tau-GFP:Pax6Sey/Sey thalamus (n=6); Pax6Sey/Sey
ventral telencephalon with tau-GFP:Pax6+/+ thalamus (n=4).
In situ hybridisation
RNA probes were labelled with digoxigenin, as described by the
manufacturer (Roche Diagnostics, UK). The Sonic hedgehog (Shh),
Pax6, Liml/Lhxl, Nkx2.2 and Dlx2 plasmids were provided by J.
Rubenstein, the Netrin 1 plasmid by M. Tessier-Lavigne, the Hbnf
plasmid by T. Vogt and L. Amet and the VMAT2 plasmid by R.
Edwards. Sense probes were synthesised for controls. Embryos were
dissected from anaesthetised mothers (0.3 ml of 25% urethane in
sterile saline, i.p.) in phosphate-buffered saline (PBS) at 4°C and fixed
for 3-12 hours in 4% paraformaldehyde + 0.2 mM egtazic acid
(EGTA) at 4°C. The embryos were washed in PBS, dehydrated in
ethanol and cleared in xylene for 3 hours. The embryos were then wax
embedded, coronally sectioned at 6 pm and collected on TESPA-
coated slides. In situ hybridisations were performed as described by
Wilkinson (1992). Whole-mount in situ hybridisations (for Pax6,
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Nkx2.2 and Netrin 1) were performed on whole embryos or on 150-
200 pm-thick sections, as described by Shimamura et al. (1994).
Pharmacological treatments
Clorgyline (NBI, 30 mg/kg), a specific inhibitor of monoamine
oxidase A activity, was administered intraperitoneally to pregnant
dams at E17.5. Embryos were sacrificed 3 hours following injection.
Immunocytochemistry for serotonin, calretinin and Nkx2.2
5-HT immunocytochemistry was performed using a rat monoclonal
anti-5-HT antibody (1:50; Harlan-SeraLab). Calretinin
immunocytochemistry was performed using rabbit polyclonal
antibodies (1:10,000; Swant). Embryos were transcardially perfused
with saline followed by 4% paraformaldehyde in 0.1 M phosphate
buffer (PB) pH 7.4. Brains were removed and postfixed 2-5 days in
the same fixative and cryoprotected in 30% sucrose in PB. Serial
coronal sections (50 pm) were cut on a freezing microtome and
processed as described previously (Cases et al., 1996). Nkx2.2
immunocytochemistry was performed on paraffin-embedded sections.
Sections were dewaxed and rehydrated, transferred to a glass
container containing 10 mM sodium citrate pH 5.5 and antigens were
retrieved by boiling the sections in a microwave (med-high for 15
min). Tissue sections were then transferred to PBS. Non-specific
binding sites were blocked by using 2% (v:v) normal sheep serum and
2% (w:v) bovine serum albumin (BSA) in PBS. The excess blocking
solution was carefully removed and tissue sections were incubated
overnight at room temperature with a 1:30 dilution of mouse
monoclonal anti-Nkx2.2 antibody (74.5A5, Developmental Studies
Hybridoma Bank, USA). Tissue sections were washed three times in
PBS, then incubated for 2 hours with a 1:200 dilution of biotinylated
secondary sheep anti-mouse IgG (Amersham, UK). After washing
with PBS, tissue sections were incubated with a streptavidin-biotin
complex (Amersham, UK) for 2 hours, washed again in PBS and
developed as described previously (Cases et al., 1996).
Anatomical analyses
E15.5, E17.5 and El9.5 embryos were processed for wax sectioning
as described above and counterstained with Haematoxylin and Eosin
or Nissl-stained. We used the nomenclature for anatomical structures
described by Paxinos et al. (1991). To reveal the thalamocortical tract
with dioctadecyl tetramethylindocarbocyanine perchlorate (Dil;
Molecular Probes, USA), E13.5, E15.5. and E17.5 embryos were
fixed with paraformaldehyde, small crystals of Dil were placed in the
dorsal thalamus and, after diffusion, sections were cut with a
vibratome.
RESULTS
Lack of thalamocortical projections in Pax6Sev/Sev
embryos
Kawano et al. (1999) described a failure of thalamocortical
axonal development in homozygous small eye rat embryos and,
as illustrated in Fig. 1, we found a similar defect in Pax6Se>'/Se>'
mouse embryos. We labelled dorsal thalamic neurons and their
projections with antibodies to 5-HT following treatment with
clorgyline, a specific inhibitor of the degradative enzyme
monoamine oxidase A, as described by Cases et al. (1998) and
Vitalis et al. (1998). In E17.5 clorgyline-treated wild-type
embryos, we observed immunolabelled thalamocortical
sensory neurons and their axons running from the dorsal
thalamus to the cortical subplate (Fig. 1A) through the internal
capsule (Fig. IB). In E17.5 clorgyline-treated Pax6Sey/Sey
embryos, we were unable to detect 5HT-immunolabelled axons
in the subplate and internal capsule (Fig. 1C,D). Fig. 1E,F
shows staining for calretinin in sections of E17.5 wild-type and
Pax6Sey/Sey embryos. In wild-type embryos, staining was
detected in the cell bodies and axonal processes of discrete
dorsal thalamic nuclei and in the thalamocortical tract (Arai
et al., 1994; Frassoni et al., 1998). In Pax6Sey/Sey embryos,
staining was greatly decreased in the dorsal thalamus, labelled
cells were absent from the thalamic midline and there was a
loss of immunolabelled thalamocortical axons. We also
demonstrated absence of thalamocortical projections in
Pax6Sey/Sey embryos using Dil. As shown in Fig. 1G,H, from
E15.5 onwards Dil placed in the dorsal thalamus diffused to
the cerebral cortex in wild type (Fig. 1G) but did not get further
than the medial part of the ventral telencephalon in the mutants
(Fig. 1H shows at high magnification, an area in a mutant
equivalent to that indicated by an asterisk in Fig. 2C).
Analysis of thalamocortical growth in culture
The aim of these experiments was to test whether or not axons
from dorsal thalamus in Pax6Sey/Sey embryos are able to
respond to growth and/or guidance signals along their path to
the cortex. Fig. 2A shows that the thalamocortical tract is
clearly visible in our transgenic mice expressing tau-GFP on a
wild-type background (tau-GFP:Pax6+/+). Axons originate
from the dorsal thalamus, enter the ventral thalamus and turn
at the hypothalamus into the ventral telencephalon, which they
penetrate to reach the cortex (Fig. 2A). This tract is not seen
in tau-GFP:Pax6Sey/Sey embryos (Fig. 2C). To test the ability
of thalamic axons to innervate tissue encountered along the
normal thalamocortical pathway, we cultured explants of tau-
GFP:Pax6+/+ and tau-GFP:Pax6Sey/Sey thalamus in contact
with wild-type ventral telencaphalon, hypothalamus or cerebral
cortex (Fig. 2F-M; results are shown on a grey tint, which
makes axons clearer). Dorsal thalamic explants were removed
from sections appearing similar to that shown in Fig. 2A,C, as
illustrated in Fig. 2B,D. Analysis of Dlx2, Hbnf and Pax6
expression patterns (Figs 2E, 4C-F) and previous descriptions
of gene expression patterns (Stoykova et al., 1996; Warren and
Price, 1997; Kawano et al., 1999), helped us to define tissue
landmarks and to make accurate dissections.
Dorsal thalamus from tau-GFP:Pax6+/+ embryos produced
prolific outgrowth into wild-type ventral telencephalon,
extending well over half-way through the telencephalic
explants, in 76% of cultures (typical examples are shown in
Fig. 2F,G). In 62% of these cultures large numbers of thalamic
axons curved often quite sharply in a dorsal direction. These
features, illustrated in Fig. 2F,G are reminiscent of the in vivo
trajectory of thalamic axons as they grow through the internal
capsule and turn dorsally towards the neocortex (Fig. 2A). In
marked contrast, none of the cultures of tau-GFP:Pax6Sey/Sey
dorsal thalamus with wild-type ventral telencephalon showed
these features. In 60% of these cultures thalamic axons did
enter the medial part of the ventral telencephalon, but in almost
all these cases (86%) not even a single thalamic axon reached
anywhere near half-way through the telencephalic explant. A
typical example is shown in Fig. 2H. In none of these cultures,
nor in the 14% of cases where longer thalamic axons were seen
(Fig. 21 illustrates the culture in which there was most growth),
was there any evidence of a consistent turning of the thalamic
axons in a dorsal direction. Repeated observations of tau-GFP-
labelled wild-type and Pax6Sey/Sey axons in some of the cultures
during their 3 days in vitro revealed that the major features of




Fig. 1. Thalamocortical defects in Pax6sey/Sey
embryos. (A-D) 5-HT immunolabeling in
clorgyline-treated El7.5 Pax6+/+ and Pax6Sey/Sey
embryos. (A,B) Pax6+/+ embryos: 5-HT
immunolabelled sensory thalamocortical axons at
the level of (A) the subplate (sp), and (B) the
internal capsule (ic). (C,D) Pax6Sey/Sey embryos:
loss of 5-HT-immunolabelled sensory axons at the
level of (C) the subplate and (D) the internal
capsule (* marks expected position of axons in C
and D). (E,F) Calretinin immunolabelling in E17.5
Pax6+/+ and Pax6Sey/Sey embryos. (E) Pax6+/+
embryo: calretinin labelling in the stria medullaris
(sm) of the epithalamus, the laterodorsal (Id),
paraventricular (pv) and other midline nuclei of the
dorsal thalamus and in the lateral hypothalamus
(lh). Note calretinin immunopositive fibres
extending to/from the pv and Id through the
internal capsule (ic) into the subplate (sp) of the
developing cortex. (F) Pax6Sey/Sey embryo: residual
calretinin labelling in lateral regions of the
epithalamus (upper arrow), dorsal thalamus
(arrowhead) and hypothalamus (lower arrow) and
loss of labelling in the midline nuclei. Note loss of
calretinin immunopositive fibres at the level of the
internal capsule (*marks expected position of
fibres). (G,H) High-power views showing the
furthest extent of Dil labelling from the dorsal
thalamus at El5.5 in (G) Pax6+U and (H)
Pax6Sey/Sey embryos. Label is in the cerebral cortex
(cc) in wild type but has got no further than the
medial part of the ventral telencephalon (vtel) in
mutants; the mutant axons are more disorganised
than those in the wild type. The area in H
corresponds to that marked by an asterisk in Fig.
2C. Scale bars, A-F, 500 pm; G,H, 50 pm.
innervation were established quickly, within 1-2 days of the
start of culture, and there was less progression between 2 and
3 days. It is unlikely, therefore, that the defective innervation
from the tau-GFP:Pax6Sey/Sey thalamic explants can be
explained simply by a slowing of development.
In all cultures where tau-GFP:Pax6+/+ dorsal thalamus was
placed next to wild-type hypothalamus, thalamic axons
coursed around its edge and failed to innervate it (Fig. 2J), in
agreement with previous findings on the repulsive nature of the
hypothalamus for dorsal thalamic axons (Braisted et al., 1999).
The same result was obtained in all cases where tau-
GFP:Pax6Sev/S(fy dorsal thalamic explants were used (Fig. 2L).
When tau-GFP :Pax6+/+ dorsal thalamus was placed with wild-
type cortex, most cultures showed large numbers of thalamic
axons wrapping around its edges and upper and lower surfaces
(Fig. 2K). This pattern has been described before and is due to
the inability of the early cortical layers to receive thalamic
innervation (Molnar and Blakemore, 1991; Goetz et al., 1992).
In 95% of these cultures, thalamic axons extended distances
equivalent to at least half-way round the circumference of the
cortical explants. When tau-GFP:Pax6Sey/Sey dorsal thalamus
was cultured with wild-type cortex, the pattern of thalamic
axonal growth was similar to that with tau-GFP:Pax6+/+ dorsal
thalamus (Fig. 2M), although in many cases it appeared that
there were fewer thalamic axons. In 92% of these cultures large
numbers of axons extended distances equivalent to well over
half-way round the circumference of the cortical explants, as
occurred with tau-GFP:Pax6+/+ dorsal thalamus.
Several observations indicate that the inability of the
Pax6Sey/Sey dorsal thalamus to generate normal innervation of
ventral telencephalon is not caused by a non-specific inability
to grow. First, Pax6Sey/Sey dorsal thalamic explants are capable
of producing many long axons when co-cultured with wild-
type cortex, as do Pax6+/+ thalamic explants (Rennie et al.,
1994). The apparent reduction in the numbers of mutant
thalamic axons in these co-cultures is compatible with previous
observations that mutant dorsal thalamus contains fewer
neurons (proliferation in the early mutant diencephalon is
reduced; Warren and Price, 1997), although it could
conceivably be due to a defective response by some thalamic
neurons to cortex-derived growth-promoting factors. Second,
analysis of nuclear morphology with TO-PR03 showed that
Role of Pax6 in thalamic development 5171
Fig. 2. Pax6Xey/iiey thalamic explants exhibit defective tract
formation, as shown by organotypic co-culture of tau-
GFP:Pax6+/+ or tau-GFP:Pax6Sey/Sey dorsal thalamic (dt)
explants with wild-type explants of ventral telencephalon
(vfcl), hypothalamus (ht), or cerebral cortex (cc).
(A,C) Fluorescence images of coronal sections of E14.5
tau-GFP:Pax6+/+ and tau-GFP:Pax6Sey,Sey brains similar
to those from which explants were dissected. (A) tau
GFr.Pax6*'* embryo showing strong tau-GFF labelling of
thalamic axons as they turn sharply to avoid the
hypothalamus and enter the ventral telencephalon to form
the internal capsule (*). (C) tau-GFP:Pax6Sc>/Se^ embryo,
showing that the strong tau-GFP label seen in tau-
GFP:Pax6*/+ embryos is lacking from the position
normally occupied by the internal capsule (*).
(B,D) Schematic representations of sections shown in
A,C with red dotted lines indicating locations of cuts used
to isolate the tissues used in these experiments (dt, vtel, ht,
and cc) from coronal slices. Panels A-D show only one
side but note that the left and right dorsal thalamus were
left joined dorsally in culture and their cut edges, just
anterior to the border with ventral thalamus, were placed
against different tissues on each side. The border between
the ventral and dorsal thalamus, as defined by tissue
landmarks and the expression of genes such as Dlx2 and
Pax6, is shown with a blue line. (E) In situ hybridization on
a 200 (xm-thick vibratome section (pink counterstain) of a
Pax6Sey/Sey E14.5 embryo corresponding to the section in
C,D, showing expression of Pax6 (purple) in the thalamus,
where it acts as a marker of ventral thalamus even in the
mutants (Stoykova et al., 1996; Warren and Price, 1997),
and telencephalon. (F-M) Grey tint presentation of
fluorescence images showing representative examples of
co-cultures of (F,G,J,K) tau-GFP:Pax6+/+ thalamus or
(H,I,L,M) tau-GFP:Pax6Sey/Sey thalamus with (F-I) wild-
type ventral telencephalon, (J,L) wild-type hypothalamus
or (K,M) wild-type cerebral cortex. Scale bar, 200 pm.
under all conditions used here almost all cells in both
Pax6+/+ and Pax6Se>/Se>' dorsal thalamic explants
remain viable. Third, in other experiments in which
El4.5 dorsal thalamic explants were dissociated and
cultured for 3 days in serum-free medium, Pax6+/+
and Pax6Sey/Sey cells survived and grew neurites
equally well (reported in preliminary form by Edgar
et al., 1999). Therefore, the inability of the Pax6Sey/Sey
dorsal thalamus to generate normal ventral
telencephalic innervation is likely to be due to its
inability to respond to growth and guidance cues in that region.
Although the main focus of this work was the dorsal
thalamus and its axons, we carried out a few experiments to
gain a better idea of the status of the ventral telencephalon in
the mutants. In cultures of tau-GFP:Pax6+/+ dorsal thalamus
with Pax6Sey/Sey ventral telencephalon we observed prolific
innervation by long axons, indicating that the mutant ventral
telencephalon does not lack the ability to stimulate and receive
dorsal thalamic innervation (Fig. 3A). Innervation did not
appear normal, however, and many axons turned in abnormal
ways in the mutant ventral telencephalon (compare Fig. 3A
with Fig. 2F,G). We probed the Pax6Sey/Sey ventral
telencephalon for expression of Netrin 1, a potential candidate
for a chemoattractant of thalamocortical axons (Braisted et al.,
1999, 2000), and found similar expression as in wild-types
(Fig. 3B,C). Although the Pax6Sey/Sey ventral telencephalon
may be permissive for incoming thalamic axons, it is quite
possible that defects in this region contribute to the lack of
thalamocortical innervation in small eye homozygotes.
Altered expression of dorsal thalamic markers in
Pax6Sey/Sey embryos
Previous studies of the major subdivisions of the diencephalon
in small eye homozygotes, using molecular markers other than
those applied here, all identified a region equivalent to dorsal
thalamus in the mutants (Stoykova et al., 1996; Grindley et al.,
1997; Warren and Price, 1997; Kawano et al., 1999). Major
molecular defects of this region were not described. By probing
Pax6Sey/Sey embryos for expression of two mRNAs that
normally mark dorsal thalamus, we obtained evidence of
such defects. The mRNAs examined encode the vesicular
monoamine transporter type 2 (VMAT2\ Lebrand et al., 1999)
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Fig. 3. The nature of the ventral telencephalon in
Pax6Sey/Sey embryos. (A) Organotypic co-culture of tau-
GFP:Pax6+/+ dorsal thalamic explant with explant of
Pax6Se?/Sey ventral telencephalon. (B,C) In situ
hybridizations showing Netrin 1 expression in the ventral
telencephalon of Pax6+/+ and Pax6Sey/Sey E14.5 embryos.
Abbreviations as in Fig. 2. Scale bar, 200 pm.








and the secreted molecule heparin binding neurotrophic factor
(.Hbnf; Bloch et al., 1992; Rauvala et al., 1994). In E15.5 and
E17.5 Pax6+/+ embryos, VMAT2 was expressed in dorsal
thalamic nuclei (Fig. 4A; Lebrand et al., 1999). In age-matched
Pax6Sey/Sey embryos there was a severe loss of VMAT2
expression in the body of the dorsal thalamus, with only very
faint residual expression barely detectable posterodorsally
(arrow in Fig. 4B). In Pax6+/+ embryos aged E13.5 or more,
Hbnf was expressed throughout the entire body of the dorsal
thalamus, with a sharp anterior boundary at the border with the
ventral thalamus, the zona limitans intrathalamica (zli; arrow
in Fig. 4C), and in the epithalamus. In Pax6Sey/Sey embryos aged
El 3.5 or more there was a loss of Hbnfexpression in the dorsal
thalamus (Fig. 4D). Expression was retained posterodorsally
in the epithalamus (arrow in Fig. 4D). In these experiments we
used Dlx2 expression to mark the posterior ventral thalamic
border at the zli, which it does even in Pax6Sey/Sey mice (Fig.
4E,F; Warren and Price, 1997), and showed that this boundary
is well-separated from residual Hbnf expression in Pax6Sey/Sey
epithalamus (Fig. 4D). The tissue between the posterior
boundary of Dlx2 expression and the epithalamus is labelled
dorsal thalamus (dt) in Fig. 4C-F.
Ectopic expression of Lim1/Lhx1 in the Pax6Sey/Sey
dorsal thalamus
Since Pax6 is downregulated in the dorsal thalamus as
thalamocortical axons begin to form (around E12.5-E13.5;
Fig. 4. Expression of dorsal thalamic markers in Pax6Sey/Sey embryos.
In situ hybridisation on coronal sections of (A,B) E17.5 and (C-F)
E15.5 Pax6+/+ and Pax6Sey/Se>' embryos for (A,B) VMAT2 expression,
(C,D) Hbnfexpression and (E,F) Dlx2 expression. (A) Pax6+/+
embryo: VMAT2 expression in dorsal thalamic nuclei including the
ventral posteromedial (vpm) and ventral posterolateral (vpl) and
dorsolateral geniculate (dig). (B) Pax6Sey/Sey embryo: loss of VMAT2
expression in the dorsal thalamus, with only very faint residual
expression (arrow). (C) Hbnfexpression in Pax6*/+ embryo: there is
strong expression in the dorsal thalamus as well as at other sites
including the epithalamus, cells lining the 3rd and lateral ventricles,
the basal telencephalon and developing cortical plate. (D) Hbnf
expression in Pax6Sey/Se>' embryos: there is a severe loss of Hbnf
expression in the body of the dorsal thalamus with only slight
residual expression in the epithalamus (arrow). (E,F) Dlx2
expression in sections corresponding to those in C and D
respectively. Even in Pax6Sey/Sey embryos, expression is restricted to
ventral thalamus (Stoykova et al., 1996; Warren and Price, 1997),
making this a useful marker of the border between dorsal and ventral
thalamus, zli, zona limitans intrathalamica; dt, dorsal thalamus; et,
epithalamus; vt, ventral thalamus. Scale bar, 500 pm.
Auladell et al., 2000), it is possible that the incompetence of
Pax6Sey/Sey dorsal thalamic axons to navigate the ventral
telencephalon is an indirect defect caused via more persistent
changes in other regulatory genes. In Pax6Sey/Sey embryos aged
El3.5 or more, we found a striking abnormality of Liml/Lhxl
expression in the thalamus (Fig. 5). In wild-type embryos,
Liml/Lhxl was expressed in ventral thalamic nuclei but was
excluded from the dorsal thalamus (Fig. 5A,C,D), whereas in
mutants it was expressed throughout both the ventral and the
dorsal thalamus (Figs 5B,E,F). In these experiments, we
confirmed the location of the zli by staining adjacent sections
for expression of Dlx2. As described before by Mastick et al.
(1997), Liml/Lhxl expression was lost from the pretectum in
mutants (Fig. 5D,F).
Altered expression of Shh and Nkx2.2 in Pax6Sey/Sey
diencephalon
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Fig. 5. Liml/Lltxl expression in Pax6Sey/Se^ embryos. In situ
hybridisation on (A,B) sagittal and (C-F) coronal sections of
(A,B) E13.5 and (C-F) E15.5 Pax6+/+ and Pax6Sey/Sey embryos.
(A) In wild type, Liml/Lhxl is expressed in the pretectum (top
arrow), ventral to the dorsal thalamus and around the zli (bottom
arrow). (B) In mutants, Liml/Lhxl expression extends over the body
of the dorsal thalamus (arrow). (C) Rostral and (D) caudal sections of
wild type embryos: Liml/Lhxl expression is restricted to specific
nuclei in the ventral thalamus, including the ventrolateral geniculate
nucleus (vlg) rostrally. (E) Rostral and (F) caudal sections of mutant
embryos: a large band of ectopic Liml/Lhxl expression is visible
within the body of the dorsal thalamus (dt) at all rostrocaudal levels.
Note the absence of label in the pretectum (pt). In the ventral
thalamus, Liml/Lhxl expression is distorted and no longer restricted
to discrete areas. The borders of the dorsal thalamus are marked with
arrowheads; the position of the border between dorsal and ventral
thalamus was confirmed by probing for DIx2 expression in nearby
sections. Scale bar, 500 pm.
implicated in DV patterning of the central nervous system. The
expression of Shh in Pax6+/+ and Pax6Sey/Sey embryos, in
whole-mount (Fig. 6A,B) and sectioned embryos (not shown),
confirmed the findings of others (Barth et al., 1995; Shimamura
et al., 1995; Grindley et al., 1997). In both wild-type and
mutant embryos at all ages studied (E10.5, E13.5 and E15.5),
Shh was expressed along the AP axis ol" the ventral neural tube
with a dorsal deflection at the zli (Fig. 6A,B). As reported by
Grindley et al. (1997), the domain of expression at the ventral
end of the zli (the region between the short lines in Fig. 6A,B)
was slightly broader in age-matched mutants, extending a little
further into the presumptive dorsal thalamus.
In situ hybridizations for Nkx2.2 in E10.5 Pax6+/+ embryos
showed expression along the AP axis in a longitudinal band
adjacent to Shh expression (not shown; described before by
Shimamura et al., 1995; summarized in Fig. 8). In E13.5
Pax6+/+ embryos, the domain of Nkx2.2 expression remained
tightly restricted around the zli and did not encroach
on the body of the dorsal (posterior) thalamus (Fig.
6C; Shimamura et al., 1995; Kitamura et al., 1997). In
age-matched Pax6Sey/Se-v embryos, Nkx2.2 expression
extended to include the body of the dorsal thalamus euh
(Fig. 6D).
Immunocytochemical analysis of Nkx2.2
expression confirmed these findings. At E10.5,
diencephalic expression of Nkx2.2 was restricted to a
band of cells adjacent to Shh expression in both
Pax6+/+ and Pax6Sey/Sey embryos. A difference
between diencephalic expression in Pax6+/+ and Nkx2.2
Fig. 6. In situ hybridisations on dissected embryos at
E13.5. (A) Pax6+/+ embryo: Shh expression along the AP
axis of the ventral neural tube and along the zli.
(B) Pax6Sey/Sey embryo: a similar pattern is seen, but note
slight expansion of the domain of Shh expression around
the zli (described by Grindley et al., 1997; compare
distance between black bars in A and B). (C) Pax6+/+
embryo: Nkx2.2 expression flanks the zli and is confined to
a narrow strip along its posterior edge. (D) Pax6Sey/Sey
embryo: abnormal Nkx2.2 expression is seen throughout the
body of the dorsal thalamus. The black boxes in the
schematics shown in E and F indicate where panels C and
D were taken from; the bases of the panels are indicated by
red asterisks in E and F. Abbreviations as in Fig. 4; mes,
















Pax6Se>/Sey embryos emerged between El 1.5 and El2.5, with
cells labelled for Nkx2.2 dispersed in the body of the
presumptive dorsal thalamus in the mutants but not in the wild-
type embryos. This difference persisted at older ages. At El7.5
(Fig. 7), many cells expressing Nkx2.2 in the mutants were
present throughout the dorsal thalamus and the pretectum, right
up to their dorsal edge (between the arrows in Fig. 7B),
whereas Nkx2.2-positive cells were confined to the ventral
edge of these regions in wild type (Fig. 7A). The density of
ectopic labelled cells in the mutants was greatest in the anterior
and ventral parts of the dorsal thalamus.
The results of our work are summarized in Fig. 8. Our gene
expression studies indicate a respecification of the presumptive
posterior (dorsal) thalamus in prosomere 2 in Pax6Sey/Sey
embryos. In this respecification the dorsal thalamus takes on
molecular characteristics normally restricted to tissue ventral
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Fig. 7. Illustrates the results of immunocytochemistry for Nkx-2.2 in
parasagittal sections of E17.5 Pax6*/+ and Pax6Sey/Sey embryos.
(A.B) Immunochemistry and (C,D) corresponding Nissl sections. In
mutants labelled cells are found throughout the dorsoventral extent of
the diencephalon, even along its dorsal edge (between the arrows in
B). In wild type embryos they are confined in a strip running ventral
to the posterior thalamus and its surrounding structures. Scale bar, 1
mm.
8. For comparison with work in other regions of the central
nervous system, this respecification may be more easily
described as a ventralization than an anteroventralization, since
elsewhere Shh and Nkx2.2 are expressed ventrally and not, as
is the case at and around the zli, in alar regions.
DISCUSSION
Fig. 8. Summary diagram of our main findings. Gene expression:
dark blue, Shh', red (areas and dots, the latter indicating less dense
label), Nkx2.2; yellow (areas and vertical bars, the latter used where
there is overlap), Liml/Lhxl', light blue, VMAT2; orange cross-
hatching, Dlx2. Arrows and arrowheads indicate the main changes
that form the focus of this study. For clarity, the schematics provide a
qualitative summary only, they do not reflect the shape of the
diencephalon nor are they to scale. The neuron below each schematic
represents a thalamocortical axon, the red cross indicating
incompetence to respond to ventral telencephalic growth and
guidance factors.
The thalamocortical tract fails to form normally in Pax6Sey/Sey
mice. In the wild type, the tract projects from the dorsal
thalamus and travels through the ventral thalamus, avoids the
hypothalamus, turns sharply into the ventral telencephalon
(forming the internal capsule), and then reaches its target in the
cerebral cortex (Tuttle et al., 1999; Braisted et al., 1999;
Auladell et al., 2000). In Pax6s''>/Sey mice, the dorsal thalamus
does project a tract but it fails to enter the cortex and appears
to become stalled en route from the ventral thalamus to the
ventral telencephalon (Kawano et al., 1999; present study).
A comparison of timetables for Pax6 gene expression in
developing forebrain (Stoykova et al., 1996; Grindley et al.,
1997; Mastick et al., 1997; Warren and Price, 1997; Kawano
et al., 1999) and thalamocortical tract formation (Tuttle et al.,
1999; Braisted et al., 1999; Auladell et al., 2000) suggests
several locations at which Pax6 could influence the developing
thalamocortical tract. Pax6 is expressed at many points along
the thalamocortical pathway at times coinciding with critical
events in thalamocortical tract formation including the dorsal
thalamus, where Pax6 expression coincides with neurogenesis
between E10 and E13 (Angevine, 1970), the ventral thalamus,
the hypothalamus, the ventral telencephalon and the cerebral
cortex. The failure of the thalamocortical tract to form in the
absence of Pax6 function could reflect a requirement for Pax6
at one or more of these locations.
We present new evidence that supports the hypothesis that a
structure equivalent to the dorsal thalamus emerges in the
absence of Pax6 but that its subsequent differentiation and
ability to project a thalamocortical tract does require Pax6
function.
Pax6 is not required for formation of the dorsal
thalamus but is required for its correct
differentiation
Previous studies of the embryonic diencephalon in Pax6Sey/Sey
mice showing relatively normal AP expression patterns of Dlx,
Otx, Emx Wnt genes, Proxl, Gbx2, Mashl and Pax6 have
indicated that diencephalic AP patterning is not greatly
disturbed (Stoykova et al., 1996; Warren and Price, 1997;
Grindley et al., 1997). These gene expression studies have
suggested that the embryonic Pax6Sey/Sey diencephalon
possesses correlates of the histogenetic regions that in the
wild type give rise to major diencephalic structures. Despite
obvious distortions in the shape of the embryonic Pax6Sey/Sey
diencephalon (Stoykova et al., 1996), which may in part be due
to defects of cell proliferation in this region (Warren and Price,
1997), morphological features reminiscent of those that
distinguish diencephalic regions in the wild type have been
described. Equivalents of prosomeres 1-3 and their main
components, the ventral and dorsal thalamus and the
pretectum, have been identified on the basis of gene expression
and morphology in the mutants and named according to their
wild-type counterparts (Stoykova et al., 1996; Mastick et al.,
1997; Warren et al., 1997; Kawano et al., 1999; present study).
The alterations we observe in the expression patterns of
several genes (Hbnf, VMAT2, Liml/Lhxl, and Nkx2.2) are
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superimposed on these structures and reflect a failure of the
Pax6Sey/Sey dorsal thalamus to differentiate normally in the
absence of Pax6 expression. These molecular patterning
defects indicate that the differentiation program of the
Pax6Sey/Sey dorsal thalamus is disrupted during the period when
it fails to make appropriate connections with the central cortex.
Pax6 is required within the dorsal thalamus for
thalamocortical tract formation
Pax6 and dorsal thalamic tract projection
From observations of the Pax6Sey/Sey brain alone, it is
conceivable that the thalamocortical tract defect results from
an autonomous defect in the dorsal thalamus itself, or from
defects in the environment through which the thalamocortical
axons navigate, or a combination of the two. To address this
issue, we show that explants of mutant dorsal thalamus are
defective in their ability to project a tract capable of correct
navigation through wild-type ventral telencephalon. This
defect may be limited to this specific aspect of thalamocortical
growth since Pax6Sey/Sey thalamic axons innervate wild-type
cortex and avoid wild-type hypothalamus, as do wild-type
thalamic axons. These new data provide direct evidence that
Pax6 expression is required within the dorsal thalamus itself,
regardless of whether Pax6 expression is also required at other
locations.
Because our thalamic explants contained some ventral
thalamus and epithalamus as well as dorsal thalamic tissue, it
is formally possible that our results could be explained by the
lack of essential signalling to axons en passant (Wang and
Tessier-Lavigne, 1999). This possibility would demand that
adjacent tissues instruct axons leaving the dorsal thalamus in
ventral telencephalic navigation. The zli or the ventral
thalamus would be possible candidates for this type of
interaction (Mastick et al., 1997; Braisted et al., 1999; Tuttle
et al., 1999). The evidence, however, is against such a
possibility. Wild-type thalamic explants in our cultures exhibit
similar features of axon outgrowth to cultures using dorsal
thalamic explants prepared from embryonic brain at similar
ages but with surrounding tissues removed. These features
include avoidance of the hypothalamus, attraction towards the
ventral telencephalon and penetration of the cortex (Molnar
and Blakemore, 1991, Goetz et al., 1992; Braisted et al., 1999,
2000). Since these 'pure' dorsal thalamic explants have been
isolated from potential instruction by cells lying outside the
dorsal thalamus, such instructions are unlikely to be important
for these features of thalamocortical tract formation.
The design and interpretation of the explant experiments
depends on correct identification of dorsal thalamus in mutant
brain for explant isolation. Given the disturbed anatomy of the
mutant diencephalon, it was critical that in spite of these
abnormalities the dorsal thalamic explants isolated from wild-
type and mutant brain were equivalent. We argue above that
the Pax6Sey/Sey embryo does possess a structure corresponding
to the dorsal thalamus which can be identified by its
morphology and gene expression patterns. The problem of
equivalence reduces to choosing explants in which axons
projecting from Pax6Sey/Sey and wild-type dorsal thalamus have
equal opportunities to interact with target tissues. The major
defect in thalamocortical tract formation in mutants appears to
occur as axons attempt to navigate from the ventral thalamus
into the ventral telencephalon (Kawano et al., 1999; present
study). There is no evidence that axons originating from the
dorsal thalamus become stalled in the ventral thalamus or that
they fail to avoid the hypothalamus. We therefore selected
explants that centered on the dorsal thalamus but also contained
some ventral thalamic and epithalamic tissue. This ensured that
dorsal thalamus was present and enabled us to position our
explants to recreate the topography of intact brain more
accurately than if we had attempted to dissect smaller pieces
of tissue with resulting loss of anatomical landmarks. Since the
ventral thalamus/ventral telencephalon transition zone, where
thalamocortical defects in the Pax6Sey/Sey mice occur, was
absent from our thalamic explants, axons from Pax6Sey/Sey or
wild-type were able to navigate to the edge of the thalamic
explant where they were confronted by the target tissue. The
observation that thalamic axons responded to the target tissues
in ways reminiscent of their behavior in vivo supported the
accuracy of our culture system.
Pax6 and the ventral telencephalon
We also show that Pax6Sey/Sey ventral telencephalon maintains
normal expression patterns of netrin 1, a molecule implicated
in thalamocortical tract formation (Braisted et al., 2000), and
is permissive to wild-type thalamic axons. Therefore although
we cannot rule out the possibility that defects in the ventral
telencephalon contribute to the lack of thalamocortical
innervation in Pax6Sey/Sey embryos, we find no evidence that
such defects can account for the Pax6Sey/Sey thalamocortical
phenotype wholly.
Roles of Pax6 in the genetic cascade which
programs the development of dorsal thalamus
Regulation of transcription factors and secreted
morphogens by Pax6
Work on the developing spinal cord and hindbrain has
implicated Pax6, together with the secreted morphogen Shh,
the transcription factor Nkx2.2 and members of the LIM/LHX
family of homeodomain proteins in DV patterning and
neuronal fate determination in these posterior regions
(Echelard et al., 1993; Krauss et al., 1993; Roelink et al., 1994,
1995; Appel et al., 1995; Marti et al., 1995; Tanabe et al., 1995;
Ericson et al., 1995, 1996, 1997; Osumi et al., 1997; Briscoe
et al., 1999). Pax6 may play a similar role in the developing
diencephalon. It is possible that Nkx2.2 expression ventral and
anterior (at the zli) to the posterior thalamus of normal embryos
is induced by Shh, which diffuses from ventral territory and
from the zli, and directly or indirectly repressed by Pax6 in
dorsal territory. The accumulation of A7cc2.2-positive cells in
the posterior thalamus in Pax6Sey/Sey embryos older than El0.5
could result from Shh induction in the absence of a
constraining influence from Pax6. Our observation that
densities of ectopic labelling for Nkx2.2 in the mutants were
highest at the ventral and anterior parts of the posterior
thalamus could be explained because these are the parts closest
to the expression domain of Shh. Another likely contributing
factor is that, as first reported by Grindley et al. (1997), the
domain of Shh expression is slightly expanded at the ventral
end of the zli. It is interesting that the normal downregulation
of Pax6 in the developing wild-type posterior thalamus is not
followed by upregulation of expression of Nkx2.2 in this
region. This argues against the persistence of a simple
reciprocal relationship between levels of Pax6 and Nkx2.2
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expression throughout the period of posterior thalamic
development. While such a relationship may play an important
role in early patterning of this region, other factors such as the
levels of Shh protein or repressive molecules in the posterior
thalamus may constrain the dorsal edge of the domain of
Nkx2.2 later on in normal development. It is possible that
ectopic expression of Nkx2.2 in the posterior thalamus in
Pax6Sey/Sey embryos contributes to generating ectopic
expression of Liml/Lhxl in this region, as in more caudal
regions of the neural tube (Ericson et al., 1997; Briscoe et al.,
1999).
Regulation of cell surface properties by Pax6
The cerebral cortex, like the dorsal thalamus, exhibits Pax6
expression in ventricular zone cells during neurogenesis and
downregulates Pax6 expression in postmitotic cells. The
expression of Pax6 in proliferating cortical neurons influences
their postmitotic gene expression patterns and cell surface
properties with the maintenance of this genetic pattern
becoming independent of the presence of Pax6 (Warren et al.,
1999). Work on the developing cerebral cortex has implicated
Pax6 in regulating members of the cadherin family of cell
adhesion molecules (Stoykova et al., 1997) and the trk family
of neurotrophin receptors (Warren et al., 1999). In vitro
aggregation assays (Stoykova et al., 1997) and transplantation
experiments (our unpublished results) have established that the
adhesive properties of cortical cells are altered in Pax6Sey/Sey
embryos. Roles for Pax6 in regulating adhesive properties
have been elegantly demonstrated in the eye by analysis
of Pax6Sey/Sey <H> wild-type chimeras (Quinn et al., 1996;
Collinson et al., 2000). Pax6 has also been implicated in axon
pathfinding in the tract of the postoptic commissure (Mastick
et al., 1997) and spinal cord (Ericson et al., 1997) as well as
in the thalamocortical tract (Tuttle et al, 1999; Kawano et al.,
1999; present study). Consistent with its roles elsewhere in the
CNS, Pax6 probably controls thalamocortical tract formation
by regulating the cell surface properties of dorsal thalamic cells
and influencing the navigation choices made by their growth
cones.
Clarification of the molecular mechanisms of Pax6 action
will be facilitated as the tally of molecules implicated in
thalamocortical tract formation increases. At present these
include cell surface receptors DCC, Neogenin, Robol, Robo2,
RPTP8, and LAMP, and secreted molecules Netrin 1, Slitl and
Slit2 (Ringsted et al., 1999; Braisted et al., 2000; Tuttle et al.,
1999; Mann et al., 1998). A recent study by Braisted et al.
(2000) has demonstrated that Netrin 1 promotes the growth of
thalamocortical axons through the ventral telencephalon and so
it is possible that abnormalities in Pax6Sey/Sey embryos may be
contributed to by defects of receptors mediating its attractant
effects, DCC and Neogenin. Both are expressed in the normal
dorsal thalamus. Our preliminary evidence, however, suggests
that DCC is still expressed in the dorsal thalamus of Pax6Sey/Sey
embryos (T. V., unpublished observations). Given that defects
of thalamocortical axons are less severe in loss-of-function
mutation of Netrin 1 than in Pax6Se>/Sey embryos and that
blocking Netrin 1 in vitro does not abolish thalamic axon
attraction to ventral telencephalon (Braisted et al., 2000), it is
hard to explain the small eye defects on the basis of a loss of
Netrin 1 responsiveness alone. Other perhaps as yet
unidentified signalling systems are likely involved.
Conclusion
The requirement for Pax6 in the dorsal thalamus is lifted by
the time its cells become postmitotic. It is possible that Pax6
has direct effects on the expression of cell surface molecules
involved in receptor/ligand interactions, cell adhesion or axon
pathfinding before it is downregulated. However, our findings
that the defective responses of Pax6Sey/Sey dorsal thalamic
axons coincide with persistent changes in the expression
patterns of regulatory genes other than Pax6 from the early
stages of dorsal thalamic development allows that these defects
may result indirectly from the early absence of Pax6 from this
region. Genes such as Liml/Lhxl or Nkx2.2 whose expression
is influenced by Pax6 may have more direct effects, for
example up- or downregulating the expression of effector
molecules. Whether direct or indirect, we conclude that Pax6
plays an essential role in the development of the dorsal
thalamus and the ability of its axons to respond to key growth
and guidance cues.
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Embryonic Stem Cells and Transgenic Mice
Ubiquitously Expressing a Tau-Tagged
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We have generated embryonic stem (ES) cells and transgenic mice carrying a tau-tagged green fluorescent protein (GFP)
transgene under the control of a powerful promoter active in all cell types including those of the central nervous system.
GFP requires no substrate and can be detected in fixed or living cells so is an attractive genetic marker. Tau-tagged GFP
labels subcellular structures, including axons and the mitotic machinery, by binding the GFP to microtubules. This allows
cell morphology to be visualized in exquisite detail. We test the application of cells derived from these mice in several types
of cell-mixing experiments and demonstrate that the morphology of tau-GFP-expressing cells can be readily visualized after
they have integrated into unlabeled host cells or tissues. We anticipate that these ES cells and transgenic mice will prove
a novel and powerful tool for a wide variety of applications including the development of neural transplantation
technologies in animal models and fundamental research into axon pathfinding mechanisms. A major advantage of the
tau-GFP label is that it can be detected in living cells and labeled cells and their processes can be identified and subjected
to a variety of manipulations such as electrophysiological cell recording. © 2000 Academic Press
Key Words: axon; coculture; confocal microscopy; cytoskeleton; GFP; ES cells; microtubules; mitosis; tau; transgenic mice.
INTRODUCTION
In many biological experiments it is necessary to distin¬
guish between two populations of cells. It is often useful to
mark one population of cells genetically so that the cell and
its descendants can be identified indefinitely. An animal
expressing the marker in every cell would provide a univer¬
sal source of labeled cells without the need to generate new
lines for each subset of labeled cells required.
Green fluorescent protein (GFP), originally extracted
from jellyfish Aequorea victoria, requires no substrate for
detection and can be detected in fixed or living cells by
fluorescent microscopy (Chalfie et al., 1994). Over recent
years the gene encoding GFP has undergone directed evo¬
lution in the hands of biologists anxious to exploit its
experimental potential. Alterations of the GFP-coding se¬
quence have produced variants with improved expression
and detection properties in transgenic mice (Siemering et
al., 1996; Zernika-Goetz et al., 1997). By imposing different
genetic controls, transgenic mice have been produced
which express GFP either ubiquitously (Okabe et al., 1997;
Hadjantonakis et al., 1998) or in a more restricted number
of cell types (Godwin et al., 1998; Van den Pol and Ghosh,
1998; Zhuo et al., 1997). We combined the use of a strong
promoter (Niwa et al., 1991) which drives ubiquitous ex¬
pression of a GFP transgene in mice (Okabe et al., 1997;
Hadjantonakis et al., 1998) and tau tagging (Rodriguez et al.,
1999) which we anticipated would improve our ability to
visualize cell morphology, particularly long processes such
as axons and other cytoskeletal features (Callahan and
Thomas, 1994; Ludin and Matus, 1998; Kaech et al., 1996;
Preuss and Mandelkow, 1998; Mills et al., 1998; Rodriguez
et al., 1999).
We report the generation and characterization of ES cells
and transgenic mice ubiquitously expressing a tau-GFP
fusion protein. Tau-GFP labeling reveals specific subcellu¬
lar features such as the mitotic machinery by illuminating
the microtubule component of the cytoskeleton. Detection
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of tau-GFP in living preparations will provide a powerful
tool for studying microtubule dynamics in a variety of cell
types and cellular processes including axon pathfinding,
cell division, differentiation, migration, and death. Experi¬
ments in which tau-GFP-expressing cells and tissues are
cultured with nonexpressing cells or tissues demonstrate
the experimental potential of these mice in cell-mixing
experiments. Labeled cells and their processes can be visu¬
alized by fluorescence microscopy in live and fixed prepa¬
rations and their behavior can be mapped.
MATERIALS AND METHODS
Construction of Tau-GFP Expression Vector pTP6
The GFP variant mmgfp6 cDNA (Siemering et al., 1996;
Zernika-Goetz et al., 1997) was fused at its 5' end to the 3' end of
a cDNA-encoding bovine tau (Callahan and Thomas, 1994) to
generate an in-frame fusion. The fusion cDNA was inserted into
the mammalian expression vector pCAGiP (a kind gift from I.
Chambers) which uses the CAG promoter (Niwa et al., 1991) to
drive expression of the tau-GFP fusion and puromycin resistance
(Fig. la). Similar constructs containing GFP alone or GFP fused in
frame at its 3' end to the 5' end of a human tau cDNA were also
constructed.
Generation of Tau-GFP-Expressing ES Cells and
Transgenic Mice
ES cell line E14Tg2a (Hooper et al.. 1987) were maintained in the
presence of leukemia inhibitory factor (LIF) without a feeder layer
(Smith, 1991). pTP6 was linearized with Seal and introduced into
embryonic stem (ES) cells by electroporation. Ten puromycin-
resistant clones were selected and expanded for analysis. ES cells
were induced to differentiate into neurons by aggregation into
embryoid bodies (EBs) for 8 days with inclusion of retinoic acid for
the final 4 days. EBs were then dissociated and cultured in
serum-free medium on poly-D-lysine- and laminin-coated plastic
(Bain et al., 1995; Li et al., 1998). Injection of three ES clones into
blastocysts resulted in germline transrhission in two lines of
transgenic mice designated TgTP6.3 and TgTP6.4. These lines were
maintained as heterozygotes for the tau-GFP transgene.
Visualizing Mitotic Machinery in Fixed and Live
Tau-GFP ES Cells
The tau-GFP-expressing ES cell line E14Tg2aSc4TP6.3 from
which the TgTP6.3 transgenic line was derived was used for these
experiments. For live imaging, ES cells were cultured on poly-D-
lysine- and gelatin-coated glass coverslip bottomed dishes (Wilco
Wells B.V., The Netherlands) in a climate-controlled chamber (5%
C02, 37°C, humidified) on the stage of an inverted confocal
microscope. For chromosomal staining, ES cells were grown on
gelatin-coated plastic, fixed for 15 min in 4% paraformaldehyde in
PHEM buffer (Schliwa and van Blerkom, 1981) at room tempera¬
ture, permeabilized with 0.1% Triton X-100, stained in a solution
of propidium iodide containing 4 /rg/ml RNase, and mounted in
Vectashield (Vector Laboratories, Burlingame, CA). Images were
collected using an oil immersion lens.
FACS Analysis
Dissociated ES cells or cortical cells were sorted for green
fluorescence using a fluorescence activated cell sorter (FACS)
(Becton Dickinson, Rutherford, NJ) to generate histograms of green
fluorescence intensity (FL1 channel) versus cell number.
Confocal Microscopy
Cells and tissues were visualized using a Leica TCS NT confocal
microscope (Leica Microsystems, Germany). Bright-field images
were collected in the transmitted channel. GFP was detected in the
FITC (green) channel. In some cases sections were counterstained
with the nuclear dye propidium iodide which was detected in the
TRITC (red) channel. Unless otherwise stated, serial optical sec¬
tions were collected and combined. Time-lapse footage was ac¬
quired using Leica TCS NT software.
Tissue Processing for Vibratome Sections
Embryos were fixed in ice cold 4% paraformaldehyde in
phosphate-buffered saline (PBS) overnight prior to embedding in
4% low-melting-point agarose and sectioning with a Vibratome
(Technical Products International, St. Louis, MO) to produce
200-/am sections. Some preparations were counterstained with
propidium iodide before mounting in 1:1 glycerokPBS containing
10% Vectashield (Vector Laboratories).
Primary Culture of Neural Cells and Tissues
Cultures were carried out essentially as described by Lotto and
Price (1999a,b). Embryonic cortical cells were dissociated from
cortex using a papain dissociation system (Worthington Biochemi¬
cal Corporation, Freehold, NJ) and cultured on poly-D-lysine-coated
coverslips for 1 to 3 days. Organotypic slices were obtained from
embryonic brains dissected in ice-cold oxygenated Earle's balanced
salt solution and sliced into 300-/xm slices with a tissue chopper.
The regions of interest (thalamus and ventral telencephalon) were
dissected from the slices and arranged on collagen coated inserts
(Costar, UK) prior to culture for 3 days using an air interface
protocol. Slices were then fixed and imaged. For both dissociated
and organotypic culture, a defined serum-free medium was used
and cultures were fixed for between 20 and 60 min in ice cold 4%
paraformaldehyde in PBS. Some cultures were counterstained with
propidium iodide before mounting in 1:1 glycerokPBS containing
10% Vectashield (Vector Laboratories).
Production of Chimeras
Chimeras were produced as described by Tarkowski (1961)
(reviewed in Rossant and Spence, 1998). Eight-cell-stage transgenic
and nontransgenic embryos were aggregated to produce chimeras,
which were allowed to develop in vitro into blastocysts. These
were then imaged while still growing in culture medium in a
climate-controlled chamber (5% C02, 37°C, humidified) on the
stage of an inverted confocal microscope.
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Green fluorescence
FIG. 1. Expression of a tau-GFP fusion transgene in murine embryonic stem (ES) cells and TgTP6.3 transgenic mice, (a) Structure of
tau-GFP transgene. In pTP6 the tau-GFP fusion (tau-GFP) and puromycin resistance (Puro) genes are linked by an internal ribosome entry
site (IRES) and expression of both is driven by a human cytomegalovirus immediate early enhancer (HCMVIEE) coupled to the chicken
/3-actin promoter and first intron (CBA) and a bovine growth hormone polyadenylation signal (bGHpA). The plasmid was linearized with
Seal (which cuts within the ampicillin resistance (AmpR) gene) prior to introduction into ES cells by electroporation. (b-e) FACS profiles
of ES cells and cells from embryonic neocortex of TgTP6.3 transgenic mice. Histograms show green fluorescence plotted against cell
number, (c) ES cells stably transfected with pTP6 exhibit a single green fluorescent peak indicating that all cells express tau-GFP at similar
levels, (e) Cells from the El6 cerebral cortex of transgenic mice derived from these ES cells exhibit comparable green fluorescence. Profiles
of (b) untransfected ES cells and (d) embryonic neocortical cells from nontransgenic littermates indicate background levels of green
fluorescence exhibited by nonexpressing cells.
RESULTS
Generation of Tau-GFP-Expressing ES Cells and
Transgenic Mice
Linearized tau-GFP expression construct pTP6 (Fig. la)
was introduced into ES cells by electroporation. In this
construct the tau-GFP fusion protein and puromycin resis¬
tance genes are linked by an internal ribosome entry site
and expression of both is driven by a cytomegalovirus
immediate early enhancer coupled to the chicken /3-actin
promoter and first intron (Niwa et al., 1991). Ten
puromycin-resistant clones were picked at random and
expanded for analysis of tau-GFP expression. FACS analysis
of tau-GFP ES cells grown in the presence of LIF showed
that all clones exhibited broadly similar green fluorescence
intensity with the vast majority of cells being green (com¬
pare Fig. lc to untransfected control in Fig. lb). Similar
FACS profiles were also seen in ES cells stably transfected
with constructs analogous to pTP6 but which expressed
untagged GFP or an alternative GFP-tau fusion (data not
shown). Tau should cause the tau-GFP to be localized in
cellular processes including axons. To test the tau-GFP
transgene expression in neurons, tau-GFP ES cells were
differentiated into neurons by aggregating them into EBs
and growing them in the absence of LIF for 8 days with
retinoic acid included for the final 4 days. EBs were then
dissociated and cultured in serum-free medium. Compari¬
son of bright-field and fluorescence images showed that
cells with neuronal morphology continued to express the
transgene and that the tau-GFP label was distributed
evenly throughout cellular processes while being excluded
from the nucleus. All tau-GFP ES clones analyzed were of
similar appearance in this respect. This contrasted with
cells expressing untagged GFP where although the cell body
was fluorescent, the fluorescence in processes was less easy
to detect (data not shown). Three tau-GFP-expressing ES
cell clones were injected into blastocysts which were reim-
planted and allowed to develop. Germline transmission was
established for two lines. Transgenic pups could easily be
distinguished from nontransgenic littermates by examina¬
tion of ear clippings under a microscope equipped for GFP
fluorescence. Southern blot analysis (not shown) confirmed
that all animals carrying the transgene exhibited green
fluorescence.
Tau-GFP transgene expression has been maintained in both
lines over several generations. Preliminary analysis of the
TgTP6.3 line indicated that widespread tau-GFP expression
could be detected in all tissues throughout development. The
other line, TgTP6.4, exhibited strong and widespread tau-GFP
expression in many nonneural tissues but tau-GFP was al-
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FIG. 2. Confocal images showing widespread tau-GFP expression throughout development of TgTP6.3 heterozygotes. (a) Bright-field and
(b) green fluorescent images of the same field showing that at the blastocyst stage (E3.5) tau-GFP is expressed throughout two transgenic
embryos with no expression detectable in a third nontransgenic littermate. (c) Whole mount of transgenic E10.5 embryo showing expression
throughout head and body, (d) Coronal Vibratome section through head of E16 embryo showing green fluorescence throughout brain and
nonneural tissues. Bar in a, b, 20 jam; c, d( 500 /im.
most undetectable in a large proportion of the central nervous
system (CNS). Interestingly in both lines, the blood vessels
exhibited high levels of expression resulting in an unexpect¬
edly clear view of the vascular supply to the brain which was
particularly apparent in the TgTP6.4 line. The remainder of
this study focuses on the TgTP6.3 line.
In order to establish whether the tau-GFP transgene was
expressed in all cells in the CNS we examined whole mounts
and serial sections at a variety of embryonic stages (Fig. 2 and
data not shown). This suggested that expression was indeed
ubiquitous, although we would not have detected small sub¬
sets of unlabeled cells intermingled with labeled cells with
this method. When whole embryonic brain was dissociated
and plated onto coverslips we found that all cells were indeed
labeled (data not shown). To quantify tau-GFP expression in
more detail we chose embryonic cerebral cortex which con¬
tains cells at various stages of development including prolif¬
erating cells in the ventricular and subventricular zones,
postmitotic cells migrating through the intermediate zone,
and more differentiated cells in the cortical plate. Dissociated
E16 cortical cells were subjected to FACS analysis. A single
green fluorescent peak indicated that all cortical cell types
express similar levels of tau-GFP protein and that there are no
subsets of nonexpressing cells (compare Fig. le to nontrans¬
genic littermate in Fig. Id).
Tau-GFP Expression Profile during Embryonic
Development
Embryos heterozygous for a paternally derived tau-GFP
transgene were taken at various stages of development for
examination of tau-GFP expression in whole-mount prepa¬
rations. Tau-GFP-expressing embryos can first be distin¬
guished from nontransgenic littermates at the four-cell
stage indicating the onset of detectable expression (not
shown). Transgene expression becomes detectable in all
cells simultaneously. At E3.5 (blastocyst stage) the embryo
consists of several distinct cell lineages: epiblast (inner cell
mass), polar trophectoderm, and mural trophectoderm, all
of which express at similar levels (Figs. 2a and 2b). By E10.5
the embryo has undergone substantial differentiation with
head, limbs and internal organs being recognizable (Fig. 2c).
Tau-GFP expression remains widespread at this stage and
at all other ages examined throughout postnatal life (Fig. 2d
and data not shown).
Tau-GFP Efficiently Labels Long Cellular Processes
In using a tau-GFP fusion transgene we anticipated
labeling microtubule containing structures, notably the
long cellular processes which connect cells in the CNS. To
test whether this had been successfully accomplished we
looked at tau-GFP localization in cultured cells and in fiber
tracts. E16 cortex was dissociated into single cells, plated
onto coverslips, and imaged after time in culture. Tau-GFP
was present in the cytoplasm where it efficiently filled
cellular processes (compare Fig. 3b to Fig. 3a). To evaluate
our transgene as a marker of fiber tracts we chose the
thalamocortical axon (TCA) pathway (Fig. 3e) as an example
(Auladell et al., 2000). The TCA pathway consists of axons
connecting the dorsal thalamus with the cerebral cortex.
The TCA tract passes ventrally through the ventral thala-
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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mus, makes a sharp lateral turn at the hypothalamus, and
enters the ventral telencephalon through the internal cap¬
sule, before turning dorsally into the intermediate zone of
the cerebral cortex. The TCA fiber tract is highlighted by
tau-GFP label with particularly strong staining seen in the
internal capsule and intermediate zone (Fig. 3e). The direc¬
tion of fibers is apparent although individual fibers are hard
to resolve (Figs. 3f and 3h], There was strikingly reciprocity
between the localization of tau-GFP and cell nuclei (Figs.
3g and 3i). Apparent "holes" in tau-GFP labeling corre¬
spond to the nuclei of cells stained red with propidium
iodide (compare tau-GFP label in Fig. 3c with propidium
iodide staining in Fig. 3d).
Subcellular Localization of Tau-GFP in Living
Cells Reveals Mictrotubule-Containing Structures
We expected that the ability of tau-GFP to bind to
microtubules would provide a means to visualize the mi¬
crotubule component of the cytoskeleton. In living cells
these subcellular details are otherwise inaccessible.
The microtubule component of the cytoskeleton plays an
important role in cell function throughout the cell cycle
with microtubules existing in a constant state of dynamic
instability. During interphase, microtubules radiating from
a single microtubule organizing center (MTOC) fill the
cytoplasm and bundle together to form the core of develop¬
ing processes. At the onset of mitosis, the MTOC replicates
to generate two daughters, which migrate to opposing poles
of the cell. The microtubules reorganize to generate the
mitotic spindle, a structure which coordinates the equal
segregation of chromosomes to the daughter cells.
To confirm that tau-GFP labels a variety of microtubule-
containing structures we examined live preparations of
tau-GFP-expressing cells from TgTP6.3 transgenic mice
and the E14Tg2aSc4TP6.3 ES cell line from which the mice
were derived. A single optical section through live ES cells
(Fig. 4a) shows a subcellular fibrous tau-GFP labeling pat¬
tern in the cytoplasm. Live interphase cells from embryonic
heart exhibit tau-GFP label radiating from a single in¬
tensely labeled point into the cytoplasm (Fig. 4b). Neural
cells which have been dissociated and cultured exhibit long
evenly labeled processes, with a particularly strong GFP
signal extending from their base (Fig. 4c).
During mitosis tau-GFP labels the mitotic machinery.
Representative examples of fixed cells (chromosomes
stained red with the DNA stain propidium iodide) are
shown (Figs. 4d-4g). At the start of mitosis the MTOCs
replicate as the chromosomes condense (Fig. 4d). The chro¬
mosomes then congregate along the plane of division (equa¬
tor) to form the metaphase plate which is flanked (at the
poles) by the MTOCs between which the mitotic spindle is
formed (Fig. 4e) before segregating toward the MTOCs along
the mitotic spindle (Fig. 4f). Mitosis concludes as the
daughter cells separate each with a complete set of chro¬
mosomes associated with a MTOC (Fig. 4g).
The pattern of tau-GFP labeling described above is con¬
sistent with tau-GFP labeling microtubules during inter¬
phase and mitosis with particularly strong labeling seen at
the MTOC. The tau-GFP does not associate with the
FIG. 3. Tau-GFP label reveals neural processes and is excluded from the nucleus in TgTP6.3 transgenic mice, (a) Bright-field and (b) green
fluorescent images of dissociated E16 cortical cells cultured on coverslips. Tau-GFP efficiently labels all the neural processes which can
be detected by bright field microscopy, (c) Green fluorescence- and (d) propidium iodide-stained nuclei in Vibratome sections of E16 cortex.
Apparent "holes" in the tau-GFP labeling correspond to the location of nuclei showing that tau-GFP is excluded from the nucleus, (e)
Coronal Vibratome section of transgenic embryonic brain illustrating the thalamocortical axon pathway which connects the dorsal
thalamus (DT) and cerebral cortex (CC). Note the intense green fluorescence of the fiber tract in the ventral thalamus (VT), internal capsule
(ic), and intermediate zone (iz) of the cerebral cortex indicating that the entire tract is efficiently labeled, (f, h) Green fluorescence and (g,
i) propidium iodide staining in Vibratome sections of E16 brain showing (f, g) intermediate zone and (h, i) internal capsule. Note the
reciprocity of tau-GFP and propidium iodide staining which accounts for the intense labeling in fiber tracts compared to regions of high
nuclear packing density. Bar in a-d, 20 pm; e, 500 /xm; f-i, 100 /im.
FIG. 4. Confocal imaging of tau-GFP in living cells allows visualization of subcellular structures and reveals the filamentous microtubule
network, (a-c) Tau-GFP labeling of living interphase cells, (a) Filamentous tau-GFP labeling in live ES cells, (b) Tau-GFP labeling radiates
from a single point in embryonic heart cells (see also cell in top left-hand corner of a), (c) Tau-GFP labels growing processes in cultured
neurons, (d-k) Tau-GFP labels the mitotic machinery in dividing ES cells, (d-g) In fixed cells representing key stages of mitosis tau-GFP
labeling can be seen as green spots that correspond to the expected position occupied by the MTOCs. Chromosomes are stained red. The
location of the spots of tau-GFP label relative to the chromosomes matches the location occupied by the MTOCs after they: (d) replicate
during prophase to coincide with chromosome condensation and the onset of mitosis; (e) flank the chromosomes as they line up along the
plane of division (equator) during metaphase; and (f, g) segregate to the opposite poles of the cell occupied by the MTOCs at anaphase, (h-k)
Confocal images selected from time-lapse footage of a live tau-GFP-expressing ES cell undergoing mitosis. The position of tau-GFP labeling
matches the position occupied by the mitotic spindle as the cell divides, (h, i) Intense tau-GFP labeling can be seen perpendicular to and
symmetrically arranged around the plane of cell division as the cell undergoes metaphase. (j, k) The cell proceeds (j) through anaphase and
(k) telophase to generate two daughter cells (the lower daughter cell is not included in this optical section). Pairs of yellow bars in (h-k)
mark the plane of cell division. Note that the mitotic spindle appears much more strongly labeled in live cells (h, i) than in fixed cells at
comparable stages of mitosis (e, f). Images in (a, d-g, i-k) are single optical sections chosen to emphasize subcellular detail. Bar in a, c-k,
5 pm; b, 10 pm.
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chromosomes themselves as propidium iodide and tau-GFP
label do not colocalize (Figs. 4e-4g).
Time-lapse footage of a tau-GFP-expressing ES cell un¬
dergoing cell division shows that tau-GFP permits visual¬
ization of the mitotic machinery as mitosis proceeds. Im¬
ages selected from this time-lapse footage are shown (Figs.
4h-4k). Tau-GFP labels an oval structure reminiscent of
the mitotic spindle (Figs. 4h— 4i) in a cell, which goes on to
divide (Figs. 4j-k). A strong signal corresponds to the
microtubule-rich midbody which forms at the constriction
between daughter cells (Fig. 4k). Tau-GFP label is excluded
from the chromosomes, which can therefore be visualized
(particularly clear in Fig. 4j but also apparent in Figs. 4h-4i).
These patterns of tau-GFP labeling resemble the distri¬
bution of microtubules within the cell during different
phases of the cell cycle (Waters et al., 1993) and are
consistent with the localization of ectopically expressed tau
protein reported by others (Ludin and Matus, 1998; Kaech et
al., 1996; Preuss and Mandelkow, 1998; Mills et al., 1998;
Rodriguez et al., 1999) where tau decorates the microtubule
component of the cytoskeleton.
Tau-GFP-Labeled Cells Are Readily Detected in a
Variety of Cell-Mixing Experiments
We anticipate that a major application of these mice is as
a universal source of tau-GFP-labeled cells for cell-mixing
experiments. Therefore, we next assessed the properties of
our cells in three types of cell-mixing paradigm.
The production of chimeras allows analysis of cellular
interactions throughout development (Rossant and Spence,
1998). As the onset of transgene expression occurs in the
first few days after fertilization, we wanted to test whether
we could distinguish between transgenic and nontransgenic
cells in early embryos. We generated chimeras by aggregat¬
ing eight-cell-stage transgenic and nontransgenic embryos.
These chimeras were cultured and imaged while still alive.
Fluorescent images of two such chimeras undergoing blas-
tocoel formation, in which labeled and unlabeled cells have
become intermingled, are shown in Fig. 5. In one chimera
(Fig. 5a) numbers of transgenic and nontransgenic cells are
balanced and in the other (Fig. 5b) transgenic cells are more
abundant than nontransgenic cells. Note that the tau-GFP
label allows the nuclear position of expressing cells within
the chimera to be mapped. Nonexpressing cells derived
from the nontransgenic embryo appear as gaps in the green
fluorescence.
Coculture of dissociated cells is often used to investigate
how the behavior of one cell population is influenced by
proximity to another. To test the use of our cells in this
type of experiment, dissociated cells from transgenic and
nontransgenic El6 cortex were mixed and cultured after
plating onto coverslips. Bright-field images of such a cocul¬
ture show a tangle of cellular processes where it is very
difficult to assign a particular process to a particular cell
(Fig. 5c). This is resolved by examining the fluorescence
image, where tau-GFP clearly marks the morphology of
transgenic cells and allows the course of their processes to
be traced (Fig. 5d, nuclei counterstained red mark positions
of cell bodies of both expressing and nonexpressing cells).
Organotypic coculture is often used to investigate how
axons generated by one tissue respond when challenged
with the environment supplied by a second tissue. Axons in
organotypic coculture typically travel longer distances than
is seen in cultures of dissociated cells and we wanted to
confirm that tau-GFP labeling was efficient over longer
distances. In vivo, TCAs travel from the thalamus to the
cortex via the ventral telencephalon. In vitro, thalamic
explants innervate explants of ventral telencephalon. Ex-
plants of transgenic El6 thalamus were cultured with
explants of nontransgenic ventral telencephalon. After 3
days in culture the explants were fixed and imaged. Tau-
GFP-labeled fibers, which have grown into the unlabeled
explant, were clearly visible (Fig. 5e) and at higher power
individual fibers could be clearly resolved (Fig. 5f). In some
of these cultures labeled cells migrated into unlabeled
tissues and integrated into them. Examples of such cells are
shown in Fig. 5g.
DISCUSSION
We have produced a line of transgenic mice which ubiq¬
uitously express a tau-tagged GFP protein. Since transgenic
mice ubiquitously expressing untagged GFP are already
available (Okabe et al., 1997; Hadjantonakis et al., 1998), it
is important to emphasize the benefits of each labeling
system. Untagged GFP diffuses throughout the cell freely so
a labeled cell generates a uniform fluorescent signal, al¬
though the cell body tends to fluoresce much more strongly
than thin processes. Axons of cells transfected with soluble
GFP are less easy to detect than those of cells transfected
with tau-tagged GFP (this study; Rohm et al., 2000). Tau-
tagged GFP decorates the microtubule component of the
cytoskeleton and is excluded from the interphase nucleus
(this study; Ludin and Matus, 1998; Kaech et al., 1996;
Preuss and Mandelkow, 1998; Mills et al., 1998; Rodriguez
et al., 1999). This allows cellular features to be visualized in
cells expressing tau-GFP which are less clear in cells
expressing soluble GFP. For example, cell division can be
tracked by watching the fluorescent signal generated by
tau-GFP decorating the mitotic machinery, and alterations
in microtubule organization are also associated with other
processes such as cell death and migration. A potential
benefit of tau-tagged GFP over untagged GFP is that the
tagged version is anchored to the cytoskeleton so is less
likely to diffuse out of cells during tissue processing result¬
ing in loss of signal and increased background. This prob¬
lem was reported for a line of transgenic mice expressing
GFP where live preparations had to be perfused to wash
away leaking GFP (Van den Pol and Ghosh, 1998). In the
present study, slices of tau-GFP-expressing tissue can be
cultured in contact with unlabeled tissue without any
obvious deterioration of signal caused by GFP leaking from
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FIG. 5. Tau-GFP-labeled cells are easily detected in a variety of cell mixing paradigms, (a, b) Blastocyst stage aggregation chimeras
between transgenic and nontransgenic embryos. These chimeras were generated by G. MacKay. Fluorescent confocal images show (a) a
balanced chimera and (b) an unbalanced chimera in which most of the cells are of transgenic origin. In each case the position of labeled cells
can easily be mapped. The nuclear exclusion of tau-GFP facilitates the counting of labeled cells, (c) Bright-field and (d) fluorescent confocal
images of a mixed coculture of dissociated transgenic and nontransgenic cortex. Note that the morphology of cells expressing tau-GFP is
clearly marked by green fluorescence,- nuclei are stained red to aid comparison of fields, (e-g) Confocal images of organotypic coculture of
tau-GFP-expressing thalamus with nontransgenic ventral telencephalon, (e, f) Green fibers can clearly be seen as they enter unlabeled tissue
(demarcated by dotted lines in (e)) with higher magnification in (f). (g) Visualization of tau-GFP-labeled cells which have integrated into
unlabeled tissue (gray scale of fluorescent image). Bar in a, b, g, 20 /im; c, d, 10 /xm; e, 500 p.m; f, 200 (im.
the explant and the tau-GFP label remains detectable in
fixed tissue preparations after immunostaining for several
other proteins (data not shown). Tau-tagged GFP therefore
appears to be a more robust label than soluble GFP with the
advantage of illuminating the microtubule component of
the cytoskeleton.
Fixation of tau-GFP-labeled cells using the methods
employed in this study does not obviously result in a
decrease in GFP fluorescence since labeled and unlabeled
cells and their processes could easily be distinguished in
live and fixed preparations. Fixation, even when using
protocols specifically developed to preserve microtubule
structure (Schliwa and van Blerkom, 1981; Waters et al.,
1993), does however appear to alter the subcellular distri¬
bution of tau-GFP. For example, comparison of tau-GFP
labeling of the mitotic machinery in fixed and live cells
reveals that whereas in live cells the mitotic spindle is very
clearly labeled, in fixed cells it appeared much fainter and
the clearest fluorescent features are the MTOCs between
which the spindle forms. In general, fixation appears to
cause tau-GFP label to become "hazy" compared to the
sharply defined tau-GFP labeling seen in live cells, but does
not result in significant deterioration in the quality of
labeling above the subcellular level.
Of particular interest to us is that the tau-GFP is effi¬
ciently transported down cellular extensions and therefore
labels axons and fiber tracts. These can easily be detected
when growing in among unlabeled cells so providing a
useful tool for investigating axon pathfinding, in identifying
neural connections for use in electrophysiological record¬
ings, and in assessing the success with which transplanted
cells integrate into host tissues and form appropriate con¬
nections. In cell-mixing experiments, it was possible to
view the GFP fluorescence of cultures while they were
growing so providing a dynamic view of axon navigation.
Without this label the cells of interest are obscured by the
cells or tissues providing the host environment. The use of
tau-GFP obviates the need for tissue processing before the
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signal can be revealed. This is not generally the case with
carbocyanine dye labeling or immunostaining, which can
take, days or weeks and complicates the option of observing
or manipulating identified cells while they are still alive.
The ability of tau-GFP to decorate microtubules allows
the visualization of the microtubule containing cytoskel-
eton at a subcellular level. In proliferating cells expressing
tau-GFP, we show that the pattern of tau-GFP labeling can
be used to identify phases of the cell cycle. The breakdown
of the nuclear envelope is indicated as tau-GFP, excluded
from the nucleus during interphase, fills the cell. The
MTOCs are strongly labeled allowing their replication and
movement to be tracked and the formation and orientation
of the mitotic spindle is also apparent. Intense GFP labeling
corresponding to the point at which the daughter cells
separate signals the end of mitosis. Although not addressed
in such detail as cell division in this study, the indications
are that changes in microtubule structure associated with
cell differentiation, migration, and death should also be
apparent.
Although the transgene is ubiquitously expressed, the
subcellular localization of tau-GFP causes certain anatomi¬
cal features to be highlighted. In the brain, for example,
fiber tracts appear bright, regions of high nuclear packing
density appear dim, and blood vessels and membranes
(which are richly supplied with blood vessels) also appear
bright. These features can be used to provide fluorescent
anatomical landmarks which are useful when targeting
brain regions for dissection or injection.
One possible concern in using cells or tissues from these
mice is that ectopic expression of tau-GFP might compromise
cell function. Tau is a microtubule-binding protein, which is
usually only found in axons. Furthermore, disruption of nor¬
mal tau function is associated with neurodegenerative disor¬
ders such as Alzheimer's disease (reviewed in Lee and Tro-
janowski, 1999) although transgenic mice lacking tau protein
appeared to develop relatively normally (Harada et al., 1994)
and neurodegenerative pathology was not reported in trans¬
genic mice ectopically expressing a tau isoform similar to the
one we used to tag GFP (Gotz et al., 1995). Ectopic expression
of a tau-GFP fusion protein might disrupt cell function by in
some way interfering with microtubule assembly or predis¬
posing transgenic animals to neural pathological disorders
resembling Alzheimer's disease. A second concern is that as
the transgene was introduced as a random integration event, it
is possible that this insertion event mutagenized an unknown
genomic locus.
In this study, expression of our transgene has no obvious
deleterious consequences. Ubiquitously expressing ES cells
can proliferate and contribute to the germline and ubiqui¬
tously expressing mice heterozygous for the transgene ap¬
pear to develop normally and are fertile. In addition, trans¬
genic mouse lines expressing tau-tagged GFP (Rodriguez et
al., 1999) and LacZ (Mombaerts et al., 1996) in subsets of
postmitotic neurons have been produced with no report of
altered behavior. It cannot be ruled out that more subtle
cell-type-specific phenotypes will be identified with more
detailed analysis. Experiments using these ES cells and
animals should be designed with controls for possible
effects of the transgene in whatever system is being studied.
These transgenic mice were produced via the generation
of ES cells ubiquitously expressing tau-GFP protein. The
use of a bicistronic expression vector in which tau-GFP
expression was linked to puromycin resistance allowed for
selection of stably expressing clones with puromycin so
obviating screening for fluorescent clones. The similar
fluorescence of all clones picked confirms the success of
this strategy. It was also possible to screen the ES cells for
likely suitability in generating a useful transgenic mouse.
In this case we were interested in marking neurons so we
took advantage of the potential of ES cells to differentiate
into neurons in vitro (Bain et al., 1995; Li et al., 1998). If
there were ES clones which switched off tau-GFP during
the differentiation, or had for some reason become incom¬
petent to differentiate, then these could be discarded at this
stage. In this study, all clones could be induced to differen¬
tiate into cells with neuronal morphology which expressed
tau-GFP in their processes and three were picked for
generation of transgenic mice. Surprisingly, of two lines
generated only one (TgTP6.3) exhibited strong tau-GFP
expression in the brain although tau-GFP was expressed in
other tissues in both. The incomplete success of this
screening strategy emphasizes the care that must be taken
in extrapolating from neurons derived from ES cells to the
full repertoire of neuronal subtypes present in the brain.
Long-term cell-mixing experiments such as transplants
and chimeras where labeled cell populations must remain
identifiable for weeks or months after the experiment is
started demand that the label must be stable. Our cells fit
these criteria since tau-GFP expression is ubiquitous both
in ES cells before and after differentiation in vitro and in all
cells from transgenic mice derived from these ES cells. A
cell carrying our transgene and its descendants should
therefore be detectable indefinitely.
These tau-GFP-expressing ES cells and TgTP6.3 trans¬
genic mice can be used as a source of labeled cells of any cell
type for use in short- or long-term cell-mixing experiments
or to establish cell lines. Transgenic "donor" cells and
tissues can be visualized in exquisite detail after mixing and
culture with nontransgenic host tissues demonstrating the
value of our cells in cell mixing applications such as those
involved in the development of neural transplantation
technologies (Isacson et al., 1995; Scheffler et al., 1999;
Svendsen and Smith, 1999). Genetic modifications to the
labeled cells can be achieved by manipulating the ES cells
or by breeding the transgenic mice to place the tau-GFP
transgene on different genetic backgrounds.
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The cerebral cortex develops from the dorsal telencephalon, at the
anterior end of the neural tube. Neurons are generated by cell
division at the inner surface of the telencephalic wall (in the
ventricular zone) and migrate towards its outer surface, where they
complete their differentiation. Recent studies have suggested that
the transcription factor Pax6 is important for regulation of cell
proliferation, migration and differentiation at various sites in the
CNS. This gene is widely expressed from neural plate stage in the
developing CNS, including the embryonic cerebral cortex, where it is
required for radial glial cell development and neuronal migration.
We report new findings indicating that, in the absence of PaxB,
proliferative rates in the early embryonic cortex are increased and
the differentiation of many cortical cells is defective. A major
question concerns the degree to which cortical defects in the
absence of Pax6 are a direct consequence of losing the gene
function from defective cells themselves, rather than being second¬
ary to abnormalities in other cells. Cortical defects in the absence
of Pax6 become much more pronounced later in cortical develop¬
ment, and we propose that many result from a compounding of
abnormalities in proliferation and differentiation that first appear at
the onset of corticogenesis.
Introduction
The cerebral cortex arises from a sheet of undifferentiated
neuroepithelial cells that line the lateral ventricle of the dorsal
telencephalon. During development, cells proliferate in the
ventricular zone and, following their final cell division, migrate
along radial glia through the overlying intermediate zone to the
cortical plate (Angevine and Sidman, 1961; Rakic, 1974, 1988).
On arrival in the cortical plate, cells assume progressively more
superficial positions to form the six layers of the adult cortex
in an inside-first, outside-last sequence. The laminar identity of
deep layer neurons is determined by cues in the ventricular zone,
just prior to final mitotic division (McConnell and Kaznowski,
1991). The laminar identity of superficial layer neurons is
probably determined by restriction of the developmental
potential of progenitor cells (Frantz and McConnell, 1996).
The transcription factor Pax6 encodes two DNA-binding
motifs, a paired domain (Bopp etal.., 1986; Treisman etal., 1991)
and a paired-like homeodomain (Frigerio etal., 1986). In mice, it
is first expressed on embryonic day 8.5 (E8.5) in the developing
eyes, nasal structures, spinal cord and forebrain, including the
telencephalon (Walther and Gruss, 1991; Stoykova and Gruss,
1994; Grindley et al., 1995, 1997; Mastick et al., 1997; Warren
and Price, 1997). Within the telencephalon, Pax6 expression is
restricted to the ventricular zone (where neurogenesis primarily
occurs) and to the subventricular zone (where gliogenesis pri¬
marily occurs) of the dorsal telencephalon (Caric et al, 1997;
Gotz et al., 1998). Pax6 expression persists in both these regions
throughout neurogenesis and gliogenesis, suggesting that it
may play a role in these processes. Mutations in the mouse
Pax6gene result in the small eye phenotype (Hill et al., 1991).
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Homozygotes have severe defects of the eyes, face and central
nervous system (CNS), including the cerebral cortex, and die at
birth (Hogan et al., 1986; Schmahl et al., 1993; Quinn et al,
1996; Stoykova et al, 1996; Caric et al, 1997; Grindley et al,
1997; Warren and Price, 1997; Gotz etal, 1998).
Earlier studies of the small eye cerebral cortex have shown
that the ventricular and subventricular zones are enlarged, the
cortical plate is thinner than normal and within the intermediate
zone there are clusters of cells characteristic of the subven¬
tricular zone (Schmahl et al, 1993; Caric et al., 1997). It has
been shown that reduced migration of late-born cortical
precursors contributes to this phenotype, whereas early-born
cortical precursors appear to migrate relatively normally (Caric
etal, 1997). The cells that fail to migrate in the absence ofPax6
accumulate in the subventricular and intermediate zones, form¬
ing progressively more obvious cell-dense masses that show no
overt signs of differentiation as the Sey/Sey embryo approaches
term (Schmahl et al, 1993; Caric et al, 1997). In fact, these
collections of cells do express the early neuronal marker
Tujl (Caric et al, 1997), but in other respects their state of
differentiation has not been characterized. Here we report new
findings indicating that many of these cells become specified to
a neuronal fate but that they are defective in the expression
of molecules characteristic of normal mature cortical neurons.
The first part of this conclusion was drawn from studies of the
expression of the Sox11 gene in the cortex of Sey/Sey embryos.
Soxl 1 is a member of the Sox faipily of transcription factors
containing a DNA-binding motif termed the HMG box. It is
expressed in the developing CNS from E8.5 and is thought to
play a role in early stages of neuronal differentiation (Hargrave et
al, 1997). The second part of this conclusion was drawn from
studies of the expression of the genes encoding the high affinity
receptors for the neurotrophins, trkB (Klein et al, 1989,
1990) and trkC (Lamballe et al, 1994), and the low affinity
neurotrophin receptor, p75 (Chao and Hempstead, 1995). These
receptors are expressed during normal neuronal differentiation,
usually in association with sites of innervation (reviewed by
Barbacid, 1994). They are expressed in developing embryonic
cortical neurons, including those relatively mature neurons that
have migrated into the cortical plate. Expression of these
receptors was lacking in the cells that accumulated beneath the
cortical plate in the Sey/Sey cortex. Since the neurotrophins and
their receptors have been implicated in the regulation of cell
survival (Barde, 1989; Lewin and Barde, 1996), we examined
rates of cell death in the cortex of normal and Sey/Sey embryos,
but found no differences.
The primary cause of the cortical defects in Sey/Sey mice
remains unclear. It is important to discover this, since it will
indicate more clearly what the direct actions of Pax6 are in the
control of cortical development. To test the hypothesis that the
defect in late migration is due to a cell-autonomous defect in the
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Sey/Sey precursors, these cells were labelled and transplanted
into wild-type embryonic rat brains to follow their migration
and developmental potential into postnatal life (Caric et al,
1997). Sey/Sey cortical precursors showed similar integrative,
migrational and differentiative abilities to those of transplanted
wild-type mouse precursors. These results suggested that late-
born cells in the mutants have a non-autonomous defect of
migration that results from an abnormality in their environment.
Subsequendy, it has been reported that radial glial cells (which
are present in Sey/Sey cortex) (Caric et al., 1997) require Pax6
for their normal development and that at least some aspects
of this requirement may be cell-autonomous (Gotz et al., 1998).
Thus, it is likely that defects of the glial environment of migrating
neuronal precursors make a contribution to the late migratory
defects observed in the cortex of Sey/Sey mice. The question
remains of whether a glial cell defect can explain all the ab¬
normalities of the small eye cortex.
All these recent studies have focused on the later stages of
cortical development in Sey/Sey mice, when secondary defects
are likely to be numerous (Caric et al, 1997; Gotz et al., 1998).
In addition to defects of cortical radial glial cells (Gotz et al.,
1998), it is possible that the numerous extracortical defects
present in the Sey/Sey embryo contribute to the late embryonic
cortical phenotype. For example, diencephalic afferents grow to
the cortex about midway through cortical neurogenesis in the
mouse (Ferrer et al., 1992; Lotto and Price, 1995) and normal
diencephalic afferent innervation has been suggested to influ¬
ence the migration of cells in the cerebral cortex (Price and
Lotto, 1996). In Sey/Sey embryos, the diencephalon is reduced
in size and is not normally differentiated (Stoykova et al., 1996;
Warren and Price, 1997). Using molecular markers of different
regions of the diencephalon including Dlxl and Dlx2, Gbx2
and Wnt3, it has been shown (Stoykova et al, 1996; Warren et
al., 1997) that the major subdivisions of the diencephalon are
still present in the Sey/Sey forebrain, although specification of
discrete nuclei is disrupted. Our more recent work (unpublished
observations) has indicated that the dorsal thalamus, which
is normally the source of thalamocortical axons, may be re-
specified in the mutants, expressing ventral markers and failing
to innervate the cerebral cortex.
Here we considered the possibility that Pax6 may be playing
a crucial role much earlier in corticogenesis, well before
thalamocortical innervation. Given that Pax6 is required for
the correct regulation of diencephalic precursor proliferation
(Warren and Price, 1997) and is expressed in the cortical
ventricular zone, we tested whether Pax6 regulates cell pro¬
liferation in the cortex by pulse-labelling with bromodeoxy-
uridine. We observed changes in the proliferation of cortical
progenitors as early as El0.5. We then considered whether these
might be due to changes in the expression of BF1, another
transcription factor that is known to regulate cortical prolif¬
eration (Xuan et al., 1995). BF1 is a member of the winged-helix
family of transcription factors, expressed in the telencephalon
and nasal half of the optic stalk from E8 (Tao and Lai, 1992;
Hatini et al., 1994). Expression of BFl was not altered in the
mutants.
Taking our new results together with published and prelim¬
inary data suggesting that Pax6 regulates cell-cell adhesion (see
Discussion), we suggest that Pax6 plays an important primary
role in regulating the proliferation and adhesiveness of cortical
progenitors from a very early stage of corticogenesis. Loss of the
gene may result in the overproduction of cortical cells that are
more adhesive that normal. This may lead to problems with
migration that become more severe as more and more cortical
cells accumulate below the cortical plate. Further primary and
secondary defects appearing later in corticogenesis may
compound this problem and lead to the striking phenotype seen




Adult Sey/+ mice (on a Swiss background) are distinguished by their
abnormally small eyes. Sey/Sey mice die at birth and Sey/Sey embryos
were derived from Sey/+ x Sey/+ matings. The morning of a vaginal plug
was designated E0.5. Homozygotes were recognized by the absence
of eyes and a shortened snout (Hogan et al., 1986; Hill et al, 1991).
Wild-type embryos were derived from +/+ x +/♦ matings (Swiss outbred
strain).
Precursor Proliferation
Pregnant mothers were injected with bromodeoxyuridine (BrdU; 70 pg/g
in sterile saline i.p.) on E10.5, E12.5 and El 5.5 and killed by cervical
dislocation after 30 min. Fetuses were fixed in 4% paraformaldehyde and
embedded in wax. E10.5 embryos were sectioned coronally at 10 pm.
E12.5 and E15.5 embryos were sectioned parasagittal^ at 10 pm. The
sections were reacted to reveal BrdU as described (Gillies and Price,
1993). Sections were lightly counterstained with cresyl violet.
To estimate proliferative rates in E10.5 embryos, average labelling
indices (Lis) in the proliferative zone of the dorsal telencephalon were
obtained (LI: labelled cells as a proportion of total cells; Takahashi et al.,
1993). Lis were calculated from three equally spaced sections through the
dorsal telencephalon. Care was taken to ensure that the Lis were not
obtained from the ganglionic eminence, a region that does not express
Pax6.
In older embryos (El 2. 5-E15 5), proliferating cells were counted in
parasagittal sections of the neocortex. Quantified sections were from
medial, lateral and intermediate (one-third of the distance from the medial
to the lateral edge of the brain) positions. The densities of BrdU positive
cells in the proliferative zone were estimated in 150 pm wide bins
through its entire depth (three equally spaced bins per section). For each
embryo, the average density of BrdU labelled cells in the proliferative
zone was calculated and then multiplied by the volume of the proliferative
zone in that hemisphere to give an estimate of the total numbers of
proliferating cells. Hie volume of the proliferative zone was estimated
from a series of sections (l-in-9) using a computer image analysis system
(NIH Image).
In Situ Hybridizations
Digoxigenin-labelled RNA antisense probes were prepared as described
previously (Warren and Price, 1997). Pax6 and BFl plasmids were
provided by J. Rubenstein; Sox11 plasmid was provided by M. Hargrave;
trkB and trkC plasmids were provided by Bristol-Myers Squibb. Sense
probes were synthesized for controls. E10.5, E12.5, E14.5, E16.5 and
El9.5 embryos were dissected from anaesthetized mothers (0.3 ml
urethane in sterile saline, i.p.) in phosphate buffered saline (PBS) at 4°C
and fixed for 3-12 h in 4% paraformaldehyde + 0.2 mM egtazic acid
(EGTA) at 4°C.The embryos were embedded in wax, sectioned coronally
at 6 pm and collected on TESPA-coated slides. In situ hybridizations were
performed as described (Wilkinson, 1992).
Immunohistochemistry
El7.5 Sey/Sey and +/+ cortices were dissected and sectioned at 5 pm.
Immunohistochemistry was carried out with an antibody against the low
affinity neurotrophin receptor, p75 (Chemicon), using standard methods.
The primary antibody was detected with a biotinylated secondary
antibody and FITC-avidin (Vector laboratories).
RNAse Protection Assay
Total RNA was extracted from dissected cortices (cortical plate and
proliferative zone, but not striatum) of El 9.5 wild-type or Sey/Sey
embryos using the RNeasy kit (Qiagen). Ribonuclease protection
assay (RPA) was carried out (using the RPAII kit; Ambion) with
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digoxigenin-Iabelled RNA probes to trkB (pFRKl6, Klein et al., 1990;
probe detects both full-length and truncated versions), trkC (pFL25,
Lamballe et al., 1994; probe detects both full-length and truncated
versions) or fi-actin (supplied with kit). Protected RNA products (trkC,
520 nucleotides; trkB, 500 nucleotides; fi-actin, 250 nucleotides) were
separated on a 4% polyacrylamide/urea gel, transferred to a nylon
membrane and detected by exposure to film after using the digoxigenin
detection system (Boehringer Mannheim) with CDP-Star (Tropix) as a
chemiluminescent substrate. Autoradiographs were scanned using a
Biorad densitometer and band intensity quantified using Molecular
Analyst software. Levels of P-actin were used to normalize trkB and trkC
mRNA levels.
Cell Death
El7.5 Sey/Sey and +/+ cortices (four of each) were dissected, embedded
in wax and sectioned at 5 gm. TdT-mediated dUTP nick ending labelling
(TUNEL) was performed as described (Gavrieli et al., 1992). Positive
controls were done by preincubating sections with 10 gg/ml DNasel; for
negative controls, TdT was omitted. Sections at regular intervals (25, 50
and 75% of the distance between the anterior and posterior poles of the
cortex) were quantified by superimposing grids spanning the full depth
of the cortical wall and counting the numbers ofTUNEbpositive cells and
the total numbers of cells within them. The proportions of cells that were
TUNEL positive were averaged across all mutant and wild-type brains and
compared with Student's f-tcst.
Results
Early Defect in Cell Proliferation
To study the proliferation of cells in the developing dorsal
telencephalon at E10.5, we measured the proportions of cells
labelled by a 30 min pulse of BrdU (the labelling indices, Lis). As
illustrated in Figure 1, there was a significant increase in the LI
in Sey/Sey embryos (n ■ 3) compared to +/+ embryos (« « 3)
(Student's ttest; P < 0.01). Lis were also measured in the
mesencephalon, where Pax6 is not expressed, and we found no
significant differences between normal and mutant embryos
(Warren and Price, 1997).
In addition to these quantitative observations, we also noticed
that the pattern of BrdU labelling was altered in the mutants. In
E10.5 +/+ embryos, BrdU-labelled nuclei were present at the
ventricular surface of the telencephalon (arrow in Fig. IA). By
contrast there were very few BrdU-labelled nuclei at this surface
in the telencephalon of Sey/Sey embryos (arrowhead in Fig. Iff).
During normal neurogenesis, S-phase occurs in nuclei deep to
the ventricular surface that then move to undergo M-phase at this
surface (Takahashi et al., 1993). In +/+ embryos, the labelled
nuclei at the ventricular edge often had fragmented BrdU rather
than presenting a smooth nuclear profile as in the overlying
neuroepithelium; it is likely that these cells were undergoing M
phase. The absence of these nuclei in Sey/Sey telencephalon
suggests that interkinetic nuclear movement may be disrupted.
M-phase may be occurring ectopically in the middle of the
neuroepithelium or M-phase may be delayed due to elongated
S-phase or G2-phase. The shape of the BrdU-labelled nuclei
was also altered in Sey/Sey embryos, being more rounded and
less elongated than in +/+ embryos (Fig. 1), also suggestive of
disrupted interkinetic nuclear movement.
Our conclusion from these analyses of E10.5 embryos was
that, in the absence of Pax6, cell proliferation is disrupted in
several ways, including a loss of normal interkinetic movements
of progenitors and an overall increase in the proliferative rate.
Studies of older embryos indicated compatible changes in pro¬
liferation at later embryonic ages. We have described previously
how, at El2.5, the organization of proliferating cells in the
cortex, as visualized with a 30 min pulse of BrdU shortly before
F)®
<0 J*
Figure 1. High magnification views of coronal sections through the dorsal
telencephalon of A an E10.5 +/+ and B an E10.5 Sey/Sey (-/-) embryo showing BrdU
labelling. Note an increase in the proportion of BrdU-labelled cells in the Sey/Sey dorsal
telencephalon compared to +/+. Arrow in A indicates cells with fragmented BrdU
labelling; note the absence of such labelled cells at the ventricular surface in Sey/Sey
embryos (arrowhead in B). Scale bars: 25 pm.
death, is disrupted in Sey/Sey embryos in a manner similar to
that shown in Figure 1 (Caric et al., 1997). At E12.5, a 30 min
pulse of BrdU labelled significantly higher numbers of cells in
Sey/Sey embryos (57 742 ± 5291 SEM; n = 3) than in wild-type
embryos (35 043 ± 2232; n = 3; P < 0.02). These results indicate
that, during a 30 min period, more cells in the ventricular zone
are in S-phase in the mutants. The possible reasons for this
include the following: S-phase may be elongated relative to the
overall length of the cell cycle, there may be an increase in the
total number of proliferating cells, or there may be a combina¬
tion of both. By El5 5, this difference was reduced and was not
significant. The numbers of labelled cells were 127 277 ± 17 945
(n = 3) in mutant embryos and 103 683 ±15 168 (n = 3; P< 0.37)
in wild-type embryos.
Pax6 and BF1 Expression
In E10.5 +/♦ embryos, Pax6 expression was detected in the
dorsal telencephalon and at other more caudal sites, as described
previously (Walther and Gruss, 1991; Stoykova and Gruss, 1994;
Grindley et al., 1995, 1997; Mastick et al., 1997; Warren and
Price, 1997). There was variation in the intensity of staining
throughout the cortex, with labelling strongest anteriorly and
posteriorly (arrows in Fig. 2A). No expression was seen in the
ganglionic eminence (ge) of the ventral telencephalon (Fig. 2A).
By E14.5, Pax6 expression was detected uniformly thoroughout
the anterior-posterior extent of the dorsal telencephalon.
Within the proliferative zone, labelling for Pax6 expression was
more intense in the subventricular zone than in the ventricular
zone (Fig. 2B). By E16.5, staining for Pax6 expression was less
intense and was restricted to the ventricular zone (Fig. 2Q.
In El0.5 +/+ embryos, BF1 expression was detected in the
ventral telencephalon (Fig. 2D). Labelling was strongest in the
ganglionic eminence, decreased dorsally towards the developing
neocortex and was weakest at the posterior end of the cortex
(Fig. 2D). These observations suggest that different positions in
the El0.5 cortex express different relative levels of Pax6 and
BF1 (compare Fig. 2A, D). In El 4.5 +/+ embryos, staining for BF1
expression was more uniform anterior-posteriorly and was
more intense in the subventricular zone than in the ventricular
zone (Fig. 2E). These observations were similar to those for Pax6
expression: unlike Pax6 expression, BF1 expression was also
detected at the pial edge of the telencephalic wall, in the
cortical plate (Fig. 2E). In El6.5 +/+ embryos, BF1 expression





Figure 2. In situ hybridizations on sections of E10.5, E14.5 and E16.5 +/+ and Sey/Sey (-/-) embryos. A, B. C Pax6 expression in +/+ embryos. A Expression is in the cortex of
the dorsal telencephalon from E10.5 (staining is particularly strong rostroventrally and caudodorsally, arrows). B, C Expression is in the proliferative zones (the subventricular and
ventricular zones, svz and vz) of the cortical wall at E14.5 and E16.5. Dotted line in C marks the pial edge of the cortical wall; ge, ganglionic eminence. D. E. F BF1 expression in +/+
embryos. D E10.5: note expression in the ganglionic eminence of the ventral telencephalon, decreasing into the dorsal telencephalon. E E14.5: note strong expression throughout the
cortical wall, involving the proliferative zones and extending to the pial surface. F El 6.5: note strong expression throughout the cortical wall, in the cortical plate (cp), intermediate
zone (iz) and proliferative zones. G. H, IBF1 expression in Sey/Sey embryos. There is relatively normal expression of BF1 in the cortical wall of G E10.5, H E14.5 and / E16.5 mutant
embryos compared to +/+ embryos of the same age. Scale bars, A. D and G. 200 urn; rest, 100 urn.
was detected throughout the ventricular, subventricular and
intermediate zones and cortical plate, with strongest staining in
the developing cortical plate (Fig. 2F). In E10.5, E14.5 and E16.5
Sey/Sey embryos, after making allowances for morphological
abnormalities, we could detect no differences in these patterns
of BF1 expression (Fig. 2G, H, I).
In conclusion, these finding suggest that there are variations
in the expression of Pax6 and BF1 in E10.5 embryos that are
often reciprocal. Different cortical regions may have different
relative levels of expression of these two genes. These differ¬
ences appear to be lost over the following days. It appears that
Pax6 expression is not required for BF1 expression.
Sox11 Expression
In E10.5 and El2.5 +/+ embryos, Soxll expression was detected
predominantly in the ventral telencephalon in the mantle layers
of the ganglionic eminence with only a few scattered cells
stained in the proliferative zone (data not shown). Expression
was also detected in a few cells in the neocortex (Fig. 3A). By
El4.5, staining for Soxll expression was much more intense
in the developing cortical plate (Fig. 3B). It was very strong in
the superficial half of the dorsal telencephalic wall, coinciding
with the cortical plate and the upper part of the subventricular
zone (regions that would contain the most highly differentiated
postmitotic neurons). It was very weak in the deeper layers (the
ventricular zone and deeper part of the subventricular zone).
In the ventral telencephalon, Soxl 1 expression was detected in
the mantle layers of the ganglionic eminence but not in the ven¬
tricular zone (data not shown). In the region of the archicortex
that will form the hippocampus, Soxll expression was again
detected mainly among cells in the hippocampal cortical plate
and not in the ventricular zone (Fig. 3C). A similar distribution of
Soxll expression was detected at El7.5 in wild-type embryos
(data not shown).
In E10.5 and E12.5 Sey/Sey embryos, Soxll expression
appeared normal in the ganglionic eminence, an area that does
not express Pax6 (data not shown). As in wild-type embryos,
staining for Soxll was weak in the dorsal telencephalon at
these ages (Fig. 3D). In E14.5 Sey/Sey embryos, strong Soxl 1
expression was detected in the superficial half of the dorsal
telencephalic wall, as in wild-type cortex, but there was also
intense labelling of the underlying proliferative layers (Fig. 3E).
Figure 3. In situ hybridizations for Sox 11 on sections of A-C +/+ and D-F Sey/Sey [-/-) embryos. A E12.5 +/+ dorsal telencephalon: there is weak expression in the developing
neocortex (nc). B E14.5 +/+ dorsal telencephalon: there is strong expression in the cortical plate (cp) and upper subventricular zone (svz) but little in the ventricular zone (vz). C
El4.5 archicortex (hippocampal primordium): there is strong expression in the hippocampal cortical plate (he) but not in the underlying proliferative zone. 0 E12.5 Sey/Sey dorsal
telencephalon: expression was similar to that in +/+ cortex. E E14.5 Sey/Sey dorsal telencephalon: as in +/+ cortex, staining was strongest in the superficial half of the cortical
wall but there was much more than normal in the proliferative zones. F El 4.5 Sey/Sey hippocampal primordium: as in the neocortex (E). expression was present throughout the depth
of the cortical wall, including the ventricular zone, where it is normally lacking. A and D are parasagittal sections; B. C. E and F are coronal sections. Scale bars, 100 fim.
Figure 5. Localization of trkB mRNA in coronal sections of E19.5 (4) +/+ and (B, C) Sey/Sey (—/—) cortices as assessed by in-situ hybridization. Purple stain indicates the presence
of transcripts. Note the lack of trkB expression in the enlarged cell dense proliferative zone of the mutant cortex (large, pink counterstained area). Abbreviations: cp, cortical plate; iz,
intermediate zone; svz, subventricular zone; vz, ventricular zone. Scale bar, 100 |am.
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Figure 4. RNase protection assay for trkB, trkC and p-actin mRNA in total RNA
extracted from E19.5 +/+ and Sey/Sey (-/-) cortices. Protected bands: trkC, 520
nucleotides; trkB..500 nucleotides; p-actin. 250 nucleotides. Faint bands corresponding
to transcription start site and splicing variants of trkB mRNA (Klein et al.. 1990) and trkC
mRNA (Lamballe et al.. 1994) did not overlap with protected bands used for
quantification.
A similar abnormality was seen in the hippocampal primordium
(Fig. 3F). Similarly, by E17.5, Soxll expression was detected
throughout all layers of the mutant cortex, including the ven¬
tricular zone (data not shown).
In summary, our results indicate that, in both +/+ and Sey/Sey
cortex, the period of strong Soxll expression begins at a similar
time to the onset of the major phase of cortical neuronal
differentiation. In +/+ cortex, Soxll is expressed predominantly
by cells in the superficial differentiating layers, whereas in
Sey/Sey cortex it is also strongly expressed by cells in the deeper
layers, where neurons do not normally differentiate. Given that
these deeper regions contain many cells that should have
migrated into the cortical plate and that these cells express
the early neuronal marker Tujl (Caric et al., 1997), the most
parsimonious explanation of this finding is that Soxll is being
expressed by cells that are stuck below the cortical plate but are
nonetheless specified to a neuronal fate.
Loss ofNeurotrophin Receptor Expression Late in
Corticogenesis
To characterize further the cortical phenotype in small eye mice,
the expression of the genes for the high-affinity neurotrophin
receptors TrkB and TrkC was compared in Sey/Sey and wild-type
E19 5 embryos. A RPA was used to quantify the overall levels of
trkB and trkC transcripts in RNA extracted from these tissues.
Levels of ubiquitously expressed p-actin mRNA were determined
simultaneously and used to correct for differences in RNA yield
from the two types of tissue. The RPA was repeated three times
and each was quantified densitometrically; all three repeats gave
results similar to that in Figure 4, showing a large reduction in
Figure 6. Localization of p75 protein in E17.5 (A) +/+ and (B) Sey/Sey (-/-) cortices
as assessed by immunohistochemistry. Note that p75 is lacking in the cell dense
clusters in the intermediate zone/proliferative zone of the mutant cortex (arrow).
Abbreviations as in Figure 5. Scale bar, 25 urn.
the amounts of trkB and trkC transcripts relative to changes in
P-actin mRNA in Sey/Sey cortex. In-situ hybridizations indicated
that the reduction in trkB and trkC transcript levels could be
accounted for by a reduced proportion of expressing cells in the
mutants rather than a global down-regulation in expression.
Figure 5 shows expression of trkB; expression of trkC was
similar (not shown). In wild-type cortex, staining for trkB and
trkC was present in most layers (purple staining in Fig. 5A). It
was most intense in cells of the cortical plate; it was also present
in cells of the ventricular zone, and, at low levels, in cells in the
intermediate zone. In Sey/Sey cortex, trkB and trkC were
expressed in the cortical plate and at the ventricular edge of the
proliferative zone (purple staining in Fig. 5B, C), but expression
was lacking among the cells that had accumulated between the
ventricular zone and cortical plate (counterstained pink in Fig.
5B, Q. This result suggests that the failure of cells to reach the
cortical plate coincides with their failure to express receptors
characteristic of cortical plate neurons. While many of these
cells appear to express early markers of neuronal diffrentiation
[Tujl (Caric et al., 1997) and Soxll, see above], it seems that
they do not express other molecules found in more mature
neurons.
The neurotrophins also bind with low affinity to a receptor
called p75 (Chao and Hempstead, 1995). Staining with an
antibody against p75 gave a broadly similar result to the in situ
hybridizations for trkB and trkC (Fig. 6). In wild-type cortex,
staining for p75 was strongest in the cortical plate, intermediate
zone and upper part of the subventricular zone. In Sey/Sey
cortex, staining for p75 was also strongest in the cortical plate
and intermediate zone, but it was low or absent in the dense
clusters of cells that had accumulated in the intermediate and
subventricular zones. As can be seen in Figure 6, staining in the
intermediate zone outlined these clusters. This indicates that, as
for the expression of trkB and trkC, these accumulations of
cells that had failed to migrate into the cortical plate lacked
expression of receptors appropriate for their developmental age.
Cell Death
Programmed cell death during normal development is caused
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when cells activate intracellular biochemical pathways that lead
to their systematic self-destruction. This process is known as
apoptosis. Apoptosis involves fragmentation of nuclear DNA and
this can be detected by the TUNEL method used here.
Neurotrophins regulate this process; in general, the presence
of neurotrophins prevents apoptosis. In view of the results on
the expression of neurotrophin receptors, we measured rates
of apoptosis through the full depth of the cortical wall, from
ventricular edge to pia, in wild-type and Sey/Sey cortices (El7.5,
n = 4 of each). We found no significant difference (Student's
f-test); rates were similarly low in wild-type (0.090 ± 0.016%
SEM) and Sey/Sey (0.087 ± 0.022% SEM) cortices.
Discussion
Present Results and their Relationship to Previously
Published Work
Here, we report new findings suggesting increased proliferation
in the early Sey/Sey dorsal telencephalon. In broad agreement
with our results, it has also been noted (Gotz et al., 1998) that
short pulses of BrdU given to mice aged E13 5-E16.5 appeared
to label more cells in Paatf-deficient cortex than in wild type
cortex. Their study of acutely dissociated cells from wild-type
and P«*6-deficient cortex suggested that this increase was due
to an alteration of the cell cycle characteristics of the cortical
cells. As yet, it is not possible to conclude how the various
components of the cell cycle are altered. Our results may be
explained by a lengthening of S-phase relative to the length of the
cell cycle, although it is not clear how the absolute lengths of the
different components may be altered.
In further agreement with our results, Gotz et al. (1998) also
suggested that the proliferative defect in the mutants was less
apparent at the later stages of cortical neurogenesis. There is a
slight discrepancy in that their quantitative analysis of dissoci¬
ated cells suggested persistent defects to an older age than our in
vivo quantification, which showed no defects at El5.5 (this may
be accounted for by the methodological difference).
These results contrast with those from our previous analysis of
proliferation in the embryonic diencephalon. In this region, a
lack of Pax6 leads to a 50% reduction in proliferative rates from
E10.5 (Warren and Price, 1997). The telencephalon and dien¬
cephalon are both extremely complex structures and, although
adjacent in the forebrain, they differ in many ways, both
morphological and molecular. Each expresses a large number of
regulatory genes from the earliest stages of their development,
often in subregions that have specific fates (Rubenstein and
Beachy, 1998). Thus, each telencephalic and diencephalic region
expresses a characteristic cocktail of transcription factors to
which Pax6 contributes at some places and not others. It is
possible that the action of Pax6 in regulating proliferative rates
depends on what other regulatory factors that region expresses.
For example, BF1 is expressed in the developing telencephalon
and its loss severely reduces telencephalic proliferation (Xuan et
al., 1995). BF1 expression overlaps that of Pax6 in the cerebral
cortex, where its expression is maintained in the absence of
Pax6, but BF1 is not expressed in the developing diencephalon.
There are many possible ways in which Pax6 may interact with
other factors to influence proliferation. For example, Pax6
may play a modulatory role, perhaps dampening the effects of
other factors that may tend to increase proliferation rates in
the cortex (e.g. BF1 or Lhx2) (Porter et al., 1997) or decrease
proliferation rates in the diencephalon. Whether such a role is
cell-autonomous remains to be tested; there is evidence (Gotz et
al., 1998) that the numbers of at least some cortical progenitors
(those detected with radial glial markers) are affected by Pax6 on
proliferation and mediated by secreted factors.
Another of our new findings using a probe for Soxll, which
is expressed in neurons from an early stage of their development,
is compatible with our previous findings that cells that accumu¬
late beneath the cortical plate in the absence of Pax6 show signs
of early neuronal differentiation (Caric et al., 1997). Previous
work has shown that these accumulations in the late Sey/Sey
embryo comprise cells that would, in normal mice, have become
incorporated into the cortical plate (Caric et al., 1997). However,
we found that these cells lack expression of neuro- trophin
receptors that are characteristic of cortical plate cells. This
suggests that the differentiation of these cells is retarded or
prevented compared to that of cells that have entered the
cortical plate. Since these receptors are still expressed in the
cortical plate of Sey/Sey mice, Pax6 is not an absolute
requirement for their expression; rather, it may modulate
neurotrophin receptor expression. It is possible that the loss of
neurotrophin receptors in Sey/Sey mice is related to the defects
of proliferation, since neurotrophin receptors are expressed
in the ventricular zone where their activation may influence
proliferative rates (Ghosh and Greenberg, 1995). Whether the
effects of loss of Pax6 on the expression of neurotrophin
receptors are cell-autonomous or whether they are indirect
(perhaps resulting from a lack of cortical innervation; Schmahl et
al., 1993; our unpublished observations) are all open questions.
Neurotrophins and their receptors are associated with the
regulation of cell death (Barde, 1989; Lewin and Barde, 1996).
We found no evidence for an increase in cell death in the Sey/Sey
cortex (in agreement with findings of Gotz et al., 1998).
Similarly, in previous work we observed no difference from
normal in rates of cell death in the Sey/Sey embryonic
diencephalon (Warren and Price, 1997). Mice with deletions
of the neurotrophin receptors do not show a marked increase
in cell death in the cerebral cortex, perhaps because many
neurotrophic factors are expressed in the developing cortex and
there may be redundancy of action among them (Silos-Santiago et
al., 1997).
Speculations on the Primary Functions ofPax6 in, the
Developing Cerebral Cortex
The preceding discussion indicates that, despite a catalogue of
abnormalities in the cortex of Sey/Sey mice, we still have very
little information on the primary, cell-autonomous actions of
Pax6 in the regulation of cortical development. A strong
possibility is that one of the primary functions of Pax6 is to
regulate the adhesiveness of cells in which it is expressed. If
true, this might go a long way towards explaining the cortical
phenotype of the Sey/Sey embryo.
There are several lines of evidence suggesting that Pax6 may
have a cell-autonomous effect on cell-cell adhesion. In vitro
experiments have indicated that transcription factors encoded
by the Pax genes, including Pax6, bind to specific sequences
in the neural cell adhesion molecule and LI adhesion molecule
promoters (Chalepakis et al., 1994; Edelman and Jones, 1995;
Hoist et al., 1997). In vivo, it has been shown (Stoykova et al.,
1996) that loss of Pax6 leads to disruption of the boundary
between the neocortex and the lateral ganglionic eminence,
which is thought to be maintained by differential cell adhesion
(Gotz et al., 1996). They observed Dlxl-positive cells, that are
normally mainly confined to the medial and lateral ganglionic
eminences, in large numbers in the Sey/Sey neocortex. They
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suggested that this ectopic cortical expression of Dlxl in the
mutants results from abnormal migration of cells across the
border between the lateral ganglionic eminence and the cortex,
due to a loss of adhesive differences between these regions. In
later work, alterations were reported in the expression of the
homophilic adhesion molecule, R-cadherin, in the developing
cortex (Stoykova et aL, 1997). By carrying out in vitro aggrega¬
tion studies on dissociated embryonic cortical cells, we have
found evidence that those lacking Pax6 are more adhesive than
normal (shown by our own preliminary results, D. Gooday and
D.J. Price, unpublished). In the developing eye, where the study
of Sey/Sey ++ +/+ chimeras has given a clearer picture of the
cell-autonomous roles of Pax6 (Quinn et aL, 1996), it has been
proposed that the regulation of cell sorting by Pax6 is mediated
by effects on the expression of cell adhesion molecules.
The fact that migratory defects in the cortex of mice lacking
Pax6 become obvious from about midway through cortico-
genesis onwards (Schmahl et aL, 1993; Caric et aL, 1997) has
focused attention on the possibility that Pax6 plays its most
important primary roles in the cortex at relatively late stages,
during radial glial cell guided migration (Caric etal., 1997; Gotz
et al., 1998). Indeed, there is some evidence of cell autonomous
defects in radial glial cells at these stages (Gotz et aL, 1998).
However, current evidence is against a primary role for Pax6 in
the migratory capacity of late-born cortical precursors them¬
selves; if such cells are taken from Sey/Sey embryos they can
migrate apparently normally when placed into a wild-type
environment (Caric et al., 1997). Since our new data, presented
here, indicate defects of proliferation in the cortical primordium
of the Sey/Sey embryo from as early as E10.5, it is important to
consider the possibility that the abnormalities in the cortex of
Sey/Sey mice originate from primary defects at the earliest
stages of corticogenesis. It is possible that defects of cell-cell
adhesion are also present from this early time, although we have
not yet tested this; indeed, it is conceivable that adhesive defects
might account for the changes in proliferation. In the following
discussion, we consider (i) whether the various abnormalities
and their reported times of appearance in the Sey/Sey cortex
could be explained by changes in cell-cell adhesion and (ii) what
this might tell us about the actions of Pax6 in normal cortical
development.
One clue to a potentially important role for Pax6 in cortical
development comes from close analysis of data on the expression
of Pax6 in the embryonic cortex. Whereas in-situ hybridizations
from about El2.5 onwards indicate that Pax6 mRNA is ex¬
pressed by most cells in the cortical proliferative zone (Caric et
aL, 1997; present results), antibody studies have suggested that
Pax6 protein levels are very variable in this region. It appears
that only some cells contain the protein at high level, others
contain low levels or none at all (Gotz et al., 1998; our
unpublished observations). The identity of the cells that express
Pax6 protein strongly is not entirely clear, although there is
evidence that some are radial glial cells (Gotz et al., 1998).
Neither Pax6 mRNA nor Pax6 protein is present in cells that
have migrated out of the proliferating zones.
These observations indicate that Pax6 protein may be absent
from some proliferative zone cells that express Pax6 transcripts,
raising the possibility of post-transcriptional regulation of Pax6
expression in this region. One suggestion is that changes in the
levels of Pax6 protein occur as cells undergo mitosis, with the
protein being expressed at specific points in the cell cycle. Pax6
may regulate the adhesive properties of cortical precursors and
progenitors, allowing them to undergo their movements within
the ventricular zone and then migrate away from it. As a rule,
Pax6 may lower the adhesiveness of cells or alter the nature of
their adhesive interactions, allowing newborn cortical cells
to escape from the ventricular zone and/or to develop new
adhesive interactions with cells outside the proliferative zone.
Absence ofPax-6 may disturb the normal proliferative processes
in the ventricular zone and may lower the probability that
precursors can escape to the cortical plate. This may underlie the
progressive accumulation of cells in the proliferative zones as
corticogenesis continues. The build-up of these cells with
increased adhesiveness to each other may continue to lower the
chances of new precursors migrating away to the cortical plate.
This problem may be compounded by the raised proliferative
rates (the precursor cells would not only be more adhesive than
normal but there would be more of them), a lack of innervation
from subcortical structures (this innervation may normally assist
migration; Price and Lotto, 1996) and other late-acting defects
such as those in radial glia cells (Gotz et aL, 1998). The additive
effects of these problems may lead to a progressive worsening of
the abnormalities seen in the Sey/Sey cortex as corticogenesis
advances, which would explain why defects of overall cortical
structure and cell migration become obvious later in cortico¬
genesis (Caric et aL, 1997).
In this hypothesis, the fact that Sey/Sey precursor cells
migrate normally when placed in the wild-type environment
(Caric et aL, 1997) could be explained on the grounds that
dilution by wild-type cells might increase to near normal levels
the probability of mutant precursor cells being able to escape
from the ventricular zone. The normal glial environment of
the wild-type host could also allow better migration than is
possible in the Sey/Sey cortex. It is worth noting that the defects
of radial glial cells in cortex lacking Pax6, as well as the de¬
fective differentiation of cortical precursors, could both arise
as a consequence of earlier abnormalities. In conclusion, we
suggest that, while the absence of Pax6 gives rise to cortical
abnormalities that appear late in embryogenesis, the primary
defects that generate these abnormalities occur at the onset of
corticogenesis. We propose that the key roles of Pax6 in cortical
development are in the regulation of cell proliferation and/or
cell-cell adhesion.
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